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Abstract 
Hormone, Behaviour and Neuropeptide Profiles of Normal and Stressed Ewes 
Chrysanthi Fergani 
September, 2011 
 
The aim of the present study was to investigate the hormone, sexual behaviour and 
neuropeptide profiles of follicular phase ewes and examine alterations after the 
application of acute stressors. In study 1, follicular phases of intact ewes were 
synchronised with progesterone vaginal pessaries. Ewes then received saline vehicle, 
insulin (4 iu/kg) or endotoxin (LPS; 100ng/kg) at 28h after progesterone withdrawal 
(PW; time zero). In study 2, this protocol was repeated, but animals were killed at 
0h, 16h, 31h and 40h after PW and brain tissue retrieved. In study 1, there was a 
delay of 17.6h and 7.2h (P<0.05), respectively, in half the insulin-treated animals 
(‘insulin-delayed’) but not in the other half; and a delay of 22.5h and 20.7h 
(P<0.001), respectively, in all LPS-treated animals. Plasma oestradiol concentrations 
decreased after both stressors (P<0.001) and cortisol increased in all groups 
(P<0.05); whereas progesterone increased in the insulin-delayed and LPS groups only 
(P<0.05). In study 2, immunohistochemistry was used to examine transcriptional 
activation (co-expression with c-Fos) of various neuropeptides in the hypothalamus 
and preoptic area. In control ewes, the maximum percentage of dynorphin cells co-
localising c-Fos (i.e., activated) was observed at 31h after PW (52%; P<0.05), whereas 
maximum activated kisspeptin and neurokinin B cells occurred at 40h after PW (49 
and 42%, respectively; P<0.05). The percentage of activated dopamine cells 
decreased before the onset of sexual behaviour (from 70 to 26%; P<0.05) whereas β-
endorphin activation was lower during the LH surge (from 41 to 10%; P<0.05). In 
contrast, neuropeptide Y and somatostatin activation was higher during the surge 
(from 21 to 36%; P<0.08; and from 14 and 9% to 47 and 73%, respectively; P<0.05). 
However, LPS decreased the percentage of activated dynorphin cells (to 11%; 
P<0.05) and kisspeptin cells (to 22%; P<0.05). On the contrary, insulin decreased the 
percentage of activated dynorphin cells (to 27%) in two of the insulin-treated 
animals (insulin-responders) but not in the other two; whereas the percentage of 
activated kisspeptin cells increased in all insulin-treated animals (52%; P<0.05). 
Neurokinin B was not altered by either treatment. Furthermore, insulin increased 
the percentage of activated β-endorphin, neuropeptide Y and somatostatin cells in 
the ARC (to 71, 72 and 63%, respectively, P<0.05) but LPS did not have the same 
effect. In the VMN, activation of somatostatin cells was greater in all LPS treated 
animals (from 8 to 27%; P<0.05) but only in two of the insulin-treated animals (to 55 
and 76%; insulin-responders) but not in the other two (to 5 and 6%; insulin-non-
responders). These results indicate that there is a specific hormonal, behavioural and 
neuropeptide pattern during the follicular phase of intact ewes and this is disturbed 
by acute LPS or insulin administration in the late follicular phase, leading to the 
disruption of the LH surge. 
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Literature Review 
 
Introduction 
For the successful production of offspring in all mammals, it is essential for the ovum 
and sperm to be in contact at the appropriate time. This is achieved by the precise 
coordination of complex physiological and neuroendocrinological events involving the 
hypothalamic-pituitary-ovarian axis (H-P-O axis), which controls, in close synchrony, 
behaviour changes during oestrus as well as the preovulatory surge release of the 
gonadotrophin hormones. Interestingly, both reproduction and stress, (which is a 
disruptor of these events), are controlled by similar nuclei and neurotransmitters in the 
brain (Dobson et al. 2003). It is therefore useful to study pathological and physiological 
mechanisms in comparison. 
 
The GnRH network 
GnRH and the control of reproduction 
The final common pathway controlling reproductive function in vertebrates are the 
gonadotrophin releasing hormone (GnRH) neurones and their projections to the median 
eminence (ME), the site of peptide release into the pituitary portal system (Herbison 
1998). GnRH is released at the ME into the capillaries of the pituitary-portal plexus, and 
transported to gonadotrophes of the anterior pituitary to stimulate production and 
secretion of LH (luteinising hormone) and FSH (follicle stimulating hormone). From then 
on, these two hormones enter the peripheral circulation in order to reach the ovary and 
induce folliculogenesis and steroidogenesis (Skinner et al. 1995, Goodman, 1996). The 
activity of GnRH neurones, are in turn, controlled by the positive and negative feedback 
actions of the two ovarian steroids; oestradiol and progesterone (Moenter et al. 1991). 
GnRH release is also regulated by several molecules, including neurotransmitters and 
glial cell factors (Herbison 1998). There is a theory which supports that mammals have 
two forms of GnRH, GnRH I, which regulates gonadotrophin secretion, and GnRH II, 
which appears to be a neuromodulator and plays a role in sexual behaviour (Pawson et 
al. 2003) but this, has not been confirmed to date. 
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GnRH secretion mode 
During the ovine oestrous cycle, GnRH secretion can be divided into the following 
components: 1) tonic or pulsatile secretion, where groups of GnRH neurones are 
activated synchronously and the hormone is released in boluses (pulses) stimulating 
gonadal growth and steroidogenesis 2) the preovulatory GnRH surge, which consists of a 
massive and sustained release causing ovulation and luteinising the follicle in to a corpus 
luteum (CL), and possibly 3) an unknown mode of secretion responsible for the onset 
and/or maintenance of oestrous behaviour (Bowen et al. 1998). It is now well 
established that the GnRH surge is induced by the positive feedback action of oestradiol, 
whereas pulsatile GnRH secretion is controlled by the negative feedback action of both 
oestradiol and progesterone (Goodman, 1996). There is tight coupling between the 
secretory bursts of GnRH and those of LH (Clarke et al. 1987, Bowen et al. 1998) with 
one pulse of LH corresponding from one pulse of GnRH. A sustained volley of high-
frequency pulses of GnRH secretion is a fundamental step in the sequence of 
neuroendocrine events leading to ovulation during the breeding season of sheep (Barrell 
et al. 1992). 
 
GnRH neurone distribution 
Jansen et al. (1997) have identified the distribution of GnRH neurones in the sheep 
hypothalamus using neuronal tract-tracing compounds (Fig. 1). They report that the 
majority of GnRH neurones were found in the medial preoptic area (mPOA) at the level 
of the organum vasculosum of the lamina terminalis (OVLT), and these accounted for 
approximately 54% of the total GnRH neurone population. By contrast, GnRH neurones 
in the diagonal band of Broca/medial septal region (dBB/MS), anterior hypothalamic 
area/ lateral hypothalamic area (AHA/LHA) , and the arcuate nucleus (ARC) of the 
mediobasal hypothalamus (MBH) composed 15%, 22%, and 9% of the total GnRH 
population, respectively. GnRH cells that express c-Fos (a neuronal marker for 
activation) during the surge are not anatomically segregated but rather distributed 
heterogeneously among various brain regions (Jansen et al. 1997). The GnRH perikarya 
located in the mPOA are considered the most important final sites of regulation by 
neuronal populations located in the brain stem, the MBH and the mPOA and therefore 
for the generation of the GnRH surge (Dobson et al. 2003). In contrast, GnRH neurones 
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responsible for maintaining pulsatile LH secretion are speculated to reside in discrete 
regions, specifically the MBH (Jansen et al. 1997). Whether there is a distinct population 
of GnRH neurones for the control of sexual behaviour, or some of these neurones are 
able to control both events remains unknown. 
 
 
 
Fig. 1 Distribution of GnRH cell bodies in the ovine preoptic area and hypothalamus 
(Original from D. Blache).  
 
Steroid control of reproduction 
The ovarian steroid hormones oestradiol and progesterone are of central importance in 
the control of reproductive neuroendocrine function in female mammals. These 
hormones exert key regulatory actions on fertility by altering the activity of excitatory 
and inhibitory neural circuits that control the release of GnRH. Although it is known that 
both steroids exert their actions on GnRH release via nuclear receptors (Taylor et al. 
2007), the mechanisms by which ovarian hormones modulate both tonic and surge 
modes of GnRH release, as well as oestrus behaviour remain unclear. Direct 
measurements of GnRH in hypophyseal portal blood have provided strong evidence that 
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both oestradiol and progesterone inhibit GnRH pulses, and they do so by different 
mechanisms. Oestradiol alone inhibits LH (Goodman and Karsch 1980) and GnRH (Evans 
et al. 1994) pulse amplitude, whereas progesterone by itself inhibits LH (Goodman and 
Karsch 1980)and GnRH (Skinner et al. 1998) pulse frequency, an action that is enhanced 
by oestradiol (Goodman et al. 1981). However, during the late follicular phase elevated 
oestradiol triggers the preovulatory GnRH surge at the end of the follicular phase and 
initiates sexual behaviour.  
 
Steroids control the GnRH network indirectly 
GnRH neurones constitute the final common pathway of a complex neuronal network 
responding to the circulating steroid hormone milieu to control ovulation and sexual 
behaviour (Karsch et al., 1997, Caraty et al., 2002). However, steroid hormone signals do 
not impinge directly on GnRH cells as they do not possess progesterone receptors (PR) 
or oestradiol receptors subtype α (ERα; Shivers et al., 1983, Herbison and Theodosis 
1992, Lehman and Karsch, 1993, Sullivan et al. 1995, Scott et al. 2000, Skinner et al., 
2001). GnRH neurones have been reported to contain oestrogen receptor β (ERβ; 
Skynner et al., 1999; Hrabovszky et al., 2001, Herbison et al. 2001, Jansen et al., 2001, 
Skinner and Dufourny 2005) but their role is not fully elucidated, although considered 
minor (Scott et al. 2000, Orikasa and Sakuma 2003, Maeda et al., 2010) because ERβ-
knock out mice show normal fertility (Lubahn et al., 1993; Krege et al., 1998). Thus, it is 
generally accepted that cells in the brain that possess ERα are the main mediators of the 
feedback effects of steroid hormones which in turn secrete neurotransmitters to 
influence the GnRH network (Caraty et al. 1998, Herbison 1998, Smith and Jennes 2001, 
Herbison 2008). Ther phenotypes of cells that contain Erα and have been discovered to 
date are shown in Table 1. These cells are potential mediators of steroid feedback.  
 
Progesterone negative feedback 
In sheep, this action of progesterone appears to be mediated by the classical nuclear PR 
(Skinner et al. 1998), but as mentioned above, PR are generally not found in GnRH 
neurones in ewes and other species (Skinner et al. 2001). Thus, other systems most 
likely transmit the actions of progesterone to GnRH neurones. There is now general 
agreement that endogenous opioid peptides (EOP) are one of the major systems that 
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mediate progesterone negative feedback in sheep (Goodman et. al. 2004, Faradori et al. 
2005) rats (Kalra 1993). Although there are similarities in the EOP mediation of 
progesterone negative feedback in sheep, rats, and primates,there is one difference in 
this action of progesterone among these species. In rats (Goodman, 1978), the negative 
feedback action of progesterone requires the presence of oestradiol; whereas in sheep, 
progesterone alone inhibits tonic LH secretion in OVX animals (Karsch et al., 1997). OVX 
in ewes increases dynorphin concentrations in CSF collected from the third ventricle and 
preprodynorphin (PPD) mRNA in subpopulations of dynorphin neurones. Therefore it is 
hypothesised that dynorphin mediates progesterone negative feedback (Faradori et al. 
2005). 
 
Oestradiol negative feedback 
During the follicular phase oestradiol influences GnRH secretion with both negative and 
positive feedback mechanisms which are believed to be independent (Dobson etal. 
2003, Scott et al. 2000). It has been suggested that LH pulse frequency varies depending 
on the concentration of oestradiol (i.e. different parts of the brain are activated for the 
two feedback mechanisms depending on the ‘dose’ of oestradiol; Thiery and Martin 
1997). It is also believed that the neuronal cell populations that are responsible for the 
negative and positive feedback actions of oestradiol are, as mentioned above, different 
(Caraty et al. 1998). Many of the actions of oestradiol in the adult brain are thought to 
result from intracellular binding to nuclear ER (Blaustein and Olster 1989). Oestradiol 
negative feedback action on LH secretion is rapid, so classic genetic actions of oestradiol 
through nuclear receptors might not be involved in the feedback mechanism. In this 
regard, a unique non-classical action of ER was first proposed by the group led by Levine 
(McDevitt et al., 2008). In addition, it is possible that membrane ER, such as GPR30, are 
involved in the rapid suppression of GnRH/ LH secretion by oestradiol. Actually, GPR30, a 
membrane receptor of oestradiol, is also expressed in primate GnRH neurones and 
might be involved in mediating rapid oestradiol action (Noel et al., 2009). Moenter's 
group (Sun et al., 2010) has proposed that multiple mechanisms including both direct 
actions of oestradiol on GnRH neurones via GPR30 and ERβ and indirect actions via ERα 
in neurones afferent to the GnRH neurone must play a critical role in oestradiol 
feedback regulation of LH secretion.  
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Table 1. Neuronal cells that contain ERα in the ovine hypothalamus preoptic area and 
brainstem. 
 
Neurotransmitter Nucleus 
Percentage of 
cells that contain 
ERα 
Reference 
Tyrosine Hydroxylase 
(Dopamine) 
ARC 
<10% of total ER-
containing cells 
Batailler et al., 1992 
  3-5% Lehman and Karsch, 1993 
  15% Skinner and Herbison, 1997 
 POA 0% Lehman and Karsch, 1993 
  13-18% Skinner and Herbison, 1997 
 AHA 3-5% Lehman and Karsch, 1993 
  25% Skinner and Herbison, 1997 
β-endorphin ARC 15-20% Lehman and Karsch, 1993 
GABA POA 44% Herbison et al., 1993 
Neuropeptide Y ARC 3% Skinner and Herbison, 1997 
Somatostatin VMN 35% Herbison, 1995 
 ARC 13% Scanlan et al., 2003 
DβH (Noradrenaline) VLM 20-70% Simonian et al., 1998 
 NST 8-25% Scott et al., 1997 
Kisspeptin POA 50% Franceschini et al., 2006 
 ARC 93% Franceschini et al., 2006 
Glutamate ARC/VMN 52-61% Pompolo et al., 2003 
Galanin 
Hypothalamus 
and POA 
50% Tourlet et al., 2005 
GnRH POA 0% Herbison et al., 1993 
  0% Lehman and Karsch, 1993 
 
Oestradiol positive feedback 
In ruminants, oestradiol is considered as the primary “trigger” for the behavioural and 
the endocrine changes observed during the follicular phase (Fabre-Nys and Gelez 2007, 
Fabre-Nys et al.1994). Physiologically, in the ewe, as in many other species, oestradiol 
secretion from the ovarian dominant follicle(s) increases during the late follicular phase 
of the oestrous cycle. This increase exerts a ‘positive feedback’ action in central nervous 
system structures, to generate the LH surge and ovulation (Clarke et al. 1987, Caraty et 
al. 1989, Moenter et al. 1990, Goodman 1996). This is achieved both with an increase in 
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pituitary sensitivity (acting directly upon gonadotrophes to induce synthesis of GnRH 
receptors; Evans et al. 1997) together with an increase in GnRH secretion from the 
hypothalamus (Clarke and Cummins 1984). Interestingly, Ben Said et al. 2007 have 
recently reported that in two breeds of OVX ewes, the oestradiol concentration and 
duration of presence threshold for the induction of oestrus behaviour is different than 
that for the induction of the LH surge. Therefore, the activation of some oestradiol-
responsive neurones for few hours in the MBH probably corresponds to a necessary 
early step, sufficient to trigger off a chain of events leading to the induction of the 
preovulatory surge and sexual behaviour  
 
Neurotransmitters  
 
In an effort to determine which one of these sites is responsible for the generation of 
the GnRH surge, using an ovariectomised ewe model, Caraty et al. (1998), suggested 
that the primary site of oestradiol positive action for GnRH surge release is the the MBH. 
Furthermore, the implantation of a small quantity of steroids in specific brain areas has 
led to the identification of the same area as the critical site for oestradiol and 
progesterone action on female sexual behaviour (Blache et al. 1991). The synchronous 
occurrence of the GnRH surge onset and sexual behaviour onset, as well as the fact that 
oestradiol is the triggering signal for both (Fabre-Nys and Martin 1991), by acting 
primarily on the VMN, raises the question of what neuronal regulatory mechanisms 
control each of these events separately. The neurotransmitters that are expressed in 
these ER-containing cells, and transmit the oestradiol signal to the GnRH network, are 
not yet fully determined. Furthermore, changes observed in neurotransmitter signaling 
account for both the GnRH surge and oestrous behaviour and complicate the efforts to 
fully elucidate reproductive mechanisms.  
The regulation of hypothalamic GnRH secretion in the hypothalamus is provided by both 
stimulatory and inhibitory neurotransmitters/or neurohormones. As oestradiol-
receptive neurones have been identified to project to the immediate vicinity of the 
GnRH cell bodies as well as the ME it is possible that ER-expressing neuronal populations 
influence GnRH neurones at both terminal and/or cell body levels in a direct or indirect 
manner. The changes that are reported around the time of the preovulatory GnRH surge 
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concern either the surge itself or the induction of oestrous behaviour and a distinction 
between the two cannot be made in physiological situations.  
A series of neuronal systems converge on the GnRH cells to determine their output. 
Some of these are discussed below.  
 
Kisspeptin  
The G protein-coupled receptor GPR54, and its peptide ligand kisspeptin have recently 
been found in the brain and appear to play a key signalling role in the regulation of 
reproductive function in animal and human models (Pompolo et al. 2006). The Kiss 1 
gene encodes a large (132–145 amino acids) precursor that contributes to a family of 
smaller peptides, ranging from 10–54 amino acids, which act via GPR54 to stimulate 
GnRH and LH release in rodents (Navarro et al. 2005), sheep  (Messager et al. 2005), 
monkeys (Plant et al. 2006), and humans (Dhillo et al. 2005). The biologically active site 
has been mapped to a 10 amino acid sequence at the C terminal of metastin (kisspeptin 
10; Franceschini et al. 2006). While GPR54 is expressed in numerous tissues associated 
with reproductive function, there is accumulating evidence that kisspeptin acts 
predominantly at the level of the central nervous system to regulate GnRH secretion 
(Messager et al. 2005).  Furthermore, a stimulatory action on GnRH secretion was 
provided by studies showing that icv-administered kisspeptin increased GnRH levels in 
the cerebrospinal fluid within the third ventricle (3V) of the sheep brain (Messager et al. 
2005). GPR54 is expressed by GnRH neurones and is directly activated by kisspeptin to 
stimulate GnRH release in both rats and sheep (Irwig et al. 2004, Messager et al. 2005). 
Franceschini et al. (2006) have raised a highly specific antiserum against kisspeptin 10 
and determined the anatomical distribution of kisspeptin-immunoreactive cells in the 
hypothalamus of the ewe. Kisspeptin immunoreactive cells were abundant in the caudal 
ARC, the dorsomedial nucleus and the mPOA, while only a few cells were observed in 
the VMN. A small number of scattered kisspeptin10-immunoreactive cells were also 
detected alongside the walls of the third ventricle throughout its entire rostro-caudal 
extent, including within the PVN. The most striking accumulation of kisspeptin10-
immunoreactive cells was observed in the caudal ARC. Numerous varicose fibers were 
also seen running parallel to the walls of the third ventricle, some of which extending up 
to the PVN and some to the ME. These findings are consistent with the recent 
23 
 
immunofluorescent analysis of Pompolo et al (2006) with the difference that they report 
the existence of a distinct population of kisspeptin neurones in the periventricular 
nucleus (PeVN), as has been proven in rodents (Seminara, 2005). The pattern of 
distribution of kisspeptin immunoreactivity in the hypothalamus suggests a role for 
kisspeptin in the oestrogen-dependent regulation of GnRH and LH secretion in the ewe 
(Smith et al. 2005, Franceschini et al. 2006). In view of the increased association of 
kisspeptin10 fibers with blood capillaries in the ME, as well as the fact that GPR54 is 
expressed in the pituitary gland as indicated by PCR studies (Muir et al. 2001), the 
possibility that kisspeptin also act directly at the level of the pituitary gonadotrophes to 
potentiate LH secretion must also be taken into account. Furthermore Pompolo et al. 
(2006) report that GnRH and kisspeptin colocalise within cells of the POA and GnRH 
neurosecretory terminals of the ME and suggest that the two peptides might be 
cosecreted into the hypophyseal portal blood to act on the pituitary gland. However, the 
stimulatory effects in the above organ appear to be minor, as shown in rats (Navarro et 
al. 2005). In the same species, previous immunohistochemical studies failed to detect 
any kisspeptin immunoreactive cell bodies in the POA or AHA (Brailoiu et al. 2005, 
Kinoshita et al. 2005). In this species kisspeptin immunoreactive neurones were also 
detected in the PeVN and the well-defined sexually dimorphic nucleus called the 
anteroventral paraventricular nucleus (AVPV; Seminara, 2005). This difference may be 
due to species, but also due to differences in the sensitivity of detection methods. 
Within the caudal ARC of the ewe, nearly all kisspeptin immunoreactive cells co-express 
ERα compared with approximately half in the POA, indicating that there may be two 
different populations of kisspeptin neurones in this area. In rats 40–60%of kisspeptin 
neurones in the rostral PeVN of the 3V express ERα and PR (Clarkson et al. 2008), but 
similar results have not been reported in sheep. Pompolo et al. (2006) compared the 
number of immunoreactive kisspeptin neurones of ewes after ovariectomy and report 
an increase in the former cell type. This increase was observed on the ARC and not in the 
PeVN or POA kisspeptin population. This is inconsistent with findings in the rat where in 
the ARC kisspeptin mRNA expression increased after ovariectomy and decreased with 
oestradiol treatment and the reversed occurred in the PeVN and preoptic region (Smith 
et al. 2005). Therefore it can be assumed that these two kisspeptin cell populations 
represent major relays in the negative and positive feedback effects of oestrogen on 
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GnRH neurones, respectively (Dungan et.al 2006). Cells of the ARC are rapidly activated 
by oestradiol in the ewe, as indicated by c-Fos appearance within 1 h (Clarke et al. 2001). 
Furthermore, oestradiol-responsive cells of the ARC and VMH project to the BNST and 
POA (Pompolo et al. 2003, Pompolo et al. 2001), so there is a possibility that this 
pathway involves kisspeptin cells. Using GPR54- and Kiss1-null mouse models Clarkson et 
al. (2008) evaluated whether kisspeptin and/or GPR54 were essential for GnRH neurone 
activation and the LH surge. Whereas wild-type littermates all exhibited LH surges and c-
Fos in 50% of their GnRH neurones, none of the mutant mice from either line showed an 
LH surge or any GnRH neurones with c-Fos. These observations provide the first 
evidence that kisspeptin–GPR54 signaling is essential for GnRH neurone activation that 
initiates ovulation.  At present, the rodent rostral periventricular area of the 3V 
kisspeptin neurones are the only ones that meet all of the criteria necessary to be 
considered a key neural component of the positive feedback pathway: (1) They are 
sexually dimorphic favouring females in mice (Clarkson and Herbison 2006), (2) They 
express ERα and PR, (3) They project to GnRH neurones (Clarkson and Herbison, 2006), 
(4) They are activated by oestrogen positive feedback, and (5) GnRH neurones express 
GPR54 and are activated by kisspeptin (Irwig et al., 2004). This broadens considerably 
the potential roles and therapeutic possibilities for kisspeptin and GPR54 in fertility 
regulation (Clarkson et al. 2008). Contrasting results have been reported in sheep, 
where an increase in kisspeptin mRNA levels is observed in a subpopulation of ARC 
neurones just before the LH surge in ewes (Estrada et al. 2006) suggesting that this 
neuropeptide is most important in the positive feedback actions of oestradiol in this 
species. As mentioned before ovariectomy of sheep increases kisspeptin gene 
expression in the ARC, so these neurones may also play a role in steroid negative 
feedback (Smith et al. 2007). Nonetheless, it is now generally accepted that kisspeptin is 
tha major link between gonadal steroids and GnRH neurones (Carary et al., 2010). 
Recent studies have shown that nearly all kisspeptin cells in the ARC (specifically the 
middle and caudal aspects), but not the POA, co-localise two other neuropeptides that 
are important in the control of GnRH secretion: neurokinin B and dynorphin (Goodman 
et al., 2004, Goodman et al., 2007, Topaloglu et al., 2009, Lehman et al., 2010). Thus, 
this ARC cell group co-localises neuropeptides that are both stimulatory (kisspeptin) and 
inhibitory (dynorphin) to GnRH secretion (Pillon et al., 2003, Dungan et al., 2006; 
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Kauffman et al., 2007, Lehman et al., 2010) and are thus called KNDy cells (co-localising 
kisspeptin, neurokinin B and dynorphin; Cheng et al., 2009, Lehman et al., 2010a). 
 
Endogenous Opioid Peptides (EOP) 
Endogenous opioid peptides (EOP) have been implicated in mediating the feedback 
actions of oestradiol on GnRH release in several species, including the rat (Karla 1993), 
and ewe (Walsh and Clarke 1996). In this situation opioids have been regarded as a 
‘brake’ that must be removed before the GnRH surge can be initiated (Karla 1993). 
However there is also evidence that the EOP are involved in the inhibitory action of 
progesterone on GnRH release (Yang et al. 1988, Wisnant and Goodman, 1988). Opioid 
peptides can alter GnRH release via the three main receptor subtypes μ, κ and δ (Malven 
1999, Horton et al. 1987). Although all three major classes of EOP, the endorphins, 
enkephalins and dynorphins, have been shown to influence gonadotrophin secretion, 
the role of each specific one, the hypothalamic site and the mechanism by which they 
exert their inhibitory action are still largely unresolved. EOP are also involved in stress 
responses (Foradori et al. 2005) 
 
Out of all the opioid compounds found in the brain, the most attention has been given 
to the reproductive role of dynorphin (Goodman et al., 2004). Historically all three 
classes of opioids have been implicated in progesterone negative feedback, with most 
recent being dynorphin (Goodman et al. 2004, Dufourny et al. 2005). Dynorphin A is a 
member of a family of opioid peptides derived from the preprodynorphin precursor 
(PPD). PPD mRNA-expressing cells were seen in the supraoptic nucleus (SON), AHA, bed 
nucleus of the stria terminalis (BNST), VMN, dorsomedial nucleus of the hypothalamus, 
and the ARC. All of these regions also contained dynorphin A -positive cell bodies except 
for the VMN, raising the possibility that PPD is preferentially processed into other 
peptide products in the VMN (Foradori et al. 2005). Consistent with the role as steroid 
responsive cells, dynorphin cells in the sheep POA, AHA, and ARC have been shown to 
contain PR (Foradori et al. 2002). Dynorphin may also play a role in response to stress as 
a variety of stressors increase PPD mRNA expression in the PVN of sheep (Matthews et 
al. 1993). 
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There is evidence that β-endorphin is the most important opioid for oestradiol positive 
feedback for the generation of the GnRH surge. Its location is thought to be the ARC 
exclusively (Lehman and Karsch 1993, Taylor et al. 2007). Lehman and Karsch (1993) 
reported that 15±20% of ACTH/b-endorphin cells, located in the medial portion of the 
ARC, of the ewe possess ERα, while the β-endorphin content in the ARC/ME is lower 
during the surge than 10–12 h before (Domanski et al. 1991). This decreased release of 
β-endorphin by the hypothalamus during the follicular phase may be an important 
factor enabling a preovulatory release of GnRH and LH in the sheep (Pillon et al. 2003). 
Furthermore, ovine β-endorphin neurones project from the ARC directly to the POA 
(Dufourny et al. 2005) where the majority of GnRH cells are located (Lehman et al. 
1986). It should be noted, that in most studies, the method used to evaluate the role of 
β-endorphin, is the expression of pro-opiomelanocortin (POMC) gene. However, other 
POMC-derived peptides could be also involved in the control of GnRH or sexual 
behaviour in the ewe such as a-melanocyte stimulating hormone (a-MSH) known to be 
capable in female rat to inhibit LH secretion when administrated in the mPOA or in the 
ME (Gonzalez et al. 1997) and to regulate sexual behaviour (Gonzalez et al. 1993). 
Recently Pillon et al. 2003 reported that, in the ewe, a decrease of POMC mRNA occurs 
before the preovulatory surge and could be involved in the positive feedback or in the 
negative feedback induced by oestradiol occurring before the surge but that the 
variations of POMC mRNA that were observed could be also related to other events 
occurring at the time of the LH preovulatory surge such as sexual behaviour, growth 
hormone (GH) or prolactin preovulatory surges. The previous study, however, is 
contradicted by Walsh et al. (1998) who report that at the peak of the GnRH surge in 
POMC gene expression is increased in the ARC of intact ewes, respectively. There are 
several hypotheses for the role of elevated β-endorphin at the peak of the GnRH surge: 
1) its role is to terminate the GnRH surge. This would not have any impact on the LH 
surge as this has been shown to end well in advance of the fall in GnRH (Moenter et al. 
1990). 2) Its role is to terminate receptive behaviour at times when mating would not 
lead to conception (Taylor et al. 2007). 3) Increased β-endorphin release prior the surge 
acts at an inhibitory neurotransmitter to suppress the activity of a second inhibitory 
neural system that impinges on the GnRH neurones. Thus, the increase in β-endorphin 
would result in disinhibition of the GnRH neurones and result in the GnRH surge. One 
27 
 
possible neurotransmitter that might fill the role of an intermediary inhibitory neurone 
is GABA (Robinson and Kendrick 1992). 4) β-endorphin has no role in the surge-
generating mechanism and controls only pulsatile GnRH secretion (Taylor et al. 2007).  
 
Progesterone increase accompanies POMC reduction in cells that express steroid 
receptors and therefore β-endorphin is also a candidate for mediating progesterone 
negative feedback (Wisnant et al. 1992, Taylor et al. 2007). In contrast the more lateral 
areas of the ARC where there are very few, if any steroid receptive β-endorphin 
neurones did not show any change in POMC gene expression with increased 
progesterone concentrations (Taylor et al. 2007). The role of these cells remains 
unknown.  
 
Met-enkephalin is found in the paraventricular nucleus (PVN) and VMN (Taylor et al. 
2007). Recent information shows that there are sex- and steroid-associated differences 
in the met-enkephalin neurones in the PVN and suggests that they may have an 
important role in the control of LH release (Rivalland et al. 2005). Taylor et al. 2007 
report that an increase in progesterone is accompanied by a reduction of PENK 
(precursor for met-enkephalin) expression in the PVN and are therefore candidates for 
mediating progesterone negative feedback (Malven, 1999). The link between enkephalin 
neurones in the PVN and GnRH neurones is less clear. In the case of PENK although there 
are reports of a decline in mRNA expression in the VMN between luteal and follicular 
phase intact ewes (Walsh et al. 2001), this is not thought to play a role in oestradiol 
positive feedback or in the control of oestrus behaviour (Taylor et al. 2007).       
  
Recently Orphanin FQ (OFQ) a member of the EOP family has been implicated in 
reproductive endocrinology. OFQ does not exhibit appreciable binding affinity for 
classical opioid receptors rather it functions as an endogenous ligand for the opioid 
receptor like (ORL)-1 receptor (Mogil and Pasternak 2001). OFQ cells are present in the 
POA, AHA, and ARC of the hypothalamus of the rat (Neal et al. 1999). In this species this 
peptide is implicated in feeding and sexual behaviour as Sinchak et al. (1997) have 
shown that OFQ delivered into the VMN facilitates lordosis in female rats in a dose-
dependent manner. Interestingly, Foradori et al. 2007 report that dual 
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immunohistochemistry revealed an exceptionally high percentage of GnRH-
immunoreactive cells that colocalized OFQ. In addition, intracerebroventricular (icv) 
infusion of an OFQ agonist inhibited LH pulse frequency in both luteal phase and OVX 
ewes and suppressed pulse amplitude in OVX ewes. Taken together, these observations 
raise the intriguing possibility that OFQ may be acting as ultrashort feedback loop to 
synchronize GnRH pulses (Foradori et al. 2007). 
 
Neurokinin B (NKB) 
Neurokinin B is a member of the tachykinin neuropeptide family and is abundant in the 
ARC of many species (Goubillion et al., 2000, Latronico, 2009).  Dual-labelling 
experiments have shown that almost all NKB neurones (97%) express ERα (Goubillon et 
al. 2000) and the analysis of female and male brains has revealed an exceptionally 
marked female-dominant sex difference in the number of NKB neurones in the ARC 
(Goubillon et al. 2000). Central administration of a neurokinin B receptor agonist 
stimulates LH secretion in sheep and monkeys (Billings et al., 2010, Ramaswamy et al., 
2010), whereas in humans, mutations of either neurokinin B or its receptor (neurokinin 3 
receptor; NK3R) are associated with gonadotrophin deficiency and pubertal failure 
(Topaloglu et al., 2009). Moreover, many Neurokinin B-immunoreactive fibres have been 
found in close proximity to approximately 40% of the GnRH neurones located in the POA 
and also intermingled with GnRH fibres in the ME (Goubillon et al. 2000). All this 
anatomical evidence strongly suggests a role for the oestradiol-sensitive NKB cell 
population in the regulation of female reproductive function. Pillon et al. (2003 b) report 
that 4 h of oestradiol treatment, which is sufficient to induce the preovulatory-like LH 
surge and oestrous behaviour in progesterone primed OVX ewes, decreases both the 
level of preprotachykinin B (PPTB) mRNA expression in the NKB neurones of the ovine 
caudal part of the ARC of OVX ewes, and also the number of cells containing NKB mRNA. 
Interestingly, the decrease of NKB mRNA expression coincides with the time of the 
negative-feedback effect of oestradiol on GnRH secretion (Caraty et al. 1989) or closely 
precedes the induction of oestrous behaviour. Recent evidence shows that in the ARC of 
the ewe, essentially all kisspeptin neurones express dynorphin, and most also express 
NKB. In contrast, these cells do not produce g-MSH or AGRP (Goodman et al. 2007). A 
single subpopulation of neurones in the ARC contains all three neuropeptides. 
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Moreover, this subpopulation appears to be distinct from the orexigenic (producing 
AGRP and NPY) and anorexigenic (producing melanocortins and β-endorphin) neurones 
in this nucleus. Even though neurokinin B appears to be a stimulating factor of the 
GnRH/LH surge in the ewe, the mechanism by which this may be achieved is not yet 
clear as NK3R are not co-localised in GnRH neurones but on KNDy cells (Amstalden et al., 
2009). A proposed model for the actions of neurokinin B to control KNDy cell activity is 
outlined in Lehman et al., (2010) and Maeda et al., (2010), suggesting that neurokinin 
B/NK3R signaling plays a role in facilitating and synchronizing activation of kisspeptin 
neurones. This mode of secretion is described for the control of GnRH pulses; however, 
a similar mode of action could also be employed for the control of the GnRH surge 
mechanism.  
 
γ- aminobutyric acid (GABA) 
GABA is thought to be a major inhibitory neurotransmitter with a widespread 
distribution throughout the mammalian central nervous system. GABA contains steroid 
receptors (oestradiol and progesterone) and is extremely sensitive to their change in 
concentration. Moreover, close contacts between GABAergic terminals and preoptic 
GnRH cell bodies were identified in sheep (Herbison et al. 1993). Numerous studies have 
shown that administration of GABA, or GABA agonists and antagonists, alters LH 
secretion in ewes (Sliwowska et al. 2006), while in the mPOA, activity of the GABAergic 
system declines significantly just before the GnRH surge onset (Robinson et al. 1991). 
This is done by the uncoupling of the normal stimulatory influence of noradrenaline (NA) 
on GABA neurones at the time of the surge, which thereby allows an increase of the 
stimulatory influence of NA on GnRH neurones (Robinson et al. 1991, Herbison 1998). 
Therefore it is suggested that the mPOA in ewes is an important regulatory site of GABA 
on GnRH release. GABA, affects GnRH secretion by two different classes of membrane 
receptors: GABAA receptors and GABAB receptors (Bormann, 2000). Numerous 
experiments indicate that GABA may mediate both inhibitory as well as stimulatory 
effects on GnRH release through a GABAA receptor mechanism. The most reasonable 
explanation for this contradictory role may be that GABAA receptors are located on 
numerous stimulatory and inhibitory interneurones that in turn influence GnRH 
neurones. Tomaszewska-Zaremba et al. (2003) suggest that suppression of GnRH during 
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GABAA receptor activation might be viewed as the net effect of inhibitory and 
stimulatory actions, i.e. of a direct inhibitory effect on GnRH neurones, indirect 
suppressive influence on GnRH release by activation of β-endorphinergic systems, and 
indirect activation of GnRH cells by increasing NA release. GABA’s role is not however 
limited to the mPOA as quantitative immunocytochemical analysis revealed that the 
majority of axosomatic terminals in the ARC are GABAergic, and this population of 
synapses is affected by oestradiol (Kurunszi et al. 2008). However, the mode of action of 
GABA in the control of GnRH release is still far from being understood. 
   
Neuropeptide Y 
The implication of neuropeptide Y (NPY) in the hypothalamic regulation of LH and GnRH 
surges is supported in several mammalian species, notably in the rat (Kalra et al. 1995). 
In rats and sheep NPY neurones are found in the ARC of the hypothalamus 
(Antonopoulos et al. 1989) in addition to other areas in the brain and projections from 
NPY neurones in the ARC have been reported to contact GnRH neurones in the POA 
(Tillet et al. 1989). NPY immunoreactive fibres are also seen in close association with 
GnRH terminals in the external zone of the ME of the rat (Estrada et al. 2003). Thus it is 
possible that NPY could exert control over GnRH secretion by action on GnRH cell bodies 
or terminal fields. Up to 10% of NPY neurones in the ARC contain ER (Skinner and 
Herbison 1997) allowing for feedback effects of oestradiol on GnRH secretion to be 
mediated via a subset of this neuronal cell type. In the ewe, the results seem quite 
conflicting. Malven et al. (1995) showed in ovariectomized ewes that icv administration 
of anti-NPY antibodies around oestradiol treatment advanced the onset of the LH surge 
without changes in its magnitude, whereas Porter et al. (1993) claimed that in intact 
cyclic ewes, icv injection of anti-NPY antibodies prior to and during the expected time of 
the preovulatory surge delayed or abolished the LH surge, with an inhibition of oestrous 
behaviour. Pillon et al. (2003) demonstrated that a 4-h (proven to be enough to 
stimulate an LH surge and the onset of sexual behaviour) oestradiol treatment induces 
no change for preproNPY mRNA, in the infundibular nucleus (IN) of ovariectomized 
progesterone-primed ewes. Therefore as NPY content of the MBH increases just before 
and remains elevated during the preovulatory surge in ewe (Malven et al. 1995) this 
modification in mRNA expression should be able to be detected later than the time of 
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oestradiol action (Pillon et al. 2003). Estrada et al. (2003) measured NPY mRNA 
expression in the ARC across the oestrous cycle and found that levels were reduced in 
the caudal ARC during the preovulatory surge period compared to the luteal phase 
levels, which is in contrast with the rat. Furthermore, to test the hypothesis that NPY is a 
predominant negative regulator of GnRH secretion they infused NPY in the third 
ventricle and this caused a delay in the LH surge in OVX ewes. They conclude that NPY is 
a predominant negative regulator of GnRH secretion. Studies in rats suggest that NPY 
has a stimulatory role in the generation of the preovulatory GnRH surge via the Y1 
receptor although in sheep antagonism of the specific receptor did not block the surge 
(Estrada et al. 2003) and therefore influence may be exerted via a different receptor, 
e.g. Y2 or Y3 or Y4 or Y5 in this species. In the ARC of the ewe, there is a marked 
alteration in the expression of NPY, with alteration in bodyweight. Reduction of body 
weight by food restriction in OVX ewes increased NPY mRNA expression (Adam et al. 
1997, Henry et al. 2000). This peptide promotes feeding in the sheep, suggesting 
involvement in homeostatic control. NPY also stimulates the release of corticotrophin 
releasing hormone (CRH) and arginine vasopressin (AVP) and may therefore be 
fundamentally involved in `stress' responses (Clarke et al. 2001). 
 
Somatostatin 
Within the mediobasal hypothalamus (MBH) of the ewe, numerous neurones 
synthesizing somatostatin are present in the infundibular nucleus (IN) and the 
ventrolateral division of the (VMN; Bruneau and Tillet 1998). However, the physiological 
role of the somatostatin-containing neurones remains undefined. Colocalization studies 
have shown that about 70% of the neurones expressing oestrogen receptors in the VMN 
synthesize somatostatin, and 13% of the somatostatinergic neurones located in the IN 
express ERα (Scanlan et al. 2003). Therefore, the cells synthesizing somatostatin located 
in the VMN and/or the IN might play a role in the induction of the preovulatory GnRH 
surge or sexual behaviour. Pillon et al. (2004) demonstrated that icv administration of 
somatostatin, which simulates the increase in PPS mRNA expression observed by in situ 
hybridization after the oestradiol treatment, totally inhibited the pulsatility of LH 
secretion. The increase of PPS mRNA expression coincides with the time of the negative 
feedback that oestradiol exerts in the central nervous system during the preovulatory 
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period (Caraty et al. 1989) and closely precedes the induction of oestrous behaviour. 
Moreover, as preovulatory oestradiol replacement by somatostatin icv infusion 
abolished LH pulsatility and dramatically decreased the mean basal level of LH secretion, 
we hypothesized that somatostatin may be involved in the negative feedback of 
oestradiol. 
 
Galanin 
Galanin is mainly observed in the mPOA and the ARC. The highest density of 
immunoreactive fibres was found in the external layer of the ME. Numerous galanin-
immunoreactive fibres were also observed in the POA, the MBH, the periphery of the 
SON and PVN. With colchicine treatment, the number of labelled neurones increased, 
and additional galanin-immunoreactive perikarya were observed in the BNST, the lateral 
septum, the SON, the PVN and the PeVN and the PVN of the thalamus. (Chaillou et al. 
1999). Early studies performed both in the rat have shown that galanin can stimulate 
and modulate GnRH secretion from the hypothalamus and stimulate LH release from the 
anterior pituitary gland (Grafsteindunn et al. 1994). Furthermore, rodent studies have 
shown that oestrogen can stimulate galanin gene expression (Gabriel et al. 1993) and 
that galanin might act presynaptically to shape and modulate GnRH pulses 
(Grafsteindunn et al. 1994). It has subsequently been shown that essentially all GnRH 
expressing neurones in the ovine hypothalamus coexpress galanin, although not all 
galanin-expressing cells coexpress GnRH (Dufourny et al. 2003). Recent research on the 
expression of galanin in sheep has shown that over 50% of the galanin-expressing 
neurones of the POA of the ovine hypothalamus also express ERα (Tourlet et al. 2005). 
 
Noradrenaline 
Almost all noradrenergic cells are found in the brain stem and specifically in the regions 
A1 (ventrolateral medulla; VLM) and A2 (nucleus of the tractus solitarius; NTS). 
Noradrenergic cells located in A1 and A2 cell groups in the brainstem are thought to be 
of importance, for the generation of the surge in GnRH/LH secretion. NA-producing cells 
of the brain stem are involved in regulating GnRH cells and project to the POA and BNST 
(Barraclough and Wise 1982). In rats and sheep, the NA cells that project to the POA, 
express ERα and are activated by oestradiol (Rawson et al. 2001). In sheep, the A1 cells 
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provide the most significant NA input to the POA and activation of the A1 neurones 
(expression of c-Fos protein) is observed in OVX ewes within 1 h of oestradiol injection 
(Rawson et al. 2001). Although only 20% of GnRH cells appear to receive input from NA 
systems in the ewe (Pompolo et al. 2003) NA could also regulate these cells by relay via 
other forebrain regions. NA role is to stimulate GnRH secretion, but on the other hand 
NA axons also synapse directly or indirectly with GABA perikarya resulting in suppression 
of GnRH secretion. Therefore oestradiol, via brain stem NA, can both stimulate and 
suppress GnRH secretion. Together with opioids they control pulse amplitude. NA 
concentrations are elevated before the LH surge in the POA and ME while ablation of the 
NA pathway can block the LH surge. After this ablation the LH surge mechanism recovers 
fully giving evidence that there are compensatory mechanisms and NA has a ‘permissive’ 
role towards the GnRH release (i.e.,  it should be considered as a modulator that enables 
interactions between other neurones rather than a stimulator or inhibitor (Dobson et al. 
2003, Smith and Jennes 2001). It has been recorded that the infusion of NA in the 3V 
inhibits the release of LH pulses in OVX rats but this inhibition is reversed when they 
were treated with oestradiol. It would be of great interest to determine which and if in 
fact there is a threshold of oestradiol concentration, which causes this ‘switch’.  
 
Glutamate (Excitatory Amino Acids; EEA) 
Glutamate is the major endogenous EAA in the CNS that mediates excitatory synaptic 
neurotransmission through EAA receptors (Brann and Mahesh 1997). Glutamatergic 
inputs to GnRH cells have been demonstrated histologically, while glutamate fibers have 
been found in close apposition to GnRH cells in the ewe POA (Pompolo et al. 2003). 
Studies have revealed that within the hypothalamus of the rat and monkey, dense 
glutamate immunostaining is found in the magnocellular and parvocellular PVN, VMN, 
SON, LHA, suprachiasmatic nucleus (SCN), ARC, infundibular stalk, and ME (Brann and 
Mahesh 1997). Pompolo et al. (2003) used an antibody to vesicular glutamate 
transporter 2 (VGluT2) to label glutamatergic neurones (as there is a problem in 
identifying the location of the glutaminergic cell bodies as all cells use glutamate for 
biosynthetic purposes) in the areas of the ewe brain that control GnRH secretion. 
VGluT2- immunoreactive cells were observed in the ARC, VMN, POA, BNST, and A1 and 
A2 cell groups in the brainstem. As a whole, these immunolocalisation studies 
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demonstrated that glutamate is extensively localized in presynaptic terminals 
throughout the vast majority of the nuclei of the hypothalamus, and hence strategically 
positioned to control many different functions of the hypothalamus.  Microdialysis 
studies by Ping et al. (1994) in ovariectomized adult rats have shown that immediately 
before peak serum LH levels there was an enhanced release rate of glutamate in the 
POA and therefore support that EEA are necessary for the activation of GnRH neurones. 
Significant numbers of glutamatergic neurones were found to express ERα, including 
those of the ARC, VMN, which are known to be activated by oestradiol and project to 
POA where most of GnRH neurones are located. Their input may be direct or indirect. 
Approximately 40% of glutamatergic cells in the BNST/POA express ERα, allowing for 
indirect oestrogenic regulation of GnRH cells (Pompolo et al. 2003). 50% of GnRH 
neurones that express c-Fos during the LH surge have glutamate receptors (Dobson et 
al. 2003). Other factors that have been demonstrated to modulate EAA release from the 
hypothalamus include the neurotransmitter GABA, which has been shown to stimulate 
glutamate release from rat POA neurones via a GABAA receptor mediated mechanism 
(Fleischmann et al. 1995).  
 
Sexual Behaviour 
The increase in the concentration of oestradiol in the mid-follicular phase is also 
responsible for changes in sexual behaviour (Fabre-Nys and Gelez 2007, Karsch et al. 
1980). In order for sexual behaviour to occur, increasing concentrations of oestradiol 
must follow a period of exposure to progesterone, but the latter must no longer be 
present in the bloodstream (Fabre-Nys and Martin 1991). In order to determine steroid 
requirements for the occurrence of sexual behaviour, numerous studies have used an 
ovariectomised – steroid replacement ewe model. In this model, where sexual 
behaviour does not occur, administration of oestradiol alone is enough to induce both 
the LH surge and receptive behaviours (Fabre-Nys and Martin 1991). However, full 
expression of oestrus is exhibited only with the previous administration of progesterone 
for a minimum of 3 days. Progesterone priming also increases the proportion of females 
exhibiting oestrus, reduces the time to onset of sexual behaviour, and increases its 
duration and intensity (Fabre-Nys and Martin 1991).  
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Depending on age, breed, and the time of year the interval between two oestrous 
periods in domestic ruminants is 17 days and the duration of oestrus expression 6 to 36 
h (Fabre-Nys et al. 1993). In all cases, these changes in behaviour occur shortly before 
the release of the preovulatory LH surge which triggers ovulation.  
Beach (1976) proposed a useful classification of female sexual behaviour in to 3 
components: attractivity, proceptivity and receptivity. Attractivity refers to the female's 
value as a sexual stimulus to the male. Olfaction is certainly important here, as sexually 
experienced rams are able to discriminate between the smell of an oestrous female and 
a non-oestrous one. Proceptivity consists of appetitive activities shown by females such 
as ram seeking activity which is displayed by 75% of ewes. In addition females can 
display specific behavioural motor patterns which will increase the males' interest. 
These patterns include movement of the head toward the male, and tail fanning, but the 
main display that they show is just to stand still near the male (Fabre-Nys et al. 2007). 
Receptive behaviour consists of an “active immobilization” during which the female will 
resist if you try to push her. In the ram, intromission only lasts a few seconds and is 
followed by ejaculation (Banks 1963). There is no need for a series of intromission 
although the reproductive success of the ewe is enhanced if mating occurs more than 
once (Synnott et al. 1981). 
 
The preovulatory GnRH secretion, measured in portal blood and cerebrospinal fluid, 
starts at the time of the LH surge, approximately 4 h after the onset of oestrous 
behaviour, and lasts as long as receptivity (36–48 h), which is  much longer than the LH 
surge. Caraty et al. (2002) administered exogenous GnRH or GnRH antagonist and 
demonstrated that the sustained secretion plays a physiological role in extending the 
duration of oestrous behaviour by controlling receptivity. The same authors also suggest 
that during the oestrous cycle of the ewe at least two mechanisms are necessary for the 
expression of sexual behaviour around the time of ovulation: one involving oestradiol 
and one involving oestradiol-induced GnRH secretion. 
 
It has been suggested that steroid mediated oxytocin release, has an inhibitory role in 
controlling female sexual receptivity. In most mammals, a peripheral and central 
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increase of oxytocin release is observed after repeated intromissions or manual 
vaginocervical stimulation and is followed by a shortened oestrous expression. In 
addition, infusion of oxytocin into the MBH, of receptive female ewes significantly 
decreases sexual receptivity (Kendrick et al. 1993). Administration of this neuropeptide 
induces an increase of NA in the MBH and it is therefore considered that they act 
synergistically to exert an inhibitory effect on oestrous behaviour (Fabre-Nys and Gelez 
2007).  
 
Steroid hormones are believed to stimulate the onset of female sexual responses by 
modulating neurotransmitter systems. However, the effect of neurotransmitters on the 
control of female oestrus behaviour has not yet been clearly defined. DA and NA have 
received most attention and are considered to be the main regulators (Fabre-Nys and 
Gelez 2007, Fabre-Nys et al.1994). Microdialysis measurements have shown that the 
major neurochemical changes, associated with steroids, in the MBH during oestrus, 
involve these two neurotransmitters (Fabre-Nys et al.1994). NA increases transiently 
during periods of sexual receptivity and just following sexual interactions with a male 
(Fabre-Nys et al. 1997). Furthermore, antagonism of NA in the MBH reduces proceptive 
behaviour, and administration of NA enhances proceptive behaviour in sheep (Fabre-Nys 
et al., 2003). DA has a biphasic role and facilitates the expression of oestrus behaviour 
when high before oestradiol but is inhibitory after oestradiol (Fabre-Nys et al. 2003). The 
fact that these patterns of changes in DA levels are consistent only when ewes are going 
to become fully receptive suggests that they are related to the onset of sexual behaviour 
(Fabre-Nys et al. 1994). Changes in NA are thought to be modulated by DA transmission 
in the MBH as quinpirole (a DA receptor agonist) administered before oestradiol 
increases the NA release, while quinpirole administered after oestradiol reduces it 
(Fabre-Nys et al. 2003). A few other neurochemical changes have been observed in 
association with oestrous behaviour in sheep such as a decrease in serotonin and GABA. 
But the role of these substances has not been studied further in domestic ruminants. 
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Stress 
Stress can have deleterious effects on metabolism, growth, tissue repair and 
reproductive physiology. There are many different types of stress: physical (e.g. 
transport), immunological (e.g. administration of endotoxin) or psychological (e.g. 
isolation; Dobson et al. 2003) which all activate the hypothalamic – pituitary – adrenal 
axis (H-P-A axis). This activation leads to the reduction of GnRH and therefore LH 
pulsatility (frequency and amplitude) by interfering with both the hypothalamus and the 
pituitary gland resulting in a delayed or even absent LH surge (Smith et al. 2003). This 
can be accomplished through direct influence on GnRH secretion mechanisms or/and 
indirectly by the induced decrease in oestradiol production caused by impaired follicular 
growth. In monkeys, administration of oestradiol can reverse the effects indicating that 
there is a dose effect and that the HPA response is mediated by the steroid hormone 
milieu. This remains to be proven in other species as well to eliminate the possibility of a 
species-specific response (Dobson et al. 2003). It is therefore evident that stressors 
disrupt the correct function of all parts of the H-P-O axis (Dobson et al. 2000).  
 
Depending on their intensity, stressors act on the activation and/or transmission phases 
of the GnRH surge, by stimulating the PVN. Substantial pathways from the PVN to the 
central VMN and the lateral ARC have been identified (Qi et al. 2008) and this route may 
directly or indirectly disrupt GnRH cell recruitment.  
 
Adrenal stimulation is the result of increased ACTH release from the pituitary gland. This 
release is modulated by the activation of the PVN to produce two factors: corticotrophin 
releasing hormone (CRH) and arginine vasopressin (AVP) that reach the ME (there, they 
do not alter GnRH secretion for it has been found that their terminals are not closely 
associated with GnRH neurones and are secreted in the hypophyseal portal system 
(Dobson et al. 2003, Smith and Dobson 2002, Tellam et al. 2000, Rivier and Rivest, 1991). 
CRH is thought to predominate during ‘weak’ stressors while additional AVP is secreted 
during more intense stress. Even though AVP concentrations are higher in the ewe 
compared to CRH, AVP antagonists do not reverse the effects, while CRH antagonists do 
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(Rivalland et al. 2005) indicating that both of them participate in suppression and CRH’s 
role may be more important.  It is possible that CRH exerts its effects on GnRH pulse 
frequency via GABA – NA neurones, whereas AVP responses involve opiodergic cells (i.e. 
pulse amplitude) as has been proven in rats. The activation of the PVN is induced by 
prior activation of the brain stem to produce NA and NPY and the ARC to produce NPY. 
Oestradiol enhances stress induced NA suppression (when applied to the brain stem and 
PVN, not mPOA and ARC). The PVN also receives dopaminergic projections from the area 
postrema and GABA projections from the mPOA  
 
The activated CRH and AVP neurones have many tasks: to stimulate ACTH release, to 
decrease pulse frequency via direct synapse with GnRH neurones (Jasoni et al. 2005) and 
to activate GABA and opioid neurones which they in turn influence GnRH neurones 
(Tellam et al. 2000). CRH neurones from the PVN are thought to project to GABA cells in 
the mPOA. This is contradicted in recent studies by Rivalland et al (2005) who used 
retrograde tracing and c-Fos labeling to prove that there are no direct synapses from the 
PVN to the mPOA. Recently Jasoni et al. (2005) have identified approximately 30% of 
GnRH neurones in the mouse, spread throughout the GnRH neurone continuum, 
expressed CRH receptor immunoreactivity and are therefore direct targets of stress 
responses. This remains to be proven in other species such as the sheep.  
 
Another stress pathway involves amygdala (CeA, plays a role in emotional behaviour and 
motivation), which contains CRH neurones that project to the mPOA via the BNST, and 
increase GABA during stress (Rivalland et al. 2005). Stressors that require limbic 
interpretation could activate this pathway. In the rat destruction of the PVN did not 
reverse the effects of stress providing strong evidence of alternative stress pathways.  
 
Under certain conditions CRH can up-regulate (Battaglia et al. 1998) LH release or have 
no effect on it but only during periods of oestradiol negative feedback. Maybe this 
provides proof that not all populations of CRH neurones in the brain have the same role. 
This finding could be the result of neurotransmitter action unconnected to the stress 
axis or steroid feedback mechanisms may be important.  
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ACTH released from the pituitary gland has an effect on the LH surge and this is thought 
to be mediated by progesterone secreted by the adrenal glands. Progesterone’s 
deleterious effects are in turn mediated by opioids from the ARC, which project to the 
mPOA and ME. It should be noted that administration of a progesterone antagonist did 
not reverse the disruption of LH (Smith et al. 2003, Smith and Dobson 2002).  
 
There is contradiction on the role of the corticosteroids released from the adrenal gland 
medulla under the influence of ACTH. Several studies show that they are not likely to 
have a major influence, since effects have been also observed in adrenalectomized 
animals as well as the fact that after the administration of an antagonist effects are still 
observed (Rivalland et al. 2005, Smith and Dobson 2002), while their chemical nature 
does not allow them to pass the blood – brain barrier. Furthermore, corticosteroids are 
elevated for only a limited period of time due to negative feedback mechanisms on 
ACTH release resulting in their decrease even though the stressor is still being perceived 
by the animal (Smith and Dobson 2002). On the other hand, administration of a high 
dose of cortisol did cause LH secretion abnormalities (Dobson et al. 2003) while in some 
articles their role is thought to inhibit GnRH production at the level of the ME and to 
alter responsiveness at pituitary gland level (Tellam et al. 2000; mainly by binding with 
glucocorticoid receptor (GR) type II). These lead us to believe that corticosteroids are in 
fact mediators of stress effects but whether or not they are necessary still remains to be 
proven. Macfarlane et al (2000) contradict the former statement and support that 
corticosteroids are in fact necessary at least in the OVX ewe, and imply that stress-like 
concentrations were not achieved in previous studies. Furthermore they state that when 
the appropriate level of concentration is achieved there is also a reduction in LH pulse 
frequency (in intact animals) indicating that there is influence at hypothalamic level. 
They propose that the type II GR found in hypothalamic neurones are responsible for 
this decrease, mediated by the steroidal milieu. 
 
Interestingly, a recent study on female macaques reports that ‘stress sensitive’ and 
‘stress resilient’ individuals exist and that these individuals in the absence of stress have 
1) fewer serotonin neurones, 2) lower expression of 5HT2A and 2C genes (serotonin 
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receptors) in the PVN and IN 3) higher gene expression of GAD67 and CRH and 4) 
reduced GnRH transport to the pituitary (Bethea et al. 2008).  
  
The effect of stress on the exhibition of oestrous behaviour has received little attention. 
Recently Pierce et al. (2008) used a layered paradigm of psychosocial stressors and 
report a reduction in the intensity of attractivity and proceptivity expression. 
Interestingly receptivity was unaffected by stress. This provides evidence that the 
expression of various behaviours are controlled by different neuronal mechanisms.  
 
Endotoxin 
Specifically, immune/inflammatory challenges, such as bacterial endotoxin (i.e. 
lipopolysaccharides; LPS), disrupt the ovulatory cycle in sheep, by interfering with the 
GnRH, and therefore the LH, surge in OVX and intact ewes (Breen et al. 2004, Battaglia 
et al. 2000). After endotoxin administration a rise in CRH and AVP in the portal blood 
and cortisol and progesterone in the peripheral blood was observed while the GnRH and 
LH pulsatility was suppressed (i.e. the HPA axis was activated; Karsch and Battaglia 2002, 
Battaglia et al. 1998, Battaglia et al. 1997). The much higher concentration of AVP 
compared to CRH agrees with the level of severity of the stressor.  Although the exact 
mechanism by which this is achieved is not clear, endotoxin has the ability to disrupt the 
oestradiol activation phase (phase I) of the GnRH surge and not the transmission or 
release phases (phase II and III; Battaglia et al. 1999). It is suggested that this is done by 
action upon neuroendocrine centres that respond to the positive feedback signal of 
oestradiol, which leads to the GnRH surge (Karsch and Battaglia 2002, Battaglia et al. 
1999). Interestingly, Battaglia et al 1998, state that administration of endotoxin affects 
LH amplitude and frequency while at hypothalamic level there is only a decrease in 
GnRH pulse amplitude in ovx ewes. This indicates that there is an uncoupling of GnRH 
and LH pulsatile secretion. In the same study it is also noted that GnRH overcame 
suppression quicker than LH suggesting that pituitary response was compromised. In 
another study (Battaglia et al. 2000) administration of endotoxin disrupted oestradiol 
rise, blocking the LH surge but did not inhibit LH pulses in half of the animals tested 
indicating that endotoxin may also act at ovarian level impairing follicular development 
or/and inhibiting oestradiol secretion in response to gonadotrophic stimulation. Smith et 
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al. 2003 suggest that low doses of endotoxin act on the pituitary gland while high doses 
act on both the hypothalamus and the pituitary gland to suppress both pulsatile and 
surge secretion. Recently a study in rats investigated the effect of LPS administration on 
kisspeptin gene expression. In this study LPS injection decreased hypothalamic 
kisspeptin mRNA expression as well as plasma LH levels while indomethacin completely 
blocked the suppressive effects of LPS on LH secretion and kisspeptin mRNA level. And 
therefore conclude that kisspeptin systems are sensitive to immune/inflammatory 
challenge conditions and transmit these signals into the central reproductive system 
(Iwasa et al. 2008). 
 
Insulin 
Reproductive maturation and function is sensitive to the state of energy reserves of the 
organism (Fernandez-Fernandez et al. 2006, Tena-Sempere, 2007). The basis for 
alterations remains partially unknown, but it is likely to involve multiple interactions 
between the neuroendocrine networks governing energy balance and GnRH function 
that take place at different levels of the H-P-A axis (Fernandez-Fernandez et al. 2006). 
Although physiological amounts of insulin are necessary for neurone activity, the sudden 
administration of a bolus insulin injection activates the H-P-A axis due to the induction 
of hypoglycaemia (Dobson et al. 2003, Smith et al. 2003, Ohkura et al. 2000, Caraty et al. 
1990). Hypoglycaemia blocks or delays the LH surge when applied to any of the three 
phases of the surge mechanism (i.e. activation, transmission and surge). The delay in LH 
surge onset that is observed after blood glucose decreases below the 3 mmol l-1 
threshold (Dobson and Smith 2000), is thought to be mediated via opiodergic action on 
the hypothalamus (Smith et al. 2003, Clarke et al. 1990). The activation and the release 
of CRF have also been implicated (Dobson and Smith 2000, Adam and Findlay 1998). The 
glucose-sensing sites that mediate the LH suppression are considered to be central and 
not peripheral (liver; Ohkura et al. 2000) but the exact location and neurone identity 
have yet to be determined in sheep. Intriguingly, in humans there is recent evidence 
that the MBH itself is a control centre of satiety and contains glucose-excited and 
glucose-inhibited neurones that, at least in part, overlap with the neuronal populations 
that express β-endorphin, AGRP, a-MSH and NPY (Mountjoy and Rutter 2007, Penicaud 
et al. 2006). This means that their electrical activity is altered in response to increasing 
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and decreasing glucose concentrations as well as the hormone insulin itself. It is also 
mentioned that these glucose sensitive neurones may be involved in raising blood 
glucose levels (i.e. they ‘sense’ low levels of glucose). Apart from the involvement of NPY 
studies have shown the galanin neurones (Cunningham, 2004), steroidogenic factor-1-
expressing neurones in the VMN of rats (Qi et al. 2008) and POMC neurones (which also 
contain insulin receptors; Qi et al. 2008, Schioth and Watanobe 2002) have dual effects 
to regulate metabolism and reproduction. Thus, the multifunctional properties of NPY, 
POMC, steroidogenic factor-1 and galanin neurones indicate the close relationships that 
exist between the regulation of food intake and reproduction. Once again there is a 
hypothesis that kisspeptin may participate in transmitting metabolic information on to 
the centers (namely, GnRH neurones) (Tena-Sempere 2007). The initial studies linking 
energy status and the kisspeptin system were focused in the analysis of changes in 
kisspeptin 1 gene expression in situations of metabolic stress. Thus, in pubertal male and 
female rats, protocols of acute fasting (up to 72-h) were shown to induce a significant 
decrease in the relative expression levels of kisspeptin mRNA at the hypothalamus that 
was associated to the lowering of circulating LH (Castelano et al. 2005). In the same 
study it is suggested that NPY might participate in the metabolic regulation of kisspeptin 
in the hypothalamus. 
 
Aims of thesis 
Successful reproduction requires follicular maturation and oestradiol biosynthesis, 
induction of the LH surge, ovulation, and expression of sexual behaviour to be 
coordinated within a tight time frame. The ARC, VMN and mPOA have been identified 
critical sites for oestradiol and progesterone action on female sexual behaviour 
(proceptivity and receptivity) as well as the GnRH surge. Therefore, within this structure, 
there are some cell populations that are able to read the oestradiol signal from the 
growing follicles and to activate the oestrus behaviour–generating and surge-generating 
system.  The objective of the present thesis is to contribute to the better understanding 
of the two mechanisms as well as elucidate potential pathways of their disruption after 
acute stress. 
Specifically the aims of the present thesis are: 
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1. Acute insulin administration causes a disparity between the onset of oestrus 
behaviour and the LH surge in ovary-intact ewes. In the present thesis we 
examined a large number of animals to determine the effect of insulin and LPS 
on the timing of onset of sexual behaviours and the LH surge, especially with 
respect to each other’s onsets, and investigate which hormonal insult is the 
cause of the disruption. 
2. There is a difference between rodents and sheep as to which kisspeptin 
population is important for mediating oestradiol positive feedback. In rodents 
the periventricular population has been shown to be necessary for the initiation 
of the GnRH surge whereas in sheep results are conflicting. We aimed to 
investigate the activational pattern of kisspeptin cells during the follicular phase 
of intact ewes and determine the population(s) activated during the surge.  
3. The hypothalamic neuropeptide kisspeptin is essential for GnRH/LH surge release 
and, therefore, ovulation. We aimed to test the hypothesis that inhibition of 
kisspeptin activation is a major contributing factor to LH surge disruption during 
stress. If kisspeptin cells co-localise CRFR type 2 this may be a potential inhibitory 
pathway. 
4. We aimed to map the activation pattern of oestradiol receptor α (ERα) 
containing cells in the arcuate nucleus (ARC), ventromedial nucleus (VMN) and 
medial preoptic area (mPOA) during the follicular phase of intact ewes as well as 
determining whether stress-induced disruption of the LH surge involves a 
reduction of activated ERα-cells. 
5. KNDy cells are considered major regulators of GnRH secretion. We mapped the 
activation pattern of kisspeptin, neurokinin B and dynorphin (KNDy) cells in the 
middle and caudal ARC during the follicular phase of intact ewes. Furthermore 
we investigated whether KNDy cells are targets for stressors.  
6. We aimed to determine the activation pattern of dopamine, β-endorphin, 
neuropeptide Y and somatostatin cells in the mediobasal hypothalamus (MBH) 
during the follicular phase of intact ewes, as well as investigating whether these 
neuropeptides participate in the stress response to insulin or LPS.  
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Chapter 2 
Oestrus behaviour, luteinising hormone and oestradiol profiles of intact 
ewes treated with insulin or endotoxin 
Keywords: Sexual behaviour, ewe, LH surge, oestradiol, stress, cortisol.  
 
Abstract 
Acute insulin administration causes a disparity between the onset of oestrus behaviour 
and the LH surge in ovary-intact ewes. To examine the considerable variation in 
responses, in the present study we used a large number of animals to confirm findings 
with insulin, and examine whether endotoxin has the same effect. During the breeding 
season, follicular phases of intact ewes were synchronised with progesterone vaginal 
pessaries and received saline vehicle (n=22; controls), insulin (4 iu/kg; n=21 ewes) or 
endotoxin (LPS; 100ng/kg; n=10) at 28h after progesterone withdrawal (time zero). In 
controls, the LH surge onset occurred at 36.5 ± 5.7 h and first display of oestrus at 38.2 ± 
1.8 h, but there was a delay of 17.6 h (P<0.001) and 7.2 h (P<0.05), respectively, in half 
the insulin-treated animals (‘insulin-delayed’) but not in the other half; and a delay of 
22.5 h (P<0.001) and 20.7 h (P<0.001), respectively, in all LPS-treated animals. Plasma 
oestradiol concentrations decreased after both stressors, and remained low for a period 
of time equivalent to the LH surge delay (P<0.001; Rs-q= 78%). Cortisol increased for 12 
h after treatment in both insulin subgroups and the LPS group (P<0.05); whereas 
progesterone increased in the insulin-delayed and LPS groups from 4.0±0.5 ng/ml and 
5.3 ± 1.0 ng/ml to a maximum of 5.7 ± 0.3 ng/ml and 8.8 ± 1.6 ng/ml, respectively  
(P<0.05 for both comparisons). Plasma triglycerides were measured to assess insulin 
resistance, but concentrations were similar before and after treatment (0.25 ± 0.01 
mmol/l versus 0.21 ± 0.01 and 0.25 ± 0.01 mmol/l versus 0.26 ± 0.01 mmol/l in the 
insulin-non delayed and insulin delayed subgroups, respectively). Therefore, we 
hypothesise that a) when an acute stressor is applied during the late follicular phase, the 
duration of the LH surge delay is related to the duration of oestradiol signal disruption b) 
cortisol is not the key disruptor of the LH surge after insulin, c) insulin (but not LPS) can 
separate the onsets of LH surge and oestrus by approximately 10 h, providing a model to 
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identify the specific neuronal systems that control behaviour distinct from those 
initiating the GnRH surge.  
Introduction  
For the successful production of offspring, it is essential for sperm to fertilise the ovum 
at an appropriate time. This is why sexual behaviour occurs shortly before the 
preovulatory luteinising hormone (LH) surge which triggers ovulation (Fabre-Nys and 
Martin, 1991, Fabre-Nys and Gelez, 2007). There is considerable evidence that various 
types of stressors disrupt the follicular phase of the ovarian cycle and block or delay the 
LH surge (Karsch et al., 2002, Smith et al., 2003, Dobson et al., 2003) by activating the 
hypothalamic-pituitary-adrenal (H-P-A) axis. However, few studies have investigated the 
impact of acute stressors on sexual behaviour in sheep, and those have focused mainly 
on the incidence and timing of mounting (oestrus) and not other components of sexual 
behaviour which affect the chances of mating (Fletcher and Lindsay, 1968, Tilbrook and 
Pearce, 1987). For example, thermal stress reduces the frequency of estrus (Sejian et al., 
2010) and delays onset (Doney et al., 1973), as does endotoxin (Battaglia et al., 2000). 
Recently Pierce et al. (2008) used a layered paradigm of psychosocial stressors and 
reported a reduction in the intensity but not timing of attractivity (ability of ewes to 
attract rams) and proceptivity (the motivation of ewes to seek rams and initiate mating). 
Interestingly receptivity (i.e. oestrus) as well as the timing of onset of all the above were 
unaffected by this type of stress. Regarding LH, a plethora of stressors are known to 
inhibit pulsatile and surge secretion. For example, the LH surge is delayed or even 
blocked by the combination of exposure to exercise, food restriction and transfer to a 
novel environment (Bethea et al., 2008), truck transport (Dobson et al., 1999, Phogat et 
al., 1999), endotoxin administration (Battaglia et al., 1999, Karsch et al., 2002) or insulin-
induced hypoglycaemia (Medina et al., 1998, Saifullizam et al., 2010). 
From a mechanistic point of view, sexual behaviour and the LH surge are controlled by 
the hypothalamic-pituitary-gonadal (H-P-G) axis. In the ewe, as in many other species, 
increased oestradiol secretion from the ovarian dominant follicle(s) exerts a positive 
feedback action in the central nervous system to generate the LH surge and ovulation 
(Moenter et al., 1990, Goodman 1996). The decrease in progesterone concentrations 
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after luteolysis and the increase of oestradiol is also responsible for changes in sexual 
behaviour (Karsch et al., 1980, Blache et al., 1991, Fabre-Nys & Martin 1991, Fabre-Nys 
& Gelez 2007). Stressors can disrupt oestrus and the LH surge by acting on any - or all - 
of the organs that constitute the H-P-G axis (Smith and Dobson, 2002, Smith et al., 
2003). The immunological stressor endotoxin (i.e. lipopolysaccharide; LPS) or the 
metabolic stressor insulin-induced hypoglycaemia can interrupt the GnRH/LH surge by 
acting on all three parts of the H-P-G axis: inhibiting pulsatile GnRH/LH secretion at 
hypothalamic (Battaglia et al., 2000; Suzuki et al., 2001) and pituitary (Williams et al., 
2001) level, thereby blocking the preovulatory oestradiol increase; disrupting the 
process by which oestradiol generates the preovulatory GnRH/LH surge by acting upon 
neuroendocrine centres that respond to the positive feedback signal (Battaglia et al., 
1999, Karsch et al., 2002; Ghuman et al., 2011); and suppressing steroidogenesis at the 
ovarian level (Shakil et al., 1994, Downing et al., 1999, Battaglia et al., 2000).  
It has been shown recently that a sudden activation of the H-P-A axis in the late follicular 
phase, by insulin-induced hypoglycaemia, lowered oestradiol concentrations and 
delayed the LH surge; whereas, the onsets and frequencies of a range of pre-copulatory 
behaviours were not affected (Saifullizam et al., 2010). However, in that study, concern 
was expressed about the great variation in the timing of the LH surge onset after insulin 
administration. The aim of the present study was to extend the above observations by 
comparing the effects of two different types of stressors, LPS and insulin, on a larger 
number of free-running intact ewes. The stressors were applied at 28 h (and a second 
injection at 30 h, for insulin) in the mid-late follicular phase. We were interested in the 
role of steroid responses in disrupting the LH surge, pre-copulatory behaviours as well as 
oestrus, especially concerning respective timings of the onsets, in an intact ewe model. 
Materials and methods 
 Animals, study design and blood sampling procedure 
The study was performed in the mid-breeding season (October/November) on 60 
mature intact Lleyn crossbred ewes, weighing between 50 and 80 kg. Because of the 
large number of animals involved, the study was carried out in two identical replicate 
sessions with new ewes in the second batch. All ewes were penned indoors (space 15 x 7 
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metres) with 3 teaser rams. All animals were fed daily a constant diet of ad libitum hay 
and had free access to water. Frequent handling, for at least a week prior to 
commencement acclimatizing the animals to human manipulation and the blood 
sampling process ensured that minimal stress responses were incurred. All procedures 
were conducted in accordance with requirements of the UK Animal (Scientific 
Procedures) Act, 1986, and approved by the University of Liverpool Animal Welfare 
Committee. 
Ovarian follicular phases were synchronised with the administration of two intravaginal 
progesterone-releasing pessaries (Controlled Internal Drug Release [CIDR-G]; InterAg, 
Hamilton, New Zealand) for nine days and a double intramuscular (i.m.) injection of a 
synthetic prostaglandin (Lutalyse, 5 mg/ewe, Pharmacia & Upjohn, UK), 12 h before and 
at removal, to ensure adequate corpus luteum regression. The time of progesterone 
withdrawal (i.e. the commencement of the follicular phase) is referred to hereafter as 
time 0 h.  Animals treated with insulin (n=24; neutral zinc bovine insulin, Hypurin 
Neutral, CP Pharmaceuticals, Wrexham, UK) received an i.v. dose of 4 iu/kg body weight 
at 28 h and 30 h after progesterone withdrawal and those treated with endotoxin (n=12; 
Lipopolysaccharides Escherichia coli 055:B5, Sigma-Aldrich, UK; LPS) were given an i.v. 
dose of 100 ng/kg body weight at 28 h. Controls (n=24) received 2 ml of saline vehicle. 
The dose of LPS administered was lower than that used by others (Battaglia et al., 2000) 
to avoid overt clinical responses. In a preliminary trial, 6 ewes were given either 50 or 
100 ng/kg body weight LPS and we concluded that 100 ng/kg provided a robust cortisol 
response and a delayed LH surge, with minimal clinical signs of occasional coughing. In 
the main study, a total of 29 blood samples per ewe were collected at time 0 h, 10 h, 
14h, 20 h and subsequently at 2 h intervals till 80 h. Core body temperature was 
evaluated per rectum with an electronic thermometre. Two control measurements were 
obtained from all animals at 0 h then every 2 h for a period of 12 h after LPS 
administration. 
The frequent blood sampling, as well as the administration of all substances, was 
facilitated by the insertion of a silastic catheter into a jugular vein of each ewe under 
local anesthesia before progesterone withdrawal. Patency was maintained with 
heparinised saline (Multihep, 100 iu/ml, Leo Laboratories, Princes Risborough, UK) 
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administered after each blood withdrawal. Blood samples were collected from all ewes 
into heparinised glass tubes and centrifuged immediately at 1000 g for 20 min at 40C. 
Plasma was stored at -200C until analysis.  
 Plasma analysis 
Samples, in duplicate, were analysed by a second antibody Enzyme-Linked 
Immunosorbent Assay (ELISA) for LH, and by single antibody ELISA for pregnane 
metabolites (equivalent to and hereafter referred to as progesterone) or cortisol. These 
assays were performed with methods adapted from Graham et al. (2002), Munro and 
Stabenfeldt (1984) and Young et al., (2004), respectively. LH results were expressed as 
ng equivalent of NIAMDD ovine LH 21 per ml plasma. Oestradiol was measured with a 
modified radioimmunoassay (RIA) described by Walker et al. (2008) using 0.5 ml plasma 
sample extracted with 3 ml diethyl ether followed by evaporation to dryness. Inter-assay 
and intra-assay coefficients of variation for LH, progesterone, cortisol and oestradiol 
were all less than 12 %.  The minimum detectable amounts were 0.02 ng/ml; 0.16 ng/ml, 
0.8 ng/ml and 0.2 pg/ml and assay precisions (in the mid-range of the standard curve) 
were 0.1 ng/ml, 0.01 ng/ml, 0.2 ng/ml and 0.2 pg/ml, respectively. All samples from 
individual animals were measured in the same assay for each hormone with an antibody 
dilution characterised and verified in our laboratory. In general, 100 μl aliquots of 
plasma were assayed initially, and samples that were over the maximum standard were 
re-assayed after a ten-fold or fifteen-fold dilution. Plasma glucose and triglycerides were 
measured by the hexokinase/glucose 6 phosphate dehydrogenase and lipase/glycerol 
kinase methods, respectively, using commercial kits (Boehringer Mannheim, Lewes, 
Sussex) on a Konelab 20i autoanalyser (Thermo Electron Corporation). The inter-assay 
coefficient of variation was less than 10% for samples within the range of 1 to 4 mmol/l 
and 0.1 to 0.4 mmol/l for glucose and triglycerides, respectively. Analysis of glucose, 
triglycerides, cortisol and progesterone, was restricted to samples taken till 44 h after 
progesterone withdrawal, whereas LH was measured in all samples and oestradiol was 
restricted to samples taken at 0 h, 10 h, 30 h and then every other sample till the end of 
the LH surge.   
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 Visual observation of oestrous behaviour 
Ewe and ram oestrous behaviour was monitored by two trained observers for a 30-
minute observation period prior to each blood sample collection. Paint spray had been 
used to place a large symbol on the back and sides of each ewe and ram. The observers 
were elevated 1.5 m above the pen so identification of symbols and all activities could 
be seen without disturbing the animals.  At each observation period, quantitative and 
qualitative data were recorded for each ewe and ram individually. Retrospectively, the 
frequency of each behaviour was calculated. Once a minute throughout each 
observation period, it was noted if a ewe was within one metre of a ram (behavioural 
scan sampling; Martin and Bateson (1986). In addition, frequencies of the following 
behavioural signs of oestrus were noted throughout each 30 min observation period: 
perineal region of a ewe being nosed by a ram; tail fanning by a ewe (each bout of swift 
side-to-side tail movements); ewe being nudged by a ram without the ewe moving 
away; and, subsequent mounting of the ewe by a ram without the ewe moving away. 
Due to the 2-hourly observation regime, the beginning or end of a period was 
respectively defined as the first (minus 1.0 h) or last (plus 1.0 h) 30-min observation 
period the animal exhibited a particular behavioural sign; duration was taken as the time 
between the beginning and end. Behaviour onsets were considered as the first time that 
the behaviour was observed, when closely followed or accompanied by other 
behaviours. 
 Data analysis 
An LH surge was defined as a sustained increase in LH plasma concentrations (above 15 
ng/ml for 3 consecutive samples taken every two hours) and it was considered to begin 
(surge onset) and end when the first value increased or decreased, respectively, more 
than five times the assay minimum detectable quantity (i.e. > 5 ng/ml). Hormone and 
behaviour data were analysed with Minitab® 15 statistical package (MINITAB Inc, 
Pennsylvania, USA). For all analyses, statistical significance was considered when P<0.05. 
Data were tested for normality with the Anderson-Darling test. Most of the data were 
not normally distributed, even after log transformation; therefore, non-parametric 
statistical analysis was used throughout (Kruskal-Wallis and Mann Whitney tests, as well 
as Wilcoxon signed rank test for pair wise comparisons). Hormone data were compared 
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between groups at each time point unless otherwise stated. Intervals from progesterone 
withdrawal to first onset of each behaviour or the LH surge between groups, and 
between the onsets of each behaviour or the LH surge within a group were compared by 
Kaplan-Meier survival analysis (non-parametric distribution analysis). Regression analysis 
was used to determine the association between the duration of oestradiol decrease and 
the onset of the LH surge. Results are expressed as mean ± SEM.  
Results 
Two animals from each of the control, insulin and LPS groups exhibited signs of oestrus 
and were mounted by a ram within 28 h after progesterone withdrawal (i.e. before the 
predetermined time of treatment), whereas one insulin-treated animal did not respond 
to the synchronization protocol with a decrease in progesterone values. Thus, the data 
from these 7 ewes were excluded from further analysis. Treated animals did not show 
any signs of illness, with a few exceptions of mild coughing and increased respiration 
rate for the ewes that received LPS.  
 Endocrine profiles: LH, cortisol, progesterone and oestradiol 
All animals had an LH surge regardless of treatment. A delayed LH surge onset was 
defined as any time greater than the median onset in the control animals plus one inter-
quartile range. The control animals had a median onset at 35.0 h after progesterone 
withdrawal, with an inter-quartile range of 9.5 h; hence, animals classified as ‘delayed’ 
had an onset later than 44.5 h after progesterone withdrawal. During data analysis, it 
became clear that the insulin group consisted of two subgroups, referred to hereafter as 
insulin-delayed or insulin-non-delayed. 
As shown in Table 1, there was a delay to the time of LH surge onset comparing the 
controls with insulin-delayed subgroup (17.6 h delay; P<0.001) or LPS group (22.5 h 
delay; P<0.001), as well as an extra 4.9 h delay (P<0.05) for the LPS group compared to 
the insulin-delayed subgroup. However, surge durations did not differ between groups 
(P=0.7). The LH surge amplitude was lower in the insulin-delayed subgroup compared to 
the control group (73.4 ± 5.2 h vs 46.0 ± 2.3 ng/ml; P<0.05) but amplitudes for the LPS 
group were not different from controls (Table 1).  
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In all control animals, the concentration of cortisol remained between 7.1 to 15.2 ng/ml 
throughout the study; and before the application of insulin or LPS, cortisol values in all 
groups were not different (Fig. 1). Cortisol increased after LPS and insulin administration 
(P<0.05; Fig. 1) with maximum values of 100.6 ± 17.3 ng/ml, 108.7 ± 14.2 ng/ml and 
186.8 ± 9.2 ng/ml (for insulin non-delayed, insulin-delayed and LPS groups, respectively) 
4 h after the first injection. Concentrations remained elevated for 12 h after treatment 
compared to controls (Fig. 1). The LPS group had higher concentrations compared to the 
insulin subgroups at 30 h, 32 h and 34 h (P<0.05 for all comparisons; Fig. 1). Cortisol 
values in the two insulin subgroups did not differ at any time (Fig. 1).  
Progesterone concentrations at 0 h and 28 h after progesterone withdrawal were not 
different between all groups (28.0 ± 3.1 ng/ml and 4.6 ± 0.6 ng/ml, respectively). 
Thereafter, due to large between-animal variation, a within-animal comparison was 
made. Progesterone concentrations were different in the insulin-delayed and LPS 
groups, increasing from 4.0±0.5 ng/ml and 5.3±1.0 ng/ml to a mean maximum of 5.7±0.3 
ng/ml and 8.8±1.6 ng/ml, respectively (P<0.05 for both comparisons; Fig. 2). Control and 
insulin-non-delayed groups had similar concentrations of progesterone before and after 
treatment (Fig.2).  
Oestradiol concentrations between all groups were not different up to 28 h after 
progesterone withdrawal. Thereafter, oestradiol profiles varied considerably (see 
examples in Fig. 3). Thus, to evaluate the effect of insulin or LPS on oestradiol 
concentrations, the percentage change between 30 h and the average of the 2 lowest 
values, after treatment but before LH surge onset, as well as the duration of decrease, 
was calculated and compared between groups (Fig. 4). In control animals, oestradiol 
concentrations continued to increase after saline (Fig. 4), whereas in the insulin-non-
delayed animals two types of hormone profiles were observed, with oestradiol in some 
ewes appearing to be unaffected by treatment (Fig. 3; ewe Q), and others exhibiting a 
sudden decrease in concentrations followed by a quick recovery (Fig. 3; ewe W). 
Oestradiol concentrations  in the insulin-delayed and LPS groups began to decrease at 30 
h after progesterone withdrawal (i.e. 2 h after the time of treatment), exhibited a 50% 
and 40% reduction, respectively (P<0.01 for both; Fig. 4) and then returned to pre-
treatment values at 46.2 ± 1.4 h (insulin-delayed) and 52.0 ± 2.1 h (LPS) after 
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progesterone withdrawal. Thus, the duration of lowered oestradiol values was 5.1 h 
shorter in the insulin-delayed subgroup compared to the LPS group (16.2 ± 1.3 vs 21.3 ± 
1.9 h; P<0.05; Fig. 4). Furthermore, onset of the LH surge was associated with the 
duration of decreased oestradiol values (P<0.001; Rs-q= 78%). The LH surge onset in 
these two groups, occurred 7.5 ± 1.4 h after oestradiol concentrations returned to pre-
treatment values.  
 Core body temperature 
Rectal temperatures were not different between all animals prior treatment (38.7 ± 0.1 
0C). After LPS treatment, there was an increase to a maximum of 40.7 ± 0.1 0C four hours 
after treatment (38.7 ± 0.1 0C vs. 40.1 ± 0.1 0C, P<0.001; Fig. 5), in parallel with cortisol 
concentrations.  
 Glucose 
In all animals, the concentration of glucose remained between 2.7 to 3.1 mmol/l before 
treatment. Values in control animals were not different before and after saline (3.1 ± 0.1 
mmol/l vs. 3.0 ± 0.1 mmol/l; respectively). In contrast, insulin-non-delayed, insulin-
delayed and LPS concentrations of glucose decreased within 2 h of the first injection 
then returned to pretreatment values by 40h and 42 h (for the insulin-non-delayed and 
insulin-delayed subgroups, respectively; Fig. 6, panel A) and 56 h (for the LPS group; Fig. 
6, panel B) after progesterone withdrawal. Glucose concentrations were not different 
between insulin-non-delayed and insulin-delayed subgroups throughout the study (Fig 6, 
panel A).  
 Triglycerides  
Triglyceride concentrations were not different between the insulin-non-delayed and 
insulin-delayed subgroups as indicated by five measurements between 0 and 34 h after 
progesterone withdrawal (Fig. 7 insert). Insulin treatment did not affect plasma 
concentrations (before and after; 0.25 ± 0.01 mmol/l versus 0.21 ± 0.01 and 0.25 ± 0.01 
mmol/l versus 0.26 ± 0.01 mmol/l in the insulin-non delayed and insulin delayed 
subgroups, respectively; Fig. 7). 
Behavioural profiles 
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All animals displayed signs of oestrus behaviour during the study. Figure 8 shows the 
mean (± SEM) onset and duration of individual oestrus behavioural signs in control, 
insulin and LPS-treated animals. In control animals, pre-copulatory behaviour began 29.2 
± 1.3 h  after progesterone withdrawal with the ram and ewe moving near to each other 
and this state lasted longer than all other behaviours (P=0.006; Fig. 8). At 31.5 ± 1.2 h 
(2.3 h later; P<0.05), the rams began nosing the ewes’ perineal region and this lasted 
longer than subsequent behaviours (P=0.002; Fig. 8). The onset of being nosed was 
followed 6 h later by the simultaneous expression of tail fanning by the ewe, being 
nudged and mounted by a ram (at 37.5 ± 1.2 h after progesterone withdrawal; P<0.05). 
Durations of tail fanning and nudging were not different, whereas mounting lasted for 
approximately 10 h and was thus the behaviour with the minimum duration (P=0.02; Fig. 
8) and frequency (7.7 ± 0.9 mounts throughout the study; P=0.002). Being nosed was the 
most frequent and consistently observed behavioural sign between animals, with an 
average of 20.5 ± 1.4 nosing events in the controls throughout the study (P<0.05). Being 
nudged was also more frequent than being mounted (12.6 ± 1.3 nudges vs 7.7 ± 0.9 
mounts; P=0.004).  
Comparison of behaviour profiles between treatment groups especially with respect to 
the LH surge onset 
The onset, duration and total frequency of each behaviour sign was disturbed by 
treatment within each group as well as between treatment groups (Fig. 8 and Table 2). 
Onsets of all behaviours were delayed in the insulin-delayed (P<0.05, for all) and LPS 
(P<0.001, for all) groups but not in the insulin-non-delayed subgroup (P>0.5; Fig. 8). The 
duration of expression of all behaviours was not different between control and treated 
groups, apart from ewes being near the ram(s) which was shorter in the LPS group 
(P<0.05; Fig. 8). The frequency of being mounted was decreased in the LPS group 
(P=0.009 and tended to increase in the insulin-delayed subgroup; P=0.06). The total 
frequency of all other behaviours (i.e. minutes spent near ram(s), being nosed, tail 
fanning and being nudged) was not different between groups (Table 2). The interval 
from the onset of each behaviour and the LH surge was longer in the insulin-delayed 
subgroup compared to all other groups (treated and control; Fig. 8 and Fig. 9).  
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Discussion 
Responses to the administration of insulin resulted in two groups: the timing of pre-
ovulatory behaviour and the LH surge was not affected in half the ewes but, in the other 
half, the onset of behaviour was delayed by ~7 h and the LH surge by ~17 h. This 
explains the large variation in data from our smaller insulin study (Saifullizam et al, 
2010). In contrast, LPS delayed both the onsets of behaviour and the LH surge by ~22 h. 
The marked ~10 h disparity between the onsets of oestrus and the LH surge in half the 
insulin-treated ewes concurs with our recent findings that acute stress with insulin 
separated the onsets of behaviour and the LH surge in some intact ewes (Saifullizam et 
al., 2010). However, we now extend these observations by reporting that LPS does not 
have the same effect, with both components being equally delayed, suggesting that the 
dose of LPS used is a ‘stronger’ stressor than that of insulin, or the two stressors act via 
different pathway(s) to alter reproductive parameters.  
In ruminants, oestradiol is considered as the primary “trigger” for the onset of 
behavioural and GnRH/LH surge events (Fabre-Nys et al., 1994, Fabre-Nys and Gelez 
2007) although recent reports suggest that the threshold concentration for the 
induction of oestrus behaviour is lower than that for the induction of the GnRH/LH surge 
(Ben Said et al., 2007, Saifullizam et al., 2010) and therefore the triggering signals may 
be different (Caraty et al., 2002). In the present study, oestradiol concentrations 
decreased after treatment, and returned to pretreatment values after ~17 h in the 
insulin-delayed subgroup and ~22 h in the LPS group (i.e. similar times that the surges 
were delayed). Furthermore, both groups had an LH surge onset ~ 7 h after restoration 
of oestradiol concentrations. We, therefore, hypothesise that when a stressor is applied 
during the late follicular phase, the duration of the LH surge delay is related to the 
duration of oestradiol signal disruption caused by these stressors. Furthermore, the 
present findings support existing evidence that for the induction of a GnRH surge, it is 
not only important for a threshold of oestradiol concentration to be reached, but also a 
specific duration of high concentration is required (Caraty et al., 2002, Ben Said et al., 
2007).   
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Interestingly, in the LPS group, all sexual behaviours occurred at similar times relative to 
the LH surge as in controls, whereas in the insulin-delayed subgroup these behaviours 
began before oestradiol returned to pretreatment values and with a 10 h disparity. Thus, 
insulin-treated animals were able to overcome the inhibition of the behaviour 
generating mechanism, quicker than the inhibition of the GnRH surge generating 
mechanism.  We propose three possible explanations for this disparity. First, the insulin-
delayed and LPS groups had an increase in progesterone concentrations and this subtle 
change may have been the mechanism by which all sexual behaviours were blocked in 
these groups (Scaramuzzi et al., 1971, Fabre-Nys, 1998, Fabre-Nys and Gelez 2007). 
When progesterone concentrations decreased and oestradiol reached the appropriate 
threshold, sexual behaviour began. The shorter delay observed in the insulin-delayed 
group, could be due to the fact that the increase in progesterone was less intense than 
in the LPS group. Second, although not yet confirmed, the behaviour generating 
mechanism may be comprised of three phases, similar to those of the GnRH mechanism 
(activation, transmission, and surge secretion; Evans et al., 1997, Harris et al., 1998, 
Harris et al., 1999). LPS may have blocked any of those phases for longer compared to 
insulin, via an unknown mechanism. Third, in the present study, maximum LH values 
achieved during the surge were lower after insulin but not LPS, indicating that pituitary 
responsiveness to GnRH may have been compromised (Smith et al., 2003). Therefore, it 
is possible that in insulin-treated animals, GnRH pulses were restored before the 
pituitary regained sensitivity to GnRH and therefore behaviour was driven centrally by 
those pulses (Caraty et al., 1998, Caraty et al., 2002). Simultaneous GnRH/LH pulse and 
oestrus monitoring could help to elucidate this point. Interestingly, Brothers et al., 
(2010) report a profound insulin sensitivity of the pituitary gland that outlasts 
hypothalamic effects and this may be a reason for a disruption of the one-to-one 
relationship between GnRH and LH pulses.  
Progesterone withdrawal plays a major role in synchronizing physiological and 
behavioural events (Fabre-Nys and Martin 1991). In our study, all animals were primed 
with progesterone (both endogenously and via the applied CIDRs) and had similar 
concentrations at 0 h (CIDR withdrawal) and at 28 h (time of treatment). Progesterone 
has the ability to inhibit the LH surge when applied during the activation and/or 
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transmission phases (Richter et al., 2002, Smith et al., 2003, Richter et al., 2005). 
However, the dose of progesterone used in those experiments, was provided by two 
vaginal pessaries (CIDRs) and the artificial increase in peripheral concentrations were 
equivalent to luteal phase concentrations. In our studies, the increase in progesterone 
concentration in the insulin-delayed and LPS treated animals was much smaller than in 
the above studies. Furthermore, maximum progesterone concentrations after treatment 
occurred at variable times, but always after oestradiol had started to decrease. 
Therefore, it is unlikely that the progesterone increment is the sole mediator for 
lowering oestradiol concentrations and delaying the LH surge. In support of this, the 
insulin-induced LH surge delay is not reversed by administration of the 
progestin/glucorticoid receptor antagonist RU486 (Dobson and Smith 2000).  
Despite extensive investigation, there continues to be a debate whether glucocorticoids 
play a direct role in suppressing reproductive neuroendocrine function in response to 
stress. In the present study, cortisol values increased in all treated groups for a 12-h 
period after treatment, reaching higher values for ~ 4 h in the LPS group compared to 
insulin subgroups. Recent evidence in ovariectomised (OVX) ewes suggests that the 
ability of cortisol to alter LH pulse frequency (Oakley et al., 2009) as well as pituitary 
responsiveness to GnRH (Pierce et al., 2009), depends on the presence of follicular 
phase concentrations of oestradiol.  However, in the present study, as soon as the 
stressors were applied and cortisol values began to increase, there was a concurrent 
sharp decrease in oestradiol concentrations. Furthermore, cortisol increased equally in 
both delayed and non-delayed insulin treated animals. Therefore, even in the presence 
of oestradiol (there was no oestradiol decrease in the insulin-non-delayed subgroup 
even though cortisol increased) increased cortisol was not associated with delays in the 
LH surge. This leads us to believe that, in this ‘more natural’ follicular phase ewe model, 
in which ovarian steroid production, feedback mechanisms and stressor-induced 
mediator hormones were all present, cortisol was not the key disruptor of the LH surge.  
Interestingly, 50% of the animals treated with insulin did not have a delay in sexual 
behaviour or the LH surge (insulin-non-delayed subgroup). Furthermore, both insulin 
groups had similar cortisol and glucose plasma profiles throughout the study. Insulin-
non-delayed ewes had two types of oestradiol profiles, with some ewes appearing to be 
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unaffected by treatment, whilst others showed a sudden decrease in concentrations 
followed by a quick recovery. Therefore, the H-P-A axis in this group was activated 
without altering any reproductive parameters.  So, why did this split response occur? 
One might argue that, in these sheep, the activation phase occurred before treatment, 
but insulin is known to delay the LH surge when applied in any phase of the GnRH 
generation mechanism (Smith et al., 2003, Medina et al., 1998). In fact, injection of 
insulin before or even up to 16 h after the insertion of subcutaneous oestradiol implants 
in OVX ewes delayed the LH surge (Medina et al., 1998).  Furthermore, if the above was 
true then a similar split response would have been observed in the LPS treated animals. 
We tested whether insulin resistance was involved (Kaske et al., 2001), by measuring 
triglycerides, but again there was no difference between groups. Further studies of brain 
tissue obtained from these sheep may clarify this point.  
Beach (1976) proposed a classification of female sexual behaviour into three 
components: attractivity, proceptivity and receptivity. However, the sexual behaviours 
that can be observed at farm level are not all easily classified into one of the above 
categories. We measured sexual behaviour in an open-field situation (Saifullizam et al., 
2010), and recorded their sequential appearance: ~29 h after progesterone withdrawal 
the ewe and ram chose to be within 1m of each other, at ~32 h the ram(s) started to 
nose the ewes perineum and at ~38 h the ewe was tail fanning, nudged and mounted by 
the ram(s).  The fact that all behaviours were delayed together as a group, whilst 
durations and frequencies did not differ, suggests that they all have a common 
regulating factor, presumably oestradiol (Fabre-Nys and Gelez 2007).  However, the fact 
that they begin and end sequentially implies that they also have independent controlling 
mechanisms. In support of this, Pierce et al. (2008) used a layered paradigm of 
psychosocial stressors and reported a reduction in the intensity of attractivity and 
proceptivity but not receptivity. However, a recent report by Papargiris et al. (2011) 
noted that cortisol was able to suppress receptivity but not attractivity or proceptivity 
presumably by interfering with the action of oestradiol to induce receptivity. 
Furthermore, feed-restriction in female voles was followed by a decrease in circulating 
oestradiol concentrations and a reduction or suppression of attractivity, proceptivity, 
and receptivity, however, oestradiol treatment was not sufficient to restore attractivity 
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(Pierce et al., 2007).  All these observations concur that the stress-induced suppression 
of sexual behaviour cannot be attributed to a single factor, but is rather multi-factorial.  
In this aspect, it has been reported that in many species, pheromones serve as sexual 
attractants, promote sexual arousal and mating behaviour as well as modifying 
neuroendocrinological aspects of reproduction (Johnston and Bronson, 1982; Okamura 
et al. 2010). However, their precise role in exhibition of pre-copulatory behaviours or the 
effects of stressors on their production remain to be elucidated.  
Successful reproduction requires follicular maturation and oestradiol biosynthesis, 
induction of the LH surge, ovulation, and expression of sexual behaviour to be co-
ordinated within a tight time-frame. However, the LH surge onset and the onset of 
oestrus were delayed by ~17 h and ~7 h, respectively, after acute insulin administration 
and ~ 22 h and ~ 21 h, respectively, after acute LPS administration. Oestradiol 
concentrations decreased after treatment, and remained low for a period equivalent to 
the LH surge delay. We, therefore, hypothesise that when a stressor is applied during 
the late follicular phase, the duration of the LH surge delay is related to the duration of 
oestradiol signal disruption. Interestingly, 50% of the animals treated with insulin did not 
display a delay in sexual behaviour or the LH surge, even though cortisol increased and 
glucose decreased after treatment, in an identical fashion to the delayed ewes. Even 
though the reasons for this split response are not yet clear, this unexpected finding 
provides direct evidence that cortisol is not the key disruptor of either the LH surge or 
sexual behaviour after insulin administration in intact ewes.  The fact that insulin-treated 
animals were able to overcome the inhibition of the behaviour generating mechanism 
quicker than the inhibition of the GnRH surge generating mechanism by 10 h provides a 
model that can be used to identify the specific neuronal systems that control behaviour 
distinct from those initiating the GnRH surge.  
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Fig. 1 Mean (± SEM) plasma cortisol concentrations in the control (♦; n=22), insulin-non-delayed (■; n=10), 
insulin-delayed (▲; n=11) and LPS (●; n=10) treated ewes. The arrows indicate the time of treatment.  
Some error bars are within the data symbol. 
               *      Times at which both insulin subgroups were different from controls (P<0.05).  
               **    Times at which treated groups were different from controls (P<0.05). 
               ***  Times at which the LPS cortisol values were different from the control group (P<0.001) and  
                        the insulin subgroups (P<0.05). 
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 Fig. 2 Mean (± SEM) plasma progesterone concentrations within an animal before treatment (grey bars) 
and mean (± SEM) maximum concentrations after treatment (black bars), in 22 control, 21 insulin treated 
(10 insulin-non-delayed and 11 insulin-delayed) and 10 LPS treated ewes. The differences between 
concentrations within an animal are linked by the line (* P<0.05). 
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Fig. 3 Representative individual oestradiol (●) and LH (▲) hormone profiles in control (ewe I), LPS (ewe Z), 
insulin-non-delayed (ewe Q and W) and insulin-delayed (ewe R and S) treated ewes relative to 
progesterone withdrawal (time 0 h). Arrows indicate the time of treatment.   
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Fig. 4 Change of oestradiol concentration  between 28 h (i.e. the predetermined time of treatment) and 
the 2 lowest values recorded after treatment but before LH surge onset (black bars) and duration of 
decrease (grey bars),  in control (n=22), insulin (non-delayed n=10, delayed n=11) and LPS (n=10) treated 
ewes.  
* P<0. 01 compared to control and insulin-non-delayed groups; P<0.05 difference in duration    
    indicated by line and **. 
 
 
 
 
 
 
 
 
-60
-50
-40
-30
-20
-10
0
10
20
30
40
%
 
o
e
s
t
r
a
d
i
o
l
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
c
h
a
n
g
e
 
a
f
t
e
r
 
t
r
e
a
t
m
e
n
t
 
a
n
d
 
b
e
f
o
r
e
 
t
h
e
 
L
H
 
s
u
r
g
e
 
a
n
d
 
d
u
r
a
t
i
o
n
 
o
f
 
d
e
c
r
e
a
s
e
 
(
h
)
Insulin-
delayed 
Control
s 
Insulin
-non- 
delayed 
LPS 
* 
* 
* 
* 
% Change in concentration 
Duration of change (hours)  
** 
 
* 
* 
66 
 
 
 
 
Fig. 5 Mean (± SEM) plasma cortisol (■) and rectal temperature (▲) responses to LPS In 10 ewes: rectal 
temperature increased by 1.80C. The arrow indicates the time of treatment. Some error bars not visible 
are within the data symbol. 
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Fig. 6 Mean (± SEM) plasma cortisol (▲) and glucose (■) in the insulin-non-delayed (n=10; open symbols, 
panel A), insulin-delayed (n=11; closed symbols, panel A) and LPS (n=10; closed symbols, panel B) groups, 
after two injections of insulin (4 iu/kg) or a single injection of LPS (100 ng/kg). The arrows indicate the 
time of treatment. Some error bars that are not visible are within the data symbol. * P<0.05 compared to 
glucose concentrations at 28h after progesterone withdrawal (i.e., the time of treatment). 
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Fig. 7 Mean (± SEM) plasma triglyceride concentrations of the insulin-non-delayed (■; n=10), insulin-
delayed (▲; n=11) subgroups from 0 to 34 h after progesterone withdrawal. The arrows indicate the time 
of treatment. Some error bars not visible are within the data symbol. Insert: Overall group mean (± SEM) 
of individual ewe mean plasma triglyceride concentrations after 5 measurements per ewe within a 34 h 
time period.   
 
 
 
 
 
 
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0 4 8 12 16 20 24 28 32 36
T
r
i
g
l
y
c
e
r
i
d
e
s
 
m
m
o
l
/
l
Hours after progesterone withdrawal
 
0
0.05
0.1
0.15
0.2
0.25
0.3
Insulin-non-delayed Insulin delayed
Tr
ig
ly
ce
ri
d
e
s 
m
m
o
l/
l
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 Mean (± SEM) hours from first to last display of different oestrus behaviours after progesterone 
withdrawal in 22 control ewes, 21 ewes injected with 4 iu/kg insulin (non-delayed n=10, delayed n=11) at 
28 and 30 h, and 10 ewes injected with 100 ng/kg LPS at 28 h after progesterone withdrawal. Timing of 
the LH surge is also shown. Within each panel, differences between the onset of each behaviour are 
indicated by different letters at each end of each bar, respectively (P<0.05); differences between the 
duration of each behaviour are also indicated by the letters at the end of each bar (P<0.02). Differences in 
the timing of onset between panels are indicated with asterisks. Time of treatment is indicated with the 
arrows.  * P<0.05 compared to controls and insulin-non-delayed groups, **P<0.001 compared to control 
and both insulin groups, *** P<0.001 compared to controls and insulin-non-delayed groups. **** P<0.05 
compared to controls and insulin subgroups.  
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Fig. 9 Mean (± SEM) interval from the onset of individual behaviours to the LH surge onset (time 0 h on 
the graph) in 22 control, 21 ewes injected with 4 iu/kg insulin (non-delayed n=10, delayed n=11) at 28 and 
30 h, and 10 ewes injected with 100 ng/kg LPS at 28 h after progesterone withdrawal. * P<0.03 compared 
to all behaviours between all groups.  
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Table 1 Effect of saline, insulin or LPS on LH surge parameters in 22 control, 21 ewes injected with 4 iu/kg 
insulin (non-delayed n=10, delayed n=11) at 28 and 30 h, and 10 ewes injected with 100 ng/kg LPS at 28 h 
after progesterone withdrawal.  
 
               
     a  N = number of animals within each group that had a delayed LH surge onset.
 
                
    b  h = hours after progesterone withdrawal. 
               
  c Within a row P<0.05 different from control group values.  
                        d
 Within a row P<0.05 compared to the control, insulin-non-delayed group. 
                   
e
 Within a row P<0.05 compared to the control and insulin subgroups. 
 
 
 
 
 
 
 Controls Insulin-non-delayed Insulin-delayed LPS 
 
    
N 
a
 1/22 0/10 11/11 10/10 
Incidence (%) 100 100 100 100 
Onset (h 
b
)  36.5 ± 1.2 34.5 ± 0.7 54.1 ± 1.4
d
 59.0 ± 1.7
e
 
Duration (h) 12.2 ± 0.5 12.0 ± 0.8 11.4 ± 0.9  11.6 ± 0.5 
Amplitude (ng/ml) 73.4 ± 5.2 60.7 ± 9.2 46.0 ± 2.3
c
 72.2 ± 11.1 
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Table 2 Mean (± SEM) of total frequencies of different behaviours (being nosed, tail fanning, being nudged 
and being mounted) displayed per ewe during the whole oestrus period in 22 control, 21 ewes injected 
with 4 iu/kg insulin (non-delayed n=10, delayed n=11) at 28 and 30 h and 10 ewes injected with 100 ng/kg 
LPS at 28 h after progesterone withdrawal.  
 
 
 
 
 
 
 
 
 
 
 
             a 
Within a row P<0.05 compared to the control and insulin groups. 
             b 
Within a row P<0.06 compared to controls and P<0.005 compared to LPS groups. 
             c 
No statistical difference detected du 
 
 
 
 
 
 
 
 
 
Controls Insulin-non-delayed Insulin-delayed LPS 
 
     
Nosed 20.5 ± 1.4 20.6 ± 3.4 24.3 ± 3.1 19.8 ± 2.5  
     
Tail Fanning 22.9 ± 5.7 6.4 ± 3.0 
c
 17.4 ± 4.0 17.4 ± 6.3 
     
Nudged 12.6 ± 1.3 17.0 ± 3.7 20.3 ± 4.7 20.5 ± 4.2 
     
Mounted 7.7 ± 0.9  10.0 ± 2.1 12.6 ± 2.6 
b
 3.4 ± 1.3
 a 
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Chapter 3 
Kisspeptin, c-Fos and CRFR type 2 co-expression in the preoptic area and 
hypothalamus at different times during the follicular phase of intact ewes and 
alteration after insulin or endotoxin. 
 
Keywords: c-Fos, kisspeptin, CRFR type 2, stress, oestrous behaviour, LH surge, insulin, 
LPS, ewes. 
 
 
Abstract 
The hypothalamic neuropeptide kisspeptin is essential for GnRH/LH surge release and, 
therefore, ovulation. The aim of the present study was to investigate the activational 
pattern of kisspeptin cells during the follicular phase of intact ewes. Furthermore, we 
tested the hypothesis that inhibition of kisspeptin activation is a major contributing 
factor to LH surge disruption during stress and this may involve CRFR type 2. Follicular 
phases of intact ewes were synchronised with progesterone vaginal pessaries. Control 
animals were killed at 0h, 16h, 31h and 40h (n=4-6 per group) after progesterone 
withdrawal (time zero). At 28 h, groups of animals received insulin (4 iu/kg) or endotoxin 
(LPS; 100 ng/kg) and were subsequently killed at 31h (insulin; n=5 and LPS; n=5) or 40h 
(LPS; n=5). Hypothalamic sections were immunostained for kisspeptin and a marker of 
neuronal transcriptional activation, c-Fos. LH surges only occurred in 40 h control ewes: 
they had a marked increase in the percentage of kisspeptin cells co-expressing c-Fos in 
the arcuate nucleus (ARC; from 13 to 68%; P<0.05) and medial preoptic area (mPOA; 
from 22 to 47%; P<0.05) compared to animals sacrificed at all other stages. However, 
12h after LPS treatment (i.e., at 40h), the percentage of kisspeptin cells co-expressing c-
Fos was lower in the ARC and mPOA (17% and 10%, respectively; P<0.05 for both) 
whereas there was an increase 3h after insulin (i.e., at 31h; 51%; P<0.05) in the ARC but 
no change in the mPOA, compared to controls killed at the same time. Furthermore, 
dual-label immunohistochemistry for kisspeptin and CRFR type 2 revealed that 21% 
kisspeptin cells co-express CRFR type 2 in the lower part of the ARC and the median 
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eminence (ME) of control animals and this percentage increased to 52 and 58%, 3h and 
12h, respectively, after LPS, but not insulin treatment (P<0.05). These results indicate 
that the LH surge is accompanied by intense transcriptional activation in ARC and mPOA 
kisspeptin cells. However, insulin or LPS administration in the late follicular phase, 
disturb this pattern by stimulating or inhibiting kisspeptin cell activation, respectively. 
CRFR type 2 is associated with inhibition of kisspeptin cells after LPS but not insulin. 
 
Introduction 
Gonadotrophin-releasing hormone (GnRH) neurones constitute the final common 
pathway of a complex neuronal network responding to the circulating steroid hormone 
milieu to control ovulation and sexual behaviour (Karsch et al., 1997, Caraty et al., 2002). 
In the ewe, both progesterone and oestradiol exert negative feedback to suppress GnRH 
release throughout most of the oestrous cycle (Moenter et al. 1991, Goodman, 1996). In 
the late follicular phase, increasing concentrations of oestradiol, secreted by the 
dominant follicle(s), switch to positive feedback mode and trigger the onsets of the 
GnRH/LH (luteinising hormone) surges as well as sexual behaviour (Fabre-Nys and 
Martin 1991). However, steroid hormone signals do not impinge directly on GnRH cells 
as these cells do not possess progesterone receptors (PR) or oestradiol receptors 
subtype α (ERα; Shivers et al., 1983, Herbison and Theodosis, 1992, Skinner et al., 2001). 
Recent evidence has revealed that kisspeptin is high in the functional ‘hierarchy’ that 
mediates steroidal influence on GnRH neurones in a large number of species (Smith, 
2008, Roseweir and Millar, 2009, Lehman et al. 2010a, Lehman et al. 2010b). In the ewe, 
kisspeptin has been implicated in mediating oestradiol negative and positive feedback 
(Estrada et al. 2006, Smith et al. 2007, Smith et al. 2009, Smith et al. 2011) as well as 
orchestrating GnRH/LH pulsatility (Lehman et al. 2010a) and surge secretion (Smith et al. 
2009, Smith, 2009, Caraty et al. 2010), although to date kisspeptin has not been 
associated with the control of oestrus behaviour (Kauffman et al. 2007). There is 
controversy concerning which of the two main populations of kisspeptin cells (in the ARC 
or the mPOA) are involved in oestradiol positive and negative feedback, or whether 
there are distinct populations within these nuclei that fulfill each of these roles (Estrada 
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et al. 2006, Smith et al. 2009, Caraty et al. 2010). Nonetheless, it is widely accepted that 
kisspeptin is essential for the GnRH/LH surge, and therefore ovulation, in many species 
including the ewe (Clarkson et al. 2008, Oakley et al. 2009, Smith et al. 2009, Clarkson 
and Herbison 2009, Lehman et al, 2010a, Caraty et al. 2010).  
Our recent data showed that sudden activation of the hypothalamic-pituitary-adrenal 
axis in the late follicular phase by administration of lipopolysaccharide (LPS) lowered 
plasma oestradiol concentrations and delayed the onsets of pre-copulatory behaviours, 
oestrus and the LH surge of free-running intact ewes, whereas insulin-induced 
hypoglycaemia had the same effect in only 50% of animals (Fergani et al. 2011). 
However, the precise mechanisms involved in this disruption have not yet been 
elucidated. Given the crucial role of kisspeptin in regulating GnRH secretion, we 
speculate that inhibition of kisspeptin activation is involved in stress-induced 
suppression of reproductive efficiency. Indeed, a few studies report down-regulation of 
the hypothalamic kisspeptin system in rats and male rhesus monkeys after metabolic or 
immune/inflammatory stressors, such as negative energy balance (Castellano et al. 
2010), short term fasting (Wahab et al. 2010) or administration of LPS (Iwasa et al. 2008, 
Kinsey-Jones et al. 2009). Furthermore, all these stressors were accompanied by 
suppression of the hypothalamic-pituitary- gonad axis.  
Studies assessing changes in messenger RNA (mRNA), or c-Fos induction as a marker of 
neuronal activation, suggest that a common pathway for the action of stressors is to 
stimulate the cellular activity of the paraventricular nucleus (PVN), especially neurones 
secreting corticotrophin releasing factor (CRF) and arginine vasopressin (AVP) that 
project to the median eminence (ME; Caraty et al. 1990, Battaglia et al. 1998, Dobson et 
al. 2000). In the rat, CRF has a pivotal role in stress-induced suppression of GnRH pulses 
and is thus a prime candidate for transmitting the ‘stress’ signal to GnRH cells directly or 
via interneurones (Li et al. 2005). CRF administration i.c.v. profoundly decreased 
kisspeptin and Kiss1 receptor mRNA levels in both the anteroventral periventricular 
nucleus (AVPV) and arcuate nucleus (ARC) of rats (Kinsey-Jones et al. 2009). In this 
species, kisspeptin (Smith et al. 2006) and CRF receptor (CRFR) type 1 and 2 distributions 
(Chalmers et al. 1995, van Pett et al. 2000) overlap in the AVPV and ARC and, therefore, 
an interaction between the two systems seems likely. Li et al. (2006) report that insulin-
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induced hypoglycaemia or LPS involve the activation of type 2 but not type 1 CRFR, to 
mediate inhibitory actions. However, the importance of CRF has not been confirmed in 
the ewe (Caraty et al. 1997, Battaglia et al. 1998). Whether kisspeptin neurones express 
CRFR is not known, and remains to be investigated in any species. 
Based on these observations, in the present study we examined brain tissue of intact 
ewes sacrificed at various times during the follicular phase with or without the 
administration of insulin or LPS. We used c-Fos (a marker for neuronal transcriptional 
activation; Hoffman et al., 1993) to locate the brain areas that may exhibit transient 
activational events before or after the onset of pre-copulatory behaviours and oestrus, 
during the LH surge or after stress. We were particularly interested to investigate any 
possible differences in insulin treated animals that could explain our previous results 
with split responses, after the application of this stressor (Fergani et al., 2011). 
Furthermore, we aimed to map the pattern of kisspeptin activation (by measuring co-
expression with c-Fos) in the ARC and mPOA, at various times during the follicular phase, 
and test the hypothesis that inhibition of kisspeptin activation is a major contributing 
factor to the LH surge disruption after the application of LPS or insulin. Finally, we 
examined the presence of CRFR type 2 in kisspeptin cells to establish whether 
upregulation of this particular receptor is associated with failure of kisspeptin cell 
activation. 
Materials and Methods  
Animals, study design and blood sampling procedure 
The study was performed in the mid-breeding season (October/November) on 36 
mature intact Lleyn crossbred ewes, weighing between 50 and 80 kg. From two weeks 
prior to the study, the ewes were penned indoors (space 15 x 7 metres) with 3 teaser 
rams. All animals were fed daily a constant diet of ad libitum hay and had free access to 
water. Frequent handling, for at least a week ensured that procedural stressors did not 
interfere with the main part of the study by acclimatizing the animals to human 
manipulations and a simulated blood sampling process. All procedures were conducted 
in accordance with requirements of the UK Animal (Scientific Procedures) Act, 1986, and 
approved by the University of Liverpool Animal Welfare Committee. 
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Ovarian follicular phases were synchronised by the insertion of two intravaginal 
progesterone-releasing pessaries (Controlled Internal Drug Release [CIDR-G]; InterAg, 
Hamilton, New Zealand) for nine days and an intramuscular (i.m.) injection of 
prostaglandin (Lutalyse, 5 mg/ewe, Pharmacia & Upjohn, UK), 12 h before, and a second 
injection, at CIDR-G removal, to ensure corpus luteum regression. The time of 
progesterone withdrawal (i.e. the commencement of the follicular phase) is referred to 
hereafter as time 0 h.   
The experimental protocol is outlined in Fig.1. The ewes were randomly allocated to 
seven groups. One group of animals were killed at 0 h (0 h control group; n=5) and 
another group at 16 h after progesterone withdrawal (16 h control group; n=4). At 28 h, 
the remaining animals received 2 ml of saline vehicle or insulin (neutral zinc bovine 
insulin, Hypurin Neutral, CP Pharmaceuticals, Wrexham, UK; i.v. dose of 4 iu/kg body 
weight) or endotoxin (Lipopolysaccharides from Escherichia coli 055:B5, LPS, Sigma-
Aldrich, UK; i.v. dose of 100 ng/kg body weight). Three groups were killed at 31h (31h 
control, n=6; 31h insulin, n=5 and 31h LPS group, n=5) and two groups at 40h after 
progesterone withdrawal (40h control, n=5 and 40h LPS group, n=5).   
Frequent blood sampling, as well as the administration of all substances, was facilitated 
by the insertion of a silastic catheter into the jugular vein of each ewe under local 
anesthesia before progesterone withdrawal. Patency was maintained with heparinised 
saline (Multihep, 100 iu/ml, Leo Laboratories, Princes Risborough, UK) administered 
after each blood withdrawal. Blood samples (5 ml at time 0h, 16h, 24h and subsequently 
at 2h intervals till 40h) were collected from all ewes into heparinised tubes and 
centrifuged immediately at 1000 g for 20 min at 40C. Plasma was stored at -200C until 
analysis. Samples, in duplicate, were analysed by second antibody Enzyme-Linked 
Immunosorbent Assays (ELISA) for LH, and by single antibody ELISA for pregnane 
metabolites (equivalent to and hereafter referred to as progesterone) or cortisol. LH 
results were expressed as ng equivalent of NIAMDD ovine LH 21 per ml plasma. 
Oestradiol was measured with a modified radioimmunoassay (RIA) using 0.5 ml plasma 
extracted with 3 ml diethyl ether followed by evaporation to dryness. All assays were 
verified for use in sheep (Saifullizam et al., 2010). Contemporary inter-assay and intra-
assay coefficients of variation for LH, progesterone, cortisol and oestradiol were all less 
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than 12%.  The minimum detectable amounts were 0.02 ng/ml; 0.16 ng/ml, 0.8 ng/ml 
and 0.2 pg/ml and assay precisions (in the mid-range of the standard curve) were 0.1 
ng/ml, 0.01 ng/ml, 0.2 ng/ml and 0.2 pg/ml, respectively. All samples from individual 
animals were measured in the same assay for each hormone. In general, 100 μl aliquots 
of plasma were assayed initially, and samples that were greater than the maximum 
standard were re-assayed after a ten-fold or fifteen-fold dilution.  
Visual observation of oestrous behaviour 
Ewe and ram oestrus behaviour was monitored by two trained observers for a 30-
minute observation period prior to each blood sample collection. Paint spray was used 
to place a large identification symbol on the back and sides of each ewe and ram. The 
observers were elevated 1.5m above the pen so identification of symbols and all 
activities could be seen without disturbing the animals.  At each observation period, 
quantitative and qualitative data were recorded for each ewe and ram individually. Once 
a minute throughout each observation period, it was noted if a ewe was within one 
metre of a ram [behavioural scan sampling; Martin and Bateson (1986)]. In addition, the 
following behavioural signs of oestrus were counted throughout each 30 min 
observation period: ram nosing the perineal region of a ewe; ewe being nudged by a 
ram without the ewe moving away; and, mounting of the ewe by a ram without the ewe 
moving away. Due to the 2-hourly observation regime, the beginning of a period was 
respectively defined as the first (minus 1.0h) 30-min observation period the animal 
exhibited a particular behavioural sign.  
Tissue collection 
With minimal disturbance of the animals, euthanasia was carried out with 20 ml of 20% 
w/v sodium pentobarbitone (Pentobarbital, Loveridge, Southampton, UK), containing 
25,000IU heparin. Each head was retrieved immediately, jugular veins occluded and 
perfused bilaterally via the carotid arteries using a peristaltic pump (Gilson Minipulus-3, 
Villiers, France). The solutions used for perfusion were: 2 litres 0.1M phosphate buffer 
(PB; pH7.4) containing 25,000IU per litre of heparin and 1% sodium nitrate; then 2 litres 
of Zamboni fixative (4% paraformaldehyde powder and 7.5% saturated picric acid in 
0.1M PB, pH7.4); followed by 500ml of the same fixative containing 30% sucrose. The 
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brain was left within the skull for a further 4h and then 500ml of wash–out solution 
(0.1M PB, 40% sucrose and 0.1% sodium azide) was pumped through. The brain was 
retrieved immediately afterwards and 17mm hypothalamic blocks (extending from the 
optic chiasma to the mammilary bodies) were obtained. These were stored in the wash-
out solution at 40C for a week. The blocks were frozen using isopentane (2-
Methylbutane, Chromasolv®, for HPLC, Sigma-Aldrich, UK) and liquid nitrogen as 
described by Rosene et al. (1986) and stored at -800C. Frozen coronal sections (40 μm) 
were cut using a freezing microtome (Microm HM400R, Walldorf, Germany). Free-
floating sections were stored in 96-well microtest plates (catalogue number 82.1582, 
Sarstedt, UK) with each section placed in an individual well filled with cryoprotectant 
solution (Watson et al. 1986) and stored at -200C until processed for 
immunohistochemistry. 
c-Fos and kisspeptin dual-label immunohistochemistry  
A series of every 15th section through the hypothalamus and preoptic area from each 
animal was processed for c-Fos and kisspeptin staining using a dual-immunoperoxidase 
protocol in which nuclear c-Fos was detected first with nickel sulfate-enhanced 
diaminobenzidine as chromogen (ni-DAB; black reaction product), followed by detection 
of cytoplasmic kisspeptin using unenhanced diaminobenzidine (DAB; brown reaction 
product). All steps were performed at room temperature unless otherwise stated. 
Antibodies were diluted with 2.5% normal donkey serum (catalogue item S2170, 
Biosera, UK), 1% Triton X-100 (T9284, Sigma-Aldrich, UK) and 0.25% sodium azide 
(Sigma- Aldrich, UK) in 0.1M phosphate buffer saline, pH7.2 (PBS). Free-floating sections 
were washed thoroughly in PBS for 2h to remove the cryoprotectant solution followed 
by a 15min incubation in 40% methanol and 1% hydrogen peroxide (H2O2; 316989, 
Sigma-Aldrich, UK) in PBS  to inactivate endogenous peroxidases. After three 10min 
washes, sections were incubated for 1h in blocking solution (10% donkey serum in PBS). 
This was followed by a 72h incubation in rabbit anti-c-Fos antibody (AB-5, PC38, 
Calbiochem, Cambridge, MA, USA) at a dilution of 1:5000 at 40C. After incubation with 
primary antiserum, sections were washed thoroughly and incubated with biotinylated 
donkey anti-rabbit IgG (1:500; 711-065-152, Jackson Immunoresearch, West Grove, PA) 
for 2h, followed by three 10min washes and then 90min in Vectastain Elite ABC kit 
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(1:250 in PBS; PK6100, Vector Laboratories Ltd, UK). After repeating washes, nuclear c-
Fos was visualised by 5min incubation in ni-DAB (SK-4100, Vector Laboratories Ltd, UK). 
A second immunohistochemical procedure was then performed, as described above, to 
stain the second primary antibody: rabbit anti-kisspeptin serum (1:25,000; lot 564; gift 
from Prof. Alain Caraty, Nouzilly, France), incubated for 72h at 40C and then visualised 
using DAB. Finally, sections were washed in distilled water, mounted on Chrome Alum 
Gelatine coated slides and left to air-dry for 3 days. Slides were dehydrated in a series of 
solutions (5min in each) containing 73%, 85%, 96% and two changes in 100% alcohol 
followed by xylene and a coverslip was applied using DPX. Negative control sections 
were performed routinely by omitting primary antibody(s) which was substituted with 
antibody diluting solution alone. This resulted in complete loss of staining.  
CRFR type 2 and kisspeptin dual-label immunohistochemistry  
In the case of dual-labelling for CRFR type 2 (1:4000; ab12964; Abcam UK; Lakshmanan 
et al., 2007) and kisspeptin, three sections, about 240 microns apart, containing the ARC 
and ME together were chosen and a dual-immunoperoxidase staining protocol 
performed as described above. In this protocol a different type of secondary 
biotinylated antibody was used (R.T.U.; PK-7200, Vector Labs). The CRFR type 2 
immunohistochemistry was performed first and the visualization was performed with ni-
DAB to produce a black product. A second immunohistochemical procedure followed to 
stain for kisspeptin using DAB alone. The exclusion of the primary or secondary antibody 
resulted in a complete absence of staining. 
Data analysis 
Hormone, behaviour and immunohostochemistry data were analysed with Minitab® 15 
statistical package (MINITAB Inc, Pennsylvania, USA). Results are expressed as mean ± 
SEM, and for all analyses, statistical significance was regarded when P<0.05.  An LH surge 
was defined as a sustained increase (>4h) in LH plasma concentrations and was 
considered to begin (surge onset) when the first value increased more than ten times 
the minimum detectable quantity (i.e. >10 ng/ml). Cortisol, progesterone and oestradiol 
concentrations were compared between groups, per hour, with a general linear model 
(GLM) ANOVA followed by Tukey’s multiple comparisons post hoc test, when 
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appropriate. In addition, progesterone concentrations at 28h (i.e. just prior to 
treatment) were compared to the two mean consecutive maximum values recorded 
after treatment with a Wilcoxon sign rank test. 
 
Sections were examined using a microscope (Nikon Microscope, Eclipse 80i) and 
photographed with a Nikon camera using a 20× objective. The areas examined were (as 
defined by Welento et al., 1969): the VMN (4 photographs per section, 6 sections per 
ewe), ARC (3 photographs per section, 10 sections per ewe, which consisted sections 
from the rostral, middle and caudal divisions of the nucleus), ME and bed nucleus of the 
stria terminalis (BNST; 1 photograph per section, 6 sections per ewe, for both areas), 
mPOA (2 photographs per section, 5 sections per ewe), diagonal band of Brocca (dBb; 2 
photographs per section, 3 sections per ewe) and the PVN (1 photograph per section, 6 
sections per ewe). CRFR type 2 and kisspeptin data were derived from 3 photographs 
that included the lower part of the ARC and the ME. Data from these two areas were 
combined because of the small number of cells but also due to the confined location of 
the receptors; i.e., on the ‘border’ either side of the ARC and ME boundary (i.e., there 
was difficulty in distinguishing whether some receptors belonged to the ARC or to the 
ME). Sections were evaluated unilaterally and each photograph was taken from a 
random field within each area. All photographs were imported in to Image J version 
1.42q, and counts were performed using the cell count plug-in. The observer was 
unaware of the animal identity and group. The mean total number and percentage of 
single- or dual-labeled cells was summed from the photographs of each area/section and 
then averaged for each ewe and compared with GLM ANOVA followed, where 
appropriate, by Tukey’s multiple comparisons post hoc test. Means (±SEM), as presented 
in figures and results, were calculated by averaging values from ewes in each group. 
During data analysis, it became clear that there was a split response in the insulin group 
regarding the c-Fos activation of the PVN. Therefore this group was separated into two 
subgroups referred to hereafter as insulin-responders or insulin-non-responders 
depending on c-Fos activation. As this division reduced the group size to n=2/group, 
statistical analysis was not undertaken, but the data are presented for information. 
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When responses were not different between sub-groups, data were combined and 
analysed with n=4.  
Results 
Three animals exhibited signs of oestrus and were mounted by a ram within 28 h after 
progesterone withdrawal (i.e., before the predetermined time of treatment; one from 
each of the 31h INS, 31h LPS and 40h LPS groups). The data from these three ewes were 
excluded from further analyses. None of the animals showed any signs of illness, with a 
few exceptions of mild coughing and briefly increased respiration rate for the ewes that 
received LPS.  
Luteinising hormone (LH) and behavioural profiles. 
The onset of pre-copulatory behaviours, oestrus and the LH surge of individual ewes 
with respect to progesterone withdrawal (PW) are shown in Table 1.  None of the 
treated animals began an LH surge during the 40h of study. However, three of the five 
animals in the 40h-control group had an LH surge with a mean onset at 36.7 ± 1.3 h 
(Table 1). The data were analysed in two ways: the first consisted of control ewe data 
grouped according to time after PW, then by sexual behavioural status and whether an 
LH surge had occured; i.e., grouped into those killed at 0h and 16h after PW, those killed 
at 31h after PW but before the onset of sexual behaviour (Before behaviour, n=3), those 
killed at 31h or 40h after PW, after the onset of sexual behaviour but before exhibiting 
an LH surge (After behaviour, n=5) and those killed after the onset of both sexual 
behaviour and during the LH surge (Surge, n=3). This grouping allowed for a detailed 
comparison of neuropeptide profiles in control animals at different stages of the 
follicular phase in our intact-ewe model. Secondly, control and treated animal data were 
grouped according to time of killing after PW, and this was used to compare treatment 
effects. 
Control ewes: transcriptional activation in the hypothalamus and preoptic area at 
different stages during the follicular phase, in animals grouped by behaviour. 
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VMN 
The number of c-Fos positive cells in the VMN was three times greater in the ‘Surge’ 
group compared to all other stages in the follicular phase of control ewes (P<0.05 for all 
comparisons; Fig 2A).  
ARC 
The number of c-Fos positive cells in the ARC was four times greater in the ‘Surge’ group 
compared to all other stages in the follicular phase of control ewes (P<0.05 for all 
comparisons; Fig 2B). 
mPOA 
The number of c-Fos positive cells in the mPOA was three times greater in the ‘Surge’ 
group compared to all other stages in the follicular phase of control ewes (P<0.001 for 
all comparisons; Fig 2C). 
ME, dBb, BNST 
The number of c-Fos positive cells in the ME and dBb was not different at any stage in 
the follicular phase of control ewes (Fig 2D and 2E). However, the number of c-Fos 
positive cells in the BNST was three times greater in the ‘Before behaviour’ group 
compared to all other stages in control ewes (P<0.001 for all comparisons; Fig 2F).  
Control ewes: kisspeptin and c-Fos co-expression in the hypothalamus and preoptic area 
at different stages during the follicular phase, in animals grouped by behaviour. 
Distribution of kisspeptin immunoreactive cell bodies and fibres 
Examination of serial sections revealed the presence of kisspeptin immunoreactive cell 
bodies and fibres in the following anatomical structures as defined by Welento et al. 
(1969) and similar to those in previous reports (Franceschini et al. 2006, Lehman et al. 
2010a): the rostral, but primarily the medial and caudal ARC, extending up to the pre-
mammilary recess; the mPOA at the level of the organum vasculosum of the lamina 
terminalis; and the PVN (~ 30 cells per section and numerous fibres). A small number of 
scattered kisspeptin positive cells and fibres were also detected alongside the walls of 
the third ventricle, the VMN and the dorsomedial hypothalamus but this was not 
consistent in all animals. A few kisspeptin cells (~ 5-10 cells per section) were observed 
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in the internal zone of the ME, along with a dense fibre network, but this network was 
less dense in the external zone. The number of kisspeptin positive cell bodies differed 
among animals but not groups (full data not shown). No kisspeptin cells were observed 
in the dBb or the BNST.  
ARC 
There was a marked increase in the percentage of kisspeptin cells that co-expressed c-
Fos in the ‘Surge’ group compared to all other stages in the follicular phase (P<0.01; Fig 
3A).  
mPOA 
The percentage of kisspeptin cells that co-expressed c-Fos, gradually increased from 16h 
through ‘Before behaviour’ and ‘After behaviour’ to the ‘Surge’ group (P<0.05, for 
‘Surge’ compared to all other stages in the follicular phase; Fig 3C).  
Control, insulin or LPS ewes: transcriptional activation in the hypothalamus and preoptic 
area at different times during the follicular phase, in animals grouped by hours after PW. 
PVN 
The number of c-Fos positive cells in the PVN was not different between control animal 
groups (Fig. 4). A marked increase in c-Fos positive cells was observed in the PVN after 
LPS treatment (31h and 40h LPS groups; P<0.05 for both times; Fig 4) compared to 
control groups. Interestingly, the same was not observed after insulin treatment. During 
data analysis, it became clear that this was due to a split response; two out of four 
insulin-treated animals had an increase in PVN c-Fos-positive cells (12.9 ± 8.4% versus 
81.7 ± 5.7%, compared to controls; Fig 4A, 4B) but not the remaining two ewes (12.9 ± 
8.4% versus 9.7 ± 4.0%, compared to controls; Fig 4A, 4C). Therefore, the insulin treated 
animals were separated into two sub-groups, referred to hereafter as insulin-responders 
or insulin-non-responders, respectively.  
VMN 
At 31h after PW (i.e., 3h after insulin or LPS administration), there was a marked 
increase in VMN c-Fos positive cells in the LPS group (P<0.01) and the insulin-responder 
sub-group (Fig 5A). The effect of LPS was still evident when compared to the control 
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groups at 40h after PW, (i.e., 12h after the initial application of saline or LPS; P<0.05; Fig 
5A).  
ARC 
At 31h after PW (i.e., 3h after insulin or LPS administration), there was a marked 
increase in the number of ARC c-Fos positive cells in LPS (P<0.01; Fig 5B) compared to 
controls. An increase was also observed in both insulin sub-groups (from 59.9 ± 16.9 to 
215.8 ± 49.8 cells; combined insulin-responders and insulin-non-responders; P<0.01; Fig 
5B) compared to controls. At 40h after PW (i.e., 12h after the initial application of saline 
or LPS), when the majority of control animals were undergoing an LH surge, control and 
LPS group data were not different (Fig 5B). 
mPOA 
At 31h after PW (i.e., 3h after insulin or LPS administration), the number of c-Fos 
positive cells in the mPOA increased in the LPS group (P<0.03; Fig 5C), but not in either 
insulin subgroup, compared to controls. At 40h after PW (i.e., 12h after the initial 
application of saline or LPS), when the majority of control animals were undergoing an 
LH surge, control and LPS group data were not different (Fig 5C). 
ME, dBb, BNST 
The numbers of c-Fos positive cells in the ME and BNST were not altered after the 
application of insulin or LPS (Fig 5D and 5F). However, at 31h and 40h after PW (i.e., 3h 
and 12h after LPS administration) LPS treatment groups had markedly increased 
numbers of c-Fos positive cells in the dBb compared to controls (P<0.05; Fig 5E); 
whereas, insulin had no effect (Fig 5E). 
 
Control, insulin or LPS ewes: kisspeptin and c-Fos co-expression in the hypothalamus and 
preoptic area at different times during the follicular phase, in animals grouped by hours 
after PW. 
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PVN 
There was no difference between groups, in the percentage of kisspeptin cells that co-
expressed c-Fos in the PVN (16.9 ± 4.3 %; full data not shown).  
ARC 
At 31h after PW (i.e. 3h after insulin or LPS administration), the percentage of kisspeptin 
cells that co-expressed c-Fos increased in both insulin sub-groups compared to controls 
(from 10.7 ± 1.7 to 51.0 ± 1.0%; combined insulin-responders and insulin-non-
responders;  P<0.05; Fig 3B), whereas the LPS group was not different to controls (Fig 
3B). However, at 40h after PW (i.e., 12h after LPS administration) the percentage of 
kisspeptin cells that co-expressed c-Fos was markedly lower in LPS treated animals 
compared to controls (P<0.01; Fig 3B). Photomicrographs of sections of the ARC in 
control and LPS treated animals are shown in Fig 6. 
mPOA 
At 31h after PW (i.e., 3h after insulin or LPS administration), the percentage of kisspeptin 
cells that co-expressed c-Fos was not different between control and treated groups (Fig 
3D). However, at 40h after PW (i.e., 12h after LPS administration), the percentage of 
kisspeptin cells that co-expressed c-Fos was markedly lower in LPS treated animals 
compared to controls (P<0.01; Fig 3D).  
CRFR type 2 and kisspeptin  
Distribution of cells containing CRFR type 2 in the ARC + ME 
Examination of sections containing ARC and ME structures revealed the presence of 
CRFR type 2 immunoreactivity in the lower part of the ARC, as well as the internal zone 
of the ME. At cellular level, the receptors had a ‘ring-like’ morphology and were 
cytoplasmic in nature (Fig 7D, 7E, 7F). 
CRFR type 2 immunoreactivity 
There was no difference in the number of CRFR type 2 cells between control and insulin 
treated animals (Fig 7A). However, LPS treatment increased CRFR type 2 
immunoreactivity in the lower part of the ARC + ME (P<0.001; Fig 7A). This was evident 
at 31h and 40h after PW (i.e. 3h and 12h after LPS administration).  
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Kisspeptin and CRFR type 2 co-expression. 
In control and insulin-treated animals, there was no difference in the percentage of 
kisspeptin cells that co-expressed CRFR type 2 (average throughout: 21.3 ± 2.6%; Fig 7B). 
However, at 31h and 40h after PW (i.e., 3h and 12h after LPS administration), the 
percentage of dual–labelled cells doubled in the LPS groups (P<0.05; Fig 7B, 7G). There 
was no difference between groups in the percentage of CRFR type 2-positive cells that 
co-localised kisspeptin (average throughout: 10.6 ± 1.9%; Fig 7C).  
Hormone data 
Cortisol  
In all control animals, mean plasma cortisol concentrations remained low throughout 
(10.5 ± 0.7 ng/ml; Fig. 8). Before the application of insulin or LPS (i.e., at 24 and 28h after 
PW), cortisol concentrations did not differ from values in controls (Fig. 8). At 30h, 
cortisol concentrations in both insulin-treated groups were elevated compared to 
controls (from 9.5 ± 0.7 to 70.4 ±5.8 ng/ml; combined insulin-responders and insulin-
non-responders; P<0.001; Fig. 8). At 30h, both groups of LPS animals, had higher values 
compared to control and insulin-treated groups (P<0.001; Fig. 8). In the 40h LPS group, 
ewes had increased concentrations compared to the controls at 32, 36 and 40h (for each 
P<0.05; Fig. 8). Mean maximum cortisol concentrations (157 ± 19.8 ng/ml) for the LPS 
groups were observed 2h after treatment (Fig. 8).  
Progesterone 
All groups had similar plasma progesterone concentrations at 0h and 28h after PW (33.7 
± 2.0 ng/ml and 6.6 ± 0.4 ng/ml, respectively). There was considerable between-animal 
variation, and values between treated and control groups were not different at each 
time point after treatment; therefore, a within-group comparison was also made. 
Control and insulin sub-groups had similar concentrations of progesterone before and 
after treatment (Fig.9). Progesterone concentrations were different in the 40h LPS 
group, increasing from 6.9 ± 1.0 ng/ml to a mean maximum of 9.9 ± 1.6 ng/ml after 
treatment (P<0.05; Fig. 9).  Progesterone concentrations after PW in control animals are 
also shown in Fig. 10.  
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Oestradiol 
In control animals, plasma oestradiol concentrations continued to increase from 28h 
after PW to maximum values between 32h and 36h after PW (Fig 10A). However, after 
treatment with insulin, oestradiol concentrations were lower 2h after the first injection 
compared to controls killed at the same time (from 9.5 ± 0.8 to 4.1 ± 0.4 pg/ml; 
combined insulin-responders and insulin-non-responders; P<0.05; Fig. 10B). In contrast, 
in LPS ewes the decrease occurred more slowly: values tended to be lower than controls 
8h after treatment (i.e., at 36h after progesterone withdrawal; P<0.07; Fig.10A) and 
thereafter continued to decrease significantly until ewes were killed at 40h (P<0.02; Fig 
10A).  
Discussion 
The present results demonstrate that during the LH surge of intact ewes (and not at 
other stages in the follicular phase) there is an intense transcriptional activation of 
kisspeptin cells located in the ARC and mPOA. This suggests that cells in these areas 
contribute to oestradiol positive feedback to stimulate the GnRH/LH surge in this 
species. However, LPS treatment in the late follicular phase inhibited kisspeptin 
activation in the ARC and mPOA, whereas insulin stimulated kisspeptin activation in the 
ARC but had no effect in the mPOA. Dual-label immunohistochemistry revealed that 21% 
of kisspeptin cells co-express CRFR type 2 in control and insulin-treated ewes but this 
doubled in LPS treated animals. Thus, CRFR type 2 is associated with inhibition of 
kisspeptin transcriptional activation and the disruption of the LH surge after LPS but not 
after insulin. 
Controls: kisspeptin and c-Fos co-expression in the hypothalamus and POA at different 
stages of the follicular phase.  
At all times during the follicular phase c-Fos positive cells were observed in all the brain 
areas examined with a marked increase in the VMN, ARC and mPOA during the LH surge. 
Interestingly, at 31h after PW (i.e., the time when oestradiol was reaching maximum 
concentrations) activation was low in the VMN, ARC and mPOA.  As the GnRH surge 
generating mechanism consists of three phases (activation, transmission and surge 
secretion; Evans et al., 1997, Harris et al., 1998, Harris et al., 1999), our results suggest 
 91 
 
that these areas are involved in the surge secretion phase. These findings concur the 
work of Richter et al., (2005) who examined ovariectomised (OVX) animals during the 
activation phase of the surge generating mechanism (4h after oestradiol administration) 
as well as during the surge onset (20-25h after oestradiol). They also report higher 
transcriptional activation of the ARC and mPOA in the latter stage but not the former.  
Oestradiol implants in the mediobasal hypothalamus (MBH; the vicinity of the ARC and 
VMN) initiated pre-copulatory behaviours and oestrus (Blache et al., 1991). We did not 
detect an increase in MBH (ARC or VMN) activation in animals before or after the onset 
of sexual behaviour and before the LH surge. This does not exclude involvement of these 
areas in sexual behaviour. It may be that the phenotype of cells changes to stimulate 
sexual behaviour, even though the overall number of c-Fos activated cells remains the 
same. A similar conclusion might be drawn regarding the lack of variation during the 
follicular phase in the number of c-Fos positive cells in the ME or dBb. In contrast, an 
increase in BNST activation was observed in animals just before the expected onset of 
pre-copulatory behaviours/oestrus suggesting that this area may be an intermediary 
between the MBH and GnRH neurones in the mPOA for the control of oestrous 
behaviour (Caraty et al., 2002) and/or the GnRH/LH surge (Pompolo et al., 2001, Pereira 
et al., 2010). Indeed, the BNST is an ERα-rich area (Goubillion et al., 1999) that receives 
projections from the MBH and also sends projections to the mPOA where most GnRH 
cell bodies are located (Pompolo et al., 2001, Pereira et al., 2010). However, it must be 
noted that the animals in our ‘Surge’ group were also exhibiting sexual behaviour and, 
therefore, the transcriptional increase observed in the VMN and ARC could, in part, be 
involved with changes in behaviour as well.  
In the ewe, there are contradictory results concerning which of the two main 
populations of kisspeptin cells (the ARC or the mPOA) are involved in positive or 
negative oestradiol feedback. In the present study, the LH surge of intact ewes was 
accompanied by an intense transcriptional activation of kisspeptin neurones located in 
both these areas. Regarding the ARC, all regions (rostral, middle and caudal) contributed 
equally to the increase. This, together with the observation that oestradiol acts in the 
MBH to induce the LH surge in the ewe (Blache et al., 1991; Caraty et al., 1998) suggests 
that these ARC cells are involved in oestradiol positive feedback. However, as the 
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oestradiol signal initiating the GnRH surge begins well in advance of the surge itself 
(Evans et al., 1997), we cannot conclude that ARC kisspeptin cells are solely responsible 
for the feedback effects of oestradiol, but are most likely only involved in the surge 
secretion mechanism. Indeed, in the present study, plasma oestradiol concentrations in 
control animals were elevated at 28h, reached a maximum at 32h-36h after PW and 
then decreased just as the LH surge occurred, but we did not observe a striking change 
in ARC kisspeptin neurone activity around the time of oestradiol maximum 
concentrations. However, we cannot rule out the possibility that activation in ARC 
kisspeptin neurones may have occurred at other times than those we examined in the 
present study; or the 11% of ARC kisspeptin cells that were activated prior to the surge 
were sufficient of transmit the positive oestradiol signal to GnRH neurones. Indeed, the 
LH response to exogenous kisspeptin increases during the cycle and is highest in the pre-
ovulatory phase in rats and women (Roa et al., 2006, Dhillo et al., 2007). Recent reports 
indicate that ARC kisspeptin neurones co-express c-Fos in OVX ewes 1–2h after 
administration of a short oestradiol signal, i.e., 12–18h before the onset of the LH surge 
(Smith et al., 2009). This raises the possibility that ARC kisspeptin neurones are activated 
in response to the initial oestradiol increase and are involved in the early stages of the 
surge induction process. However, in the same study, kisspeptin mRNA increased only 
immediately prior to the LH surge of non-steroid-treated intact ewes. This 
incompatibility in results may be due to the use of ovariectomised or intact animals with 
high supplementary oestradiol doses that could produce different c-Fos activation 
patterns than are normally seen in intact animals with physiological oestradiol 
concentrations. Almost all kisspeptin cells in the ARC, but not elsewhere, co-express 
dynorphin and neurokinin B (Goodman et al., 2007). Therefore, activation of kisspeptin 
cells may reflect increased activity of any of the three neurotransmitters, dynorphin, 
neurokinin B and/or kisspeptin in this region.  
Turning to the mPOA, we observed a gradual increase in kisspeptin activation during the 
follicular phase with maximum activation during the surge. Interestingly, the proportion 
of activated cells was in the same range as the proportion of POA kisspeptin cells that 
express ERα in this species (Franceschini et al., 2006). Two recent studies also report an 
increase in c-Fos activity of the mPOA kisspeptin cells at the time of the preovulatory LH 
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surge (Hoffman et al., 2010) and an increase in kisspeptin mRNA in the late follicular 
phase (Smith et al., 2009). However, as mentioned above, in the ewe, oestradiol acts in 
the MBH, not the POA, to induce the LH surge (Blache et al., 1991; Caraty et al., 1998) so 
we speculate that mPOA kisspeptin neurones are activated secondarily (possibly via the 
ARC) during oestradiol positive feedback. Indeed, Lehman et al. (2010a) report the 
existence of projections from ARC kisspeptin neurones to POA kisspeptin neurones, 
indicating that activation of one population could influence another. The recent 
demonstration that both ARC and mPOA kisspeptin cell populations in sheep are 
sexually dimorphic is consistent with the view that the two populations could be 
involved in the GnRH surge inducing process (Cheng et al., 2010).  
Kisspeptin has also been implicated in oestradiol negative feedback. Ovariectomy 
increases kisspeptin peptide and kisspeptin mRNA expression in the ARC of ewes 
(Pompolo et al., 2006, Smith et al., 2008) and rats (Smith et al., 2006) while oestradiol 
replacement diminishes this effect. In our study, kisspeptin activation remained low 
during the follicular phase except at the time of the LH surge. One way of interpreting 
these results is that a low level of oestradiol inhibits the expression of kisspeptin, leading 
to reduced GnRH secretion, consistent with negative feedback regulation.  
Insulin or LPS: kisspeptin and c-Fos co-expression in the hypothalamus and POA in ewes 
after treatment in the late follicular phase. 
Expression of c-Fos in the ovine central nervous system is a useful marker for the 
identification of brain regions activated by stressors (Vellucci and Parrott, 1994). In the 
present study, LPS administration in the late follicular phase lowered plasma oestradiol 
concentrations and activated specific brain areas at different times. Interestingly, an 
increase in activation was observed in the ARC, VMN, mPOA and dBb as soon as 3h after 
treatment, whereas plasma oestradiol concentrations decreased 8h after the 
administration of LPS. Thus, there could be at least two mechanisms activated during 
LPS inhibition of the ovarian cycle; one involving disruption of GnRH/LH pulses and, 
therefore, reducing oestradiol secretion; and the other, preventing the ability of the 
surge-generating mechanism to respond to the preovulatory oestradiol increase 
(Battaglia et al., 1999, Karsch and Battaglia, 2002). Furthermore, LPS markedly 
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decreased the proportion of activated kisspeptin cells three- to four-fold in the ARC and 
mPOA, and this was evident 12h after treatment. Therefore, we cannot be sure which of 
the two mechanisms disrupted kisspeptin cell activation.  
Cortisol and progesterone suppress pulsatile GnRH/LH secretion (Karsch et al., 1987, 
Debus et al., 2002, Oakley et al., 2009) and disrupt the positive feedback effect of 
oestradiol to trigger an LH surge (Kasa-Vubu et al., 1992, Skinner et al., 1998, Richter et 
al., 2002, Smith et al., 2003, Richter et al., 2005, Pierce et al., 2009, Wagenmaker et al., 
2009a). In the present study, cortisol increased to maximum concentrations 2h after 
administration of LPS, and may be involved in the GnRH surge mechanism disruption. By 
contrast, the timing of maximum progesterone values varied considerably between 
animals, from 2h to 10h after treatment. Thus, we cannot determine which mechanism 
is disrupted by progesterone. The potential influence of pyrexia remains to be 
determined: maximum temperatures after the same dose of LPS were reached 4h after 
treatment (Fergani et al., 2011) indicating that pyrexia, presumably via prostaglandin, 
may contribute to the attenuation of GnRH pulses. Nonetheless, as the LPS treated 
animals did not have an LH surge at the same time as controls, we conclude that the 
inhibition of the kisspeptin system is a major contributing factor in LH surge disruption 
after an immune/inflammatory challenge in the ewe. Our data agree with findings in rats 
showing that kisspeptin and kisspeptin receptor mRNA are reduced in the ARC and POA 
concomitant with gonadotrophin hormone secretion suppression (Iwasa et al., 2008, 
Kinsey-Jones et al., 2009).  
Oestradiol concentrations decreased within 2h after insulin treatment, but only after 8h 
following LPS administration. The reason for this time lag in oestradiol decrease 
between the two stressors is not understood, however, we have already shown that 
hypoglycaemia is induced immediately after insulin administration (Fergani et al., 2011) 
and could be one cause of GnRH/LH surge and pulse inhibition leading to immediate 
oestradiol suppression (Dobson and Smith, 2000). Interestingly, we observed a split 
response in the insulin-treated animals with two showing an intense activation in the 
PVN and VMN (insulin-responders) whereas the other two were not different to controls 
(insulin-non-responders). A similar divergence was observed in our previous study 
(Fergani et al., 2011) when 10 out of 20 animals treated with insulin did not have a delay 
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in sexual behaviour or the LH surge (insulin-non-delayed subgroup). Taking into account 
the fundamental importance of the PVN in response to stress (Antoni, 1986) and the 
importance of the VMN in inducing the GnRH surge (Caraty et al., 1998), we speculate 
that the animals with no activation in the PVN or VMN would have gone on to have an 
LH surge at a similar time as the controls, whereas the others would have had a delayed 
surge. Interestingly, cortisol concentrations increased equally in both insulin sub-groups. 
This was also observed in our earlier study indicating that cortisol is not solely 
responsible for the LH surge disruption after insulin (Fergani et al., 2011). The reason for 
this divergence is not known, and it is particularly interesting that even though PVN 
activation did not occur, plasma cortisol concentrations were elevated. Furthermore, the 
split response does not involve insulin-resistance (Fergani et al., 2011). In this aspect, 
Tilbrook and Clarke (2006) discuss the existence of individuals that are more sensitive to 
the negative feedback of glucocorticoids, resulting in stress hypo-responsiveness. Thus, 
insulin may be a less severe stressor than LPS, and certain individuals being more stress-
resilient, are able to recover from the stress axis activation very quickly.  
Transcriptional activation in the ARC also increased in both insulin subgroups probably 
because the ARC and the VMN play a pivotal role in glucose-sensing and energy balance 
(Cone et al., 2001, Routh, 2003). Indeed, it has been hypothesised that ARC is central in 
metabolic regulation and relays peripheral signals to appetite regulating systems in 
other parts of hypothalamus including the VMN and PVN (Elmquist, 2001). It is likely that 
even though insulin-induced hypoglycaemia was ‘perceived’ by the ARC, resulting in 
activation, the transmission of the signal towards the VMN and the PVN was disturbed. 
Nonetheless, the observation that LPS activated more brain areas than insulin may be 
associated with the intensity of the stressor (Tilbrook et al., 2002), i.e., more inhibitory 
pathways are activated after LPS treatment and this may be associated with LPS delaying 
the LH surge for longer than insulin (Fergani et al., 2011). The precise phenotype of all 
the activated cells remains to be elucidated.  
Intriguingly, acute insulin administration in the late follicular phase immediately 
increased five-fold the number of kisspeptin cells co-expressing c-Fos in the ARC but had 
no effect on mPOA kisspeptin neurones. These data are consistent with findings in the 
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rat regarding the mPOA, but differ regarding the ARC: there was only a tendency 
towards suppression of kisspeptin mRNA levels (Kinsey-Jones et al., 2009). Furthermore, 
short-term fasting decreases kisspeptin mRNA expression in the whole hypothalamus of 
rats (Castellano et al., 2010) and monkeys (Wahab et al., 2010). The differences between 
these studies could be attributed to the level of hypoglycaemia that was recorded after 
acute insulin and fasting, respectively. For example, in our model there is a 60% 
decrease in glucose concentrations (Fergani et al., 2011), whereas in fasted monkeys 
there was only a 20% decrease. To date, it is not known whether kisspeptin neurones 
express insulin receptors, although the latter are abundant in the ARC (Qi et al., 2008) 
and could be responsible for the observed effects. Finally, we cannot rule out the 
possibility of transient stimulation which may have been followed by a decrease in 
kisspeptin activation after a short period of time.  
The percentage of activated kisspeptin cells in the PVN (17%) did not vary during the 
follicular phase or after the application of stressors. This is not surprising as this area is 
deprived of ER (Lehman et al. 1993, Blache et al. 1994, Herbison et al. 1993) and so this 
population of cells is probably not involved in direct control of reproduction. However, it 
would be interesting to identify possible connections between kisspeptin cells in the ARC 
and cells in the PVN, as a potential pathway for conveying a stress signal between these 
two areas.  
Kisspeptin and CRFR type 2 co-expression.  
Although precise neural inputs to the mPOA, ARC and VMN during stress-induced 
suppression of kisspeptin remain to be determined, CRF is a prime candidate. In the rat, 
CRF has a pivotal role in stress-induced suppression of the GnRH pulse generator, while 
CRF antagonists reverse the response (Cates et al., 2004). A differential role for CRFR 
type 1 and CRFR type 2 was observed in suppression of pulsatile LH secretion in the rat: 
insulin-induced hypoglycaemia and LPS stressors involve activation of CRFR type 2 while 
psychological stress (e.g., restraint) involves both CRFR type 1 and type 2 (Li et al., 2005, 
Li et al., 2006). However, all three of these stressors, as well as intracerebroventricular 
(icv) administered CRF, markedly decrease kisspeptin and kisspeptin receptor mRNA 
levels (Kinsey-Jones et.al, 2009). In the sheep, the evidence is less compelling. In OVX 
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ewes, CRF stimulation and inhibition of GnRH occur simultaneously after LPS 
administration (Battaglia et al., 1998); in contrast, icv administration of CRF either 
increases (Naylor et al., 1990, Caraty et al., 1997) or has no effect (Clarke et al., 1990, 
Caraty et al., 1997) on LH pulse frequency. In addition, CRF antagonist was unable to 
prevent the inhibitory effect of hypoglycaemic stress on LH pulses in the sheep (Clarke et 
al., 1990). However, in the present study, there was an abundance of CRFR type 2 in the 
lower part of the ARC and the ME. In addition, 21% kisspeptin cells express this type of 
receptor and that doubled 3h and 12h after LPS treatment. This indicates that CRFR type 
2 may be involved in down-regulation of kisspeptin transcriptional activation. However, 
there was a large number of CRFR type 2 that co-localised with cells of unknown 
phenotype. There are, therefore, two possible pathways for CRF suppression of GnRH, 
one being the direct association of CRF and GnRH cell terminals in the external zone of 
the ME (Ghuman et al., 2010) and the other being the regulation of kisspeptin and other 
cell types in the ARC and ME via CRFR type 2. Indeed, cells that originate from the ARC, 
including kisspeptin cells, send projections towards GnRH terminals (Jansen et al., 1996, 
Smith et al., 2011,). Whether CRFR type 1 or 2 co-localise with GnRH neurones in the 
mPOA in the ewe as in rats (Jasoni et al., 2005) remains to be investigated.  
Conclusion 
Our data indicate that the LH surge of intact ewes is accompanied by an intense 
transcriptional activation of kisspeptin neurones located in the ARC and the mPOA. 
Taking into account that the GnRH surge mechanism consists of three phases (activation, 
transmission and surge secretion) our results suggest that these kisspeptin cells are 
involved in the surge secretion phase.  The cells that become active before the LH surge, 
when oestradiol concentrations are initially elevated remain to be phenotyped. By 
contrast, acute LPS treatment prevented the LH surge from occurring and this was 
accompanied by a failure of kisspeptin neurone activation. Interestingly, insulin 
increased activation of kisspeptin neurons in the ARC immediately after treatment 
indicating stressor specific differences. Furthermore, we found that co-expression of 
CRFR type 2 in kisspeptin cells increased after LPS but not insulin, indicating that this is 
one of the pathways leading to kisspeptin inhibition and the disruption of the LH surge. 
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Fig.1 Diagram of the chronological order of events in the experimental protocol (a) before and (b) 
after the onset of the follicular phase. CNTR = control; INS = insulin; LPS = E. coli 
lipopolysaccharide 
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Fig. 2 Mean (±SEM) number of c-Fos positive nuclei in the A) VMN, B) ARC, C) mPOA, D) ME, E) dBb and F) 
BNST, at different stages in the follicular phase of control ewes. Animals were grouped according to time 
as well as hormonal and behavioural status; i.e., grouped into those killed at 0h and 16h after PW, those 
killed at 31h or 40h after PW but before the onset of sexual behaviour (Before behaviour, n=3), those 
killed at 31h after PW, after the onset of sexual behaviour but before exhibiting an LH surge (After 
behaviour, n=5) and those killed after the onset of both sexual behaviour and during the LH surge (Surge, 
n=3).* P<0.05 compared to all other stages in the follicular phase. 
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Fig. 3 Mean (±SEM) % number kisspeptin cells that co-express c-Fos in the ARC A, B) and mPOA C, D) 
during the follicular phase of intact ewes. Animals in A and C are grouped according to time as well as 
hormonal and sexual behavioural status; i.e. grouped into those killed at 0h and 16h after progesterone 
withdrawal, those killed at 31h or 40h after PW but before the onset of sexual behaviour (Before 
behaviour, n=3), those killed at 31h or 40h after progesterone withdrawal, after the onset of sexual 
behaviour but before exhibiting an LH surge (After behaviour, n=5) and those killed after the onset of both 
sexual behaviour and during the LH surge (Surge, n=3). In B and D animals are grouped according to killing 
time after PW i.e. control ewes at 0h, 16h, 31h and 40h (n=4-5 per group; black bars) as well as after LPS 
at 31h and 40h (n=4 for both times; grey bars). There were no split responses observed in the 31h insulin-
treated animals i.e., insulin-responders (n=2; white bars) and insulin-non-responders (n=2; hatched bars) 
and therefore statistical analysis was carried out in both groups combined (n=4). Treatment with insulin or 
LPS was at 28h after progesterone withdrawal.  *P<0.05 compared to all other control and treated groups. 
# P<0.05 compared to 0h, 16, 31h control, 31h LPS, and 40h LPS groups. 
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Fig. 4 A) mean (±SEM) number of c-Fos positive nuclei in the PVN of control ewes at 0h (n=5), 16h 
(n=4), 31h (n=6) and 40h (n=5) in to the follicular phase as well as after LPS (31h LPS and 40h LPS; n=4 
for both groups). There was a split response observed in the insulin treated animals: half showed an 
increase in c-Fos-positive nuclei (insulin responders; n=2) and half did not (insulin-non-responders; 
n=2), therefore, statistical analysis was not carried out and the data are presented for information. B) 
and C) photomicrographs of the paraventricular nucleus stained for c-Fos and kisspeptin in insulin 
responders and insulin non-responders, respectively. Scale bar 50 μm.  Treatment with insulin or LPS 
was at 28h after PW.  * P<0.05 compared to control groups.  
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Fig. 5 Mean (±SEM) number of c-Fos positive nuclei in the A) VMN, B) ARC, C) mPOA, D) ME, E) dBb 
and F) BNST, at different times during the follicular phase of control and treated ewes. Animals are 
grouped according to killing time after PW, i.e., control ewes at 0h, 16h, 31h and 40h (n=4-5 per 
group; black bars) as well as after LPS at 31h and 40h (n=4 for both times; grey bars) and insulin at 
31h (insulin-responders, n=2; white bars and insulin-non-responders, n=2; hatched bars). Due to the 
split response in the VMN after insulin treatment, statistical analysis was not carried out and the data 
are presented for information. However, in the ARC, mPOA, ME, dBb and BNST, there were no split 
responses observed and therefore statistical analyses were carried out with both groups combined 
(n=4). Treatment with insulin or LPS was at 28h after PW. Fig 5A:* P<0.05 compared to controls. Fig. 
5B and 5C: * P<0.05 compared to 0h, 16h, 31h controls. Fig 5E: * P<0.05 compared to control and 
insulin subgroups combined. 
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Fig. 6 Photomicrographs of the ARC nucleus that were dual-labeled for kisspeptin cells and their co-
expression with c-Fos in control animals during the LH surge (A and B) as well as 12 h after LPS 
treatment in the late follicular phase (C and D). The right panels in each section are the higher 
magnifications (20 μm) of the boxed areas shown in the left panels (50 μm). Black arrows indicate 
examples of dual-labeled cells, and arrowheads indicate single-labeled kisspeptin-positive cells. 
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Fig. 7 (A) Mean (±SEM) number of CRFR type 2-positive cells in the lower part of the ARC and ME, (B) 
mean (±SEM) % number of kisspeptin cells that co-express CRFR type 2 and (C) mean (±SEM) % 
number of CRFR type 2-positive cells that co-express kisspeptin during the follicular phase of control 
and treated ewes. Animals are grouped according to killing time after PW i.e. control ewes at 0h, 16h, 
31h and 40h (n=4-5 per group; black bars) as well as after insulin at 31h (insulin-responders, n=2; 
white bars and insulin-non-responders, n=2; hatched bars) and LPS at 31h and 40h (n=4 for both 
times; grey bars). There were no split responses observed in the insulin-treated animals and 
therefore, statistical analysis was carried out in both groups combined (n=4). Treatment with insulin 
or LPS was at 28h after PW. (D), (E), (F) Immunohistochemically identified CRFR type 2-positive cells 
and dual-labelled kisspeptin and CRFR type 2 cells in the lower part of the ARC and ME. Black arrows 
indicate examples of dual-labelled cells, and white arrows indicate single-labelled CRFR type 2 cells. 
Scale bar: 20μm. *P<0.05 compared to control and insulin sub-groups combined.  
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Fig. 8 Mean (±SEM) cortisol concentrations in 31h control (■; n=6), 31h insulin-responders (x; n=2), 
31h insulin-non-responders (▲; n=2), 31h LPS (o; n=4), 40h control (♦; n=5) and 40h LPS (●; n=4) 
groups. There was no split response observed in the insulin-treated animals and therefore statistical 
analysis was carried out with both groups combined (n=4). The arrow indicates time of treatment. 
Some error bars are within the data symbols.  
*     Time at which cortisol values from all treated groups were differed from the control groups       
       (P<0.003).  
**  Time at which 40h LPS group values differed from the control group  (P<0.05). 
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Fig. 9 Mean (±SEM) plasma progesterone concentrations at 28h after PW (before treatment; grey 
bars) and two mean (±SEM) consecutive maximum concentrations recorded after treatment (black 
bars), in the 31h control (31h CNTR; n=5), 31h LPS (n=4), 31h insulin-responders (31h INS-responders; 
n=2), 31h insulin-non-responders (31h INS-non-responders; n=2), 40h control (40h CNTR; n=5), and 
40h LPS (n=4) groups. Due to the considerable between-animal variation, a within-group comparison 
was made. The differences between concentrations within an animal are linked by the line (* P<0.05). 
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Fig. 10 A) Mean (±SEM) plasma oestradiol concentrations in 40h control (■; n=5) and 40h LPS (●; n=4) 
groups. Mean (±SEM) plasma progesterone concentrations in 40h control animals (×; n=5) during the 
follicular phase are also shown for comparison with oestradiol profiles. Progesterone concentrations 
after treatment are shown in Fig. 9. The arrow indicates the time of treatment. B) Mean (±SEM) 
plasma oestradiol concentrations at 28h after PW (i.e., before treatment; grey bars) and at 31h after 
PW (i.e., after treatment; black bars) in the 31h control (31h CNTR; n=5), 31h LPS (n=4), 31h insulin-
responders (31h INS-responders; n=2), 31h insulin-non-responders (31h INS-non-responders; n=2). At 
28h after PW oestradiol concentrations were not different between groups. # Time at which 40h LPS 
group tended to differ from the 40h control group (P<0.07). *Time at which 40h LPS group differed 
from the 40h control group (P<0.02).  
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Table 1 Onset of the LH surge, pre-copulatory behaviour and oestrus (hours after PW) of individual 
ewes treated with saline or LPS or insulin at 28h after PW. Ewes were killed at 0h, 16h, 31h (31h 
control, 31h insulin and 31h LPS groups) or 40h (40h control and 40h LPS groups) after PW. There was 
no sexual behaviour or LH surge recorded in control ewes killed at 0h or 16h.   
 
 
Near Ram Being nosed Being nudged Mounted LH surge 
 
 
31h CNTR 
     
Sheep B      
Sheep C      
Sheep D 25 27 27   
Sheep E 26 26    
Sheep F      
Sheep P 25 25    
31h LPS       
Sheep Z      
Sheep Δ 27 27 29 29  
Sheep Я      
Sheep Ω      
31h INS       
Sheep O 23 27 27   
Sheep Q      
Sheep R      
Sheep S 29 29 29 29  
40h CNTR  
     
Sheep H 38 38 38   
Sheep I 40 36 40 40  
Sheep K 24 24 28 32 38 
Sheep L 22 22 34 34 38 
Sheep M 28 30 30 30 34 
40h LPS  
     
Sheep T 26 26    
Sheep θ      
Sheep®      
Sheep Ξ 34 34 34 34  
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Chapter 4 
Oestradiol receptor α and c-Fos co-expression in the medial preoptic area, arcuate 
nucleus and ventromedial nucleus at different times during the follicular phase of 
intact ewes and alteration after insulin or endotoxin 
 
Keywords: c-Fos, oestradiol receptor alpha, stress, oestrous behaviour, LH surge, insulin, 
LPS, ewes. 
 
Abstract 
Oestradiol triggers the GnRH surge by activating ERα cells in the brain. The aim of the 
present study was to investigate the activation pattern of oestradiol receptor α (ERα) 
containing cells in the arcuate nucleus (ARC), ventromedial nucleus (VMN) and medial 
preoptic area (mPOA) during the follicular phase of intact ewes as well as determining 
whether stress-induced disruption of the LH surge involves a reduction of activated ERα-
cells. Follicular phases of intact ewes were synchronised with progesterone vaginal 
pessaries. Control animals were killed at 0h, 16h, 31h and 40h (n=5-6 per group) after 
progesterone withdrawal (PW; time zero). At 28h, groups of animals received insulin 
(INS; 4 iu/kg) or endotoxin (LPS; 100 ng/kg) and were subsequently killed at 31h (INS; 
n=5 and LPS; n=5) or 40h (LPS; n=5). Hypothalamic sections were immunostained for ERα 
and a marker of neuronal transcriptional activation, c-Fos. LH surges occurred only in 
40h control ewes: these animals had a marked increase in the percentage of ERα cells 
co-expressing c-Fos in the ARC (from 25 to 64%; P<0.05) and mPOA (from 17 to 40%; 
P<0.05) from 31h after PW and throughout the LH surge, as well as the VMN, but only 
during the surge (from 32 to 65%; P<0.05). However, when ewes were re-grouped 
according to behavioural status, there was a marked increase in the percentage of ERα-
containing cells that co-expressed c-Fos in the VMN after the onset of sexual behaviour 
compared to before (from 5 to 57%; P<0.000). At 31h and 40h after PW (i.e., 3h and 12h 
after treatment, respectively), LPS decreased the percentage of ERα cells co-expressing 
c-Fos in the ARC (from 64 and 56% to 12 and 18%, respectively; P<0.05) and mPOA (from 
40 and 62% to 11 and 13%, respectively; P<0.05), but there was no change in the VMN, 
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compared to controls. In contrast, at 31h after PW (i.e., 3h after treatment), insulin did 
not alter the percentage of ERα cells co-expressing c-Fos in the ARC compared to 
controls, whereas, two of four insulin-treated animals had a decrease in the mPOA (from 
40 to 12%) and an increase in the VMN (from 32 to 78%) while two other had no 
increase (47 and 44%, for the mPOA and VMN, respectively). These results indicate that 
there is a specific temporal pattern of ERα-containing cell activation in the ARC, VMN 
and mPOA during the follicular phase of intact ewes and that this is disturbed by acute 
LPS or insulin administration in the late follicular phase.  
Introduction 
The ovarian steroid hormone oestradiol is of central importance in the control of 
reproductive neuroendocrine function in female mammals. For the greater part of the 
ovarian cycle in ewes, oestradiol and progesterone, act synergistically to restrain 
GnRH/LH (gonadotrophin releasing hormone/luteinising hormone) secretion through 
negative feedback action. However, during the late follicular phase, minute-by-minute 
portal blood sampling has revealed a ‘switch’ from inhibition to enhancement of GnRH 
secretion (Evans et al., 1995, Karsch et al., 1997). This constitutes oestradiol positive 
feedback and triggers the onsets of GnRH/LH surge secretion. However, steroid hormone 
signals do not impinge directly on GnRH cells as these cells do not possess progesterone 
receptors (PR) or oestradiol alpha receptors (ERα; Shivers et al., 1983, Herbison and 
Theodosis, 1992, Skinner et al., 2001). Some GnRH neurones express, ERβ (Hrabovszky et 
al., 2001) although it is unlikely that ERβ plays a major role in the feedback regulation of 
GnRH/LH secretion, because ERβ knock-out mice have normal fertility (Lubahn et al., 
1993; Krege et al., 1998). The surge generating mechanism has been well characterised 
in the ovariectomised (OVX) ewe (Evans et al., 1997) and consists of three phases: i) 
activation, during which oestradiol concentrations reach a threshold and must remain 
elevated for a few hours (Moenter et al., 1990, Caraty et al., 2002). This signal is 
‘perceived’ by neuronal cells that contain oestradiol receptors (ERα), and respond by 
becoming activated; ii) transmission, during which the activation signal is transmitted 
from ERα cells to GnRH neurones, either directly or via one or more interneurones; iii) 
surge secretion, during which there is a discharge of GnRH and LH. The latter two stages 
are hypothesised to be oestradiol independent (Evans et al., 1997). The decrease in 
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plasma progesterone concentrations after luteolysis and the increase of oestradiol are 
also responsible for changes in sexual behaviour (Karsch et al., 1980, Fabre-Nys and 
Martin 1991, Fabre-Nys and Gelez 2007). However, it remains to be elucidated whether 
a similar ‘behaviour generating mechanism’ exists.  
The full phenotype and precise location of activated cells at each stage of the surge 
generating mechanism remain largely unknown. However, recent evidence has revealed 
that kisspeptin neurones, located in the medial preoptic area (mPOA) and arcuate 
nucleus (ARC), possess ERα (Franceschini et al., 2006), and mediate most steroidal 
influences (negative and positive) on GnRH neurones (Smith, 2008, Roseweir and Millar 
2009, Lehman et al., 2010a, Caraty et al., 2010). We have recently mapped the 
transcriptional activation of kisspeptin neurones in the mPOA and ARC, at various times 
in the follicular phase of intact ewes (Chapter 3), and found activation of kisspeptin cells 
to be low (consistent with negative feedback, Caraty et al., 2010), except during the LH 
surge (i.e., surge secretion phase, consistent with positive feedback, Smith et al., 2009). 
Thus, at least one other cell type is involved in the activation stage of the surge 
generating mechanism.  
Sudden activation of the hypothalamus-pituitary-adrenal axis in the late follicular phase 
by the immunological stressor endotoxin (i.e., lipopolysaccharide; LPS) lowered plasma 
oestradiol concentrations and delayed the onsets of pre-copulatory behaviours, oestrus 
and the LH surge of free-running intact ewes; whereas, the metabolic stressor insulin-
induced hypoglycaemia had the same effect in only 50% of animals (Fergani et al., 2011). 
Furthermore, immunohistochemical analysis of c-Fos protein expression (a marker of 
neuronal transcription activation; Hoffman et al., 1993) revealed that this disruption 
involved the activation of unknown cell types located in the VMN, ARC and mPOA 
(Chapter 3). In considering potential pathways by which stressors disrupt the follicular 
phase and sexual behaviour, it is important to note that there are four distinct 
mechanisms that may be involved: i) suppression of steroidogenesis at the ovarian level 
(Shakil et al., 1994, Downing et al., 1999, Battaglia et al., 2000); ii) suppression of GnRH 
pulsatility (frequency or amplitude) from the hypothalamus (Battaglia et al., 1997, 
Dobson and Smith, 2000); iii) suppression of LH pulsatile release from the pituitary 
(Williams et al., 2001, Brothers et al., 2010); and/or iv) prevention of the ability of the 
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surge-generating mechanism to respond to the preovulatory increases in plasma 
oestradiol concentrations (Battaglia et al., 1999, Karsch et al., 2002; Ghuman et al., 
2011). The first three mechanisms could potentially deprive the ovarian follicle from the 
necessary gonadotrophin drive, thereby blocking the preovulatory oestradiol increase; 
however, the mechanism involved in surge disruption is not yet clear. This could involve 
inhibition of ERα-cell activation at appropriate times. Furthermore, there is evidence 
that the disrupting factors for each of these mechanisms (GnRH/LH pulse and surge 
secretion as well as steroidogenesis) may be different (Breen et al., 2004).  
In the present study, we examined brain tissue of intact ewes sacrificed at various times 
during the follicular phase with or without the administration of insulin or LPS. Our aim 
was to map the pattern of ERα transcriptional activation (by measuring colocalisation 
with c-Fos) in the ARC, VMN and mPOA, and correlate with peripheral plasma 
progesterone and oestradiol concentrations, as well as the exhibition of sexual 
behaviour and the LH surge. Furthermore, we sought to determine whether the 
disruption of the surge mechanism after LPS or insulin involves inhibition of ERα-cell 
activation in the ARC, VMN or mPOA as well as describing the temporal relationships 
between these changes and alterations in plasma steroid concentrations. 
 
Materials and Methods  
Animals, study design and blood sampling procedure 
In this investigation we used tissue collected during the breeding season for an earlier 
study details of which are given in Chapter 3. 
Visual observation of oestrous behaviour 
Details are given in Chapter 3. 
Tissue collection 
Details are given in Chapter 3. 
ERα and c-Fos dual-label immunofluorescence 
For ERα/c-Fos analysis, three sections (40μm)  from the mPOA (at the level of the 
organum vasculosum of the lamina terminalis (OVLT) and six from the middle and caudal 
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ARC (three from each level) were processed for dual-label immunofluorescence. All steps 
were performed at room temperature unless otherwise stated. Antibodies were diluted 
with 2.5% normal donkey serum (catalogue item S2170, Biosera, UK), 1% Triton X-100 
(T9284, Sigma-Aldrich, UK) and 0.25% sodium azide (Sigma) in 0.1M phosphate buffer 
saline, pH 7.2 (PBS). Free-floating sections were washed thoroughly in PBS for 2h to 
remove the cryoprotectant solution followed by 1h incubation in blocking solution (10% 
donkey serum in PBS). This was followed by 72h incubation at 40C with a mixture of 
polyclonal rabbit anti-c-Fos antibody (AB-5, PC38, Calbiochem, Cambridge, MA, USA) at a 
dilution of 1:5000 along with monoclonal mouse anti-ERα (ID5, M7047, Dako, 
Carpinteria, CA, USA) at a dilution of 1:50. After incubation with the primary antisera, 
sections were washed thoroughly and incubated with a mixture of donkey anti-rabbit 
Cy3 (711-165-152, Jackson Immunoresearch, West Grove, PA) and donkey anti-mouse 
DyLight 488 (715-485-151, Jackson Immunoresearch, West Grove, PA) both diluted 1:500 
for 2h.  Thereafter, sections were washed with PBS followed by a final wash with double-
distilled water, mounted on chrome alum gelatine coated slides and cover-slipped with 
Vectashield anti-fading mounting medium (Vector Laboratories Ltd, UK, H-1000). The c-
Fos (Ghuman et al. 2010) and ERα (Skinner and Herbison, 1997) antibodies have been 
validated for the use in ovine neural tissue. In addition, negative controls that omitted 
one of the primary antibodies completely eliminated the appropriate fluorescence 
without obviously affecting the intensity of the other fluorescent probe.  
Data analysis 
Sections were examined under an epi-fluorescent microscope (Zeiss Axio Imager. M1) 
and photographed by digital microphotography (Hamamatsu ORCA I-ER digital camera, 
Hamamatsu Photonics, Welwyn Garden City, Herts) using a 20× objective. Photographs 
acquired with an image analysis program AxioVision (Zeiss Imaging Systems) and 
consisted of single c-Fos staining, single ERα staining as well as a merged image to 
produce a spectral combination of green (fluorescein) and red (rhodamine) that resulted 
in yellow-marked dual labeled cells. The areas examined were (as defined by Welento et 
al., 1969): VMN (4 photographs per section, 2 sections per ewe), ARC (3 photographs per 
section, 3 sections per ewe, which consisted sections from the rostral, middle and caudal 
divisions of the nucleus) and mPOA (at the level of the OVLT, 2 photographs per section, 
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3 sections per ewe). Sections were evaluated unilaterally and each photograph was 
taken from a random field within each nucleus. All photographs were imported in to 
Image J version 1.42q, where counts were performed using the cell count plug-in. Initial 
counts were carried out on the merged image and ERα and c-Fos colocalisation was 
confirmed using side by side images of the individual ERα and c-Fos micrographs and 
visually identifying cells that contained both ERα label and c-Fos label with respect to 
microscopic tissue landmarks. The observer was unaware of the animal identity and 
group. The mean total number and percentage of single- or dual-labeled cells was 
summed from the photographs of each area/section and then averaged for each ewe 
and compared with GLM ANOVA, followed, where appropriate, by Tukey’s multiple 
comparisons post hoc test. Mean (±SEM), as presented in figures and results, was 
calculated by averaging values for each group. 
The data were analysed in two ways: the first consisted of control ewe data grouped 
according to time after PW, then by sexual behavioural status and whether an LH surge 
had occured; i.e., grouped into those killed at 0h and 16h after PW, those killed at 31h 
after PW but before the onset of sexual behaviour (Before behaviour, n=3), those killed 
at 31h or 40h after PW, after the onset of sexual behaviour but before exhibiting an LH 
surge (After behaviour, n=5) and those killed after the onset of both sexual behaviour 
and during the LH surge (Surge, n=3). This grouping allowed for a detailed comparison of 
neuropeptide profiles in control animals at different stages of the follicular phase in our 
intact-ewe model. Secondly, control and treated animal data were grouped according to 
time of killing after PW, and this was used to compare treatment effects. 
 During data analysis, it became clear that there was a split response in the insulin group 
regarding the percentage of ERα-containing cells that co-expressed c-Fos in the mPOA 
and VMN. Therefore, this group was separated into two subgroups referred to hereafter 
as insulin-responders or insulin-non-responders (verified previously in Chapter 3 as with 
or without c-Fos activation in the paraventricular nucleus, respectively).  As this division 
reduced the group size to n=2/group, statistical analysis was not undertaken, but the 
data are presented for information. When responses were not different between sub-
groups, data were combined and analysed with n=4.  
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Regression analysis was used to examine the association between the percentage of 
change from 0h to the two mean consecutive lowest or highest plasma progesterone or 
oestradiol values, respectively, and the percentage of ERα cells that co-expressed c-Fos 
in each area in control animals.  
 
Results 
Luteinising hormone (LH) and behavioural profiles. 
LH and behaviour profiles have been presented in detail in Chapter 3.  
Control ewes: ERα and c-Fos co-expression in the ARC, VMN and mPOA at different 
stages during the follicular phase, in animals grouped by behaviour.  
ARC 
The percentage of ERα containing neurones that co-expressed c-Fos increased two-fold 
in the ‘Before behaviour’, ‘After behaviour’ and ‘Surge’ groups compared to 0h and 16h 
groups (P<0.05, for all comparisons; Fig. 1A). 
mPOA 
The percentage of ERα-containing neurones that co-expressed c-Fos sequentially 
increased from 0h towards ‘Before behaviour’, to ‘After behaviour’ as well as animals in 
the ‘Surge’ group (P<0.05, for all comparisons; Fig. 1C).  
VMN 
The percentage of ERα-containing neurones that co-expressed c-Fos gradually decreased 
from 0h towards the ‘Before behaviour’ group (P<0.05; Fig. 1E) and then suddenly 
increased ten-fold in ‘After behaviour’ and ‘Surge’ animals (P<0.05; Fig. 1E).  
Oestradiol 
Oestradiol data have been presented in Chapter 3. Using regression analysis, the 
percentage of ERα-containing cells that co-expressed c-Fos was positively associated 
with the percentage change in oestradiol concentration between 0h to the mean two 
consecutive highest plasma oestradiol values: in the mPOA (P=0.001, RSq=51.1%; Fig. 
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1D) and to a lesser extent in the VMN (P=0.02, RSq=21.1%; Fig. 1F) but not the ARC 
(P=0.7; Fig. 1B).  
Progesterone 
Progesterone data have been presented in Chapter 3. Furthermore, the percentage of 
ERα-containing cells that co-expressed c-Fos was associated with the percentage change 
in progesterone concentration between 0h to the mean two consecutive lowest plasma 
progesterone values: in the ARC (P=0.000, RSq=64. %; Fig. 1B) and the mPOA (P=0.000, 
RSq=51. %; Fig. 1D) but not the VMN (P=0.1; Fig. 1F).  
Cortisol 
Cortisol data have been presented in chapter 3. 
Control, insulin or LPS: ERα and c-Fos co-expression in the ARC, VMN and mPOA at 
different times during the follicular phase, in animals grouped by hours after PW.   
Photomicrographs of sections from the ARC and the mPOA dual-labelled for ERα and c-
Fos are shown in Fig. 2 and Fig. 3, respectively. Mean numbers of c-Fos and ERα 
containing cells in the ARC, mPOA, and VMN, are given in Table 1.  
ARC 
With respect to PW, the percentage ERα containing cells that co-expressed c-Fos in 
controls was increased at 31h and remained high at 40h, the time of the LH surge 
(P<0.000 for both; compared to 0h and 16h control groups, Fig. 4A). However, at 31h 
after PW (i.e., 3h after LPS administration), there was a marked decrease in the 
percentage of ERα-containing neurones the co-expressed c-Fos in the LPS group 
(P<0.000) compared to controls (Fig. 4A). The effect of LPS was still evident between the 
control and LPS groups at 40h after PW, (i.e., 12h after the initial application of saline or 
LPS; P<0.000, Fig. 4). All insulin-treated animals (insulin-responders and insulin-non-
responders combined; n=4) did not differ from controls, but were different compared to 
LPS-treated animals (P<0.05; Fig. 4A). 
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mPOA 
With respect to PW, there was a gradual increase in co-expression with c-Fos, with 31h 
and 40h control groups having a higher percentage of ERα-containing cells that co-
expressed c-Fos compared to 0h and 16h control groups (P<0.01; for all comparisons, 
Fig. 4B). However, at 31h after PW (i.e., 3h after insulin or LPS administration), there was 
a marked decrease in the percentage of ERα-containing neurones that co-expressed c-
Fos in the LPS (P<0.05) and in the insulin-responders sub-group; Fig. 4B) but not in the 
other insulin-non-responders sub-group. Differences between the control and LPS 
treatments  were still evident in the 40h groups, (i.e., 12h after the initial application of 
saline or LPS; P<0.000; Fig. 4B). 
VMN 
With respect to PW, the percentage of ERα-containing cells that co-expressed c-Fos was 
increased in control animals at 40h compared to 0h and 16h groups (P<0.02; Fig. 4C). 
Percentages in the 31h control group varied considerably between animals (see before) 
and therefore there was no difference from the rest of the control groups.  However, at 
31h after PW (i.e., 3h after insulin or LPS administration), there was a marked increase in 
the percentage of ERα-containing neurones that co-expressed c-Fos in the insulin-
responders, but not in the 31h control, LPS, and the insulin-non-responder groups. At 
40h after PW (i.e., 12h after the initial application of saline or LPS), the percentage of 
ERα-containing cells that co-expressed c-Fos increased in the 40h LPS group compared to 
the 31h LPS group (P<0.02) but were not different compared to the 40h control group. 
Discussion 
The present results extend our knowledge concerning the steroidal regulation of the 
GnRH/LH surge and sexual behaviour by the ARC, VMN and mPOA. We have 
demonstrated that the pattern of ERα cell activation changes during the follicular phase 
of intact ewes as well as between regions at specific time points. Furthermore, this 
pattern is disturbed by acute insulin or LPS administration in the late follicular phase, 
and the profile of disruption differs between the two stressors. This indicates a stressor 
type or intensity differential effect on ERα cell activation which, in both cases, leads to 
disruption of the LH surge.   
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Pattern of ERα activation during the follicular phase of intact ewes.  
At 31h after PW (i.e., 1-2h before the expected onset of sexual behaviour and 
approximately 6-7 hours before the expected GnRH/LH surge onset), there was an 
marked increase in the percentage of activated ERα-containing neurones in the middle 
and caudal ARC, and this coincided with decreased progesterone and increasing 
oestradiol concentrations in plasma. This indicates that there are ERα-cells within this 
area that ‘perceive’ the steroid hormone milieu and respond by becoming 
transcriptionally activated. This is in accordance with the activation stage of the 
GnRH/LH surge mechanism. Furthermore, ERα activation was maintained throughout 
the late follicular phase and during the GnRH/LH surge, indicating that ERα cells in the 
ARC participate in the transmission and surge secretion phases of the GnRH surge 
mechanism. It has been suggested that the latter two stages are oestradiol independent, 
i.e., do not need a further or continuous oestradiol signal (Evans et al., 1997, Harris et 
al., 1998, Harris et al., 1999), however, it appears that ERα neurones are still activated 
during this period. Even though, oestradiol concentrations in the present study were 
beginning to decrease as the LH surge occurred. 
We have recently shown that the LH surge of intact ewes is accompanied by a 
simultaneous intense transcriptional activation of ARC kisspeptin neurones and not 
previously within the follicular phase (Fergani et al., 2011). This indicates that kisspeptin 
cells are only involved in the surge secretion mechanism for GnRH surge release. Thus, it 
seems that kisspeptin cells are not solely responsible for the positive feedback effects of 
oestradiol as there are other cell types activated 6-7h before the expected surge onset, 
and these are not kisspeptin cells but contain ERα. In this respect, there are a number of 
different neurochemical phenotypes containing ERα in the ARC that have been 
discovered to date as potential candidates for this role. While the most striking 
accumulation of ERα is in kisspeptin neurones in the middle and caudal ARC of female 
sheep (Franceschini et al., 2006), kisspeptin cells in this region, but not in the mPOA, co-
localise two other neuropeptides important in the control of GnRH secretion: dynorphin 
and neurokinin B (Foradori et al., 2006, Goodman et al., 2007; Topaloglu et al., 2009). 
This cell population has a very high degree (95%), of colocalisation with both ERα and PR 
(Franceschini et al., 2006; Smith et al., 2007) so could be critical for conveying the 
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respective positive and negative feedback influences of oestradiol and progesterone 
onto GnRH neurones (Lehman et al., 2010b). As 94% of kisspeptin cells co-localise 
dynorphin and 80% co-localise neurokinin B, with an equally high reciprocal co-
localisation (Goodman et al., 2007), immunohistochemical detection of kisspeptin 
protein should reflect presence of all three neuropeptides. Thus, immunohistochemical 
analysis of dynorphin or neurokinin B with c-Fos would potentially produce a similar 
pattern to the one we observed in kisspeptin cells. However, in the ewe, kisspeptin and 
dynorphin immunoreactivity and/or gene expression fluctuate depending on hormonal 
and gonadal status (Foradori et al., 2005, Smith et al., 2007, Merkley et al., 2009, Smith 
et al., 2009, Smith 2009). It is, therefore, probable that the transcriptional activation of 
ERα cells during the activation phase of the GnRH surge may reflect neurokinin B or 
dynorphin activation.  
Other potential cell types involved are β-endorphin, tyrosine hydroxylase (TH) a marker 
for dopamine, neuropeptide Y (NPY) or somatostatin (Antonopoulos et al., 1989) and a 
relatively small percentage of these possess ERα (3% to 20%; Lehman and Karsch 1993, 
Skinner and Herbison 1997, Scanlan et al., 2003). In addition, 52-61% glutamatergic 
neurones in the ARC/VMN express ERα, are activated by oestradiol, and project to the 
mPOA where most GnRH neurones are located (Pompolo et al., 2003b). Tourlet et al., 
(2005) also suggest a role for galanin in oestradiol regulation with over 50% galanin 
neurones containing ERα across the ovine hypothalamus and POA. Cells containing all 
the above neuropeptides have been implicated in the control of GnRH secretion in the 
ewe (Anderson et al., 2001, Scalan et al., 2003, Advis et al., 2003, Pompolo et al., 2003a, 
Tourlet et al., 2005 Taylor et al., 2007) and are, therefore, potential candidates for 
mediating the stimulatory effect of steroids on GnRH secretion. There are additional 
candidates containing other potential neuropeptides, also with ERα and located in the 
ARC, although their role has not yet been confirmed in the ewe, for example, 
neurotensin examined in rats (Antonopoulos et al., 1989, Alexander, 1993, Herbison, 
1998) and GABA in the monkey (Thind and Goldsmith, 1997).  
The positive feedback actions of oestradiol are likely to be exerted within the vicinity of 
the ER-expressing cells of the VMN to evoke the GnRH surge and sexual behaviour in the 
ewe (Blache et al., 1991, Caraty et al., 1998). However, after the discovery of kisspeptin 
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and its importance in regulating steroid feedback, the role of the VMN in the surge 
initiation mechanism has been under debate, as this area contains very few kisspeptin 
cells (Franchessini et al., 2006). Nevertheless, the VMN is particularly rich in ER (Lehman 
et al., 1993, Herbison et al., 1993, Blache et al., 1994,) and activation after oestradiol, 
especially in the ventrolateral aspect, is sexually dimorphic (Robinson et al., 2010). In the 
present study, the percentage of activated ERα containing neurones in the VMN 
gradually decreased from 0h towards the mid-follicular phase, before the onset of sexual 
behaviour, followed by an intense activation in animals that exhibited behaviour and an 
LH surge. This initial gradual down-regulation coincided with the decrease in plasma 
progesterone. Indeed, progesterone acts as a priming hormone in the control of sexual 
behaviour by increasing the number of ER in the VMN during the luteal phase, thereby 
increasing sensitivity to oestradiol (Blache et al., 1994). By analogy, this initial decrease 
of active ERα-neurones in the VMN may reflect decreasing progesterone concentrations. 
Interestingly, ERα activated neurones then increased ten-fold in animals exhibiting pre-
copulatory behaviours/oestrus implying that ER containing cells in the VMN may be 
involved in oestradiol stimulation of sexual behaviour. Indeed, ER in the ventrolateral 
part of the VMN has been identified as the most sensitive site for oestradiol action on 
sexual behaviour in the female rat (Rubin and Barfield, 1980, Rissman et al., 1997, Spiteri 
et al., 2009), sheep (Blache et al., 1991, Blache et al., 1994) and monkey (Michael et al., 
2005).  
The neurochemical identity of cell types located in the VMN of sheep are poorly defined. 
However, 35% of somatostatin cells in the VMN contain ER, which accounts for 70% of 
the total ER immunoreactive cells in this area (Herbison, 1995). Furthermore, these cells 
are activated in a sex-specific manner by short-term exposure to oestradiol (Robinson et 
al., 2010). Therefore, somatostatin may be involved in oestradiol actions on oestrous 
behaviour although this needs further investigation. To date dopamine and 
noradrenaline have received most attention and are major regulators of sexual 
behaviour (Fabre-Nys et al., 1994, Fabre-Nys and Gelez 2007). Indeed, dopaminergic 
neurones originating from the ARC send projections towards the VMN (Qi et al., 2008) 
which co-localises dopamine receptor 1 in sheep (Colthorpe and Curlewis, 1996). In the 
rat, noradrenergic receptors 1b increase in the VMN after oestradiol treatment (Etgen 
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and Morales, 2002). The origin of these noradrenergic fibres are the arousal-related 
neuronal groups A1 and A2 in the rat brainstem (Kow et al. 1992). Relative to this, in the 
ewe, noradrenaline increases transiently in mediobasal hypothalamus (MBH) extra-
cellular fluid during oestrus and following sexual interactions with a male (Fabre-Nys et 
al., 1997). It would be of great interest to determine whether somatostatin cells receive 
input from dopamine and/or noradrenaline, constituting a possible mechanism for the 
control of sexual behaviour in the ewe. Cells containing galanin and glutamate are also 
located in the VMN and contain ERα but their role in oestrous behaviour has not yet 
been investigated in the ewe (Tourlet et al., 2005; Pompolo et al., 2003a).  
Whether the mPOA is involved in positive or negative feedback in the ewe is 
controversial. Oestradiol implants in this vicinity elicited negative feedback but not 
positive feedback (Caraty et al., 1998). However, a recent study, using an intact but 
steroid-treated ewe model, showed that mPOA kisspeptin cells are transcriptionally 
activated during the surge and, therefore, implicated in the positive feedback process 
(Hoffman et al., 2010). Similarly, Smith et al., (2009) found an increase in kisspeptin 
mRNA in the mPOA at the time of the LH surge. We have also recently shown that ~50% 
of kisspeptin cells are activated at the time of the LH surge in the intact ewe indicating 
that the mPOA participates in positive feedback by oestradiol, and is specifically 
associated with the surge secretion phase but not signal recognition or transmission 
(Chapter 3). In the present study, the percentage of ERα containing cells that were 
transcriptionally activated in the mPOA gradually increased culminating in peak 
activation during the surge. Interestingly, we observed the same gradual escalation of 
kisspeptin neurone activation as with ERα (Chapter 3).  
Apart from the 50% of kisspeptin cells in the ovine mPOA that contain ERα, other 
potential candidates are the 40% of the gamma aminobutyric acid synthesising cells that 
contain ERα (GABA; Herbison et al., 1993). Indeed, microdialysis revealed decreased 
GABA levels in the mPOA prior to the surge (Robinson et al., 1991). Furthermore, nearly 
all dynorphin cells in this area contain PR (Foradori et al., 2002) and therefore ERα 
(Dufourny and Skinner, 2002). In addition, over 50% of galanin-containing-cells also 
contain ERα and may contribute to the escalating activation of the mPOA (Tourlet et al., 
2005).  
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Our present results demonstrate that oestradiol and progesterone have different region 
and time specific effects on activation of ERα containing cells. In the ARC, the 
activational pattern of ERα cells was correlated with circulating plasma progesterone 
concentrations but not oestradiol. Thus, it appears ERα-cells within this area are not 
activated by oestradiol in a dose-dependent manner but may rather ‘perceive’ a 
threshold of oestradiol, and respond by becoming transcriptionally active (Caraty et al., 
2002, Saifullizam et al., 2010). Furthermore, this requires low concentrations of 
progesterone. In contrast, the VMN activational pattern had a very low level of 
correlation with plasma oestradiol and none to progesterone. We, therefore, speculate 
that the VMN is activated subsequent to the initial activation of the ARC, consistent with 
the transmission phase of the surge generating mechanism. However, increased 
activation of ERα neurones in this area coincides with the occurrence of sexual 
behaviours providing evidence that this area could be involved in the sexual behaviour 
mechanism. Nonetheless, it appears that the ARC is the site to initially respond to an 
oestradiol signal of sufficiently high or increasing levels (Moenter et al., 1990). 
Interestingly, in the mPOA, there was a simple linear relationship between circulating 
plasma oestradiol and progesterone concentrations and the percentage of ERα neurones 
that were transcriptionally activated, indicating that the mPOA is regulated by ovarian 
steroids in a dose-dependent manner. The reason for this differential regulation is not 
known, however, it appears that the ARC, VMN and mPOA participate in oestradiol 
positive feedback, but are controlled by ovarian steroids in different ways.  
Pattern of ERα activation during the follicular phase of intact ewes treated with LPS or 
insulin.  
Plasma oestradiol concentrations decreased 8h after the administration of LPS, whereas 
a decrease in the percentage of activated ERα neurones, in the ARC and mPOA, occurred 
sooner (3h after treatment). These results concur with previous studies indicating that 
there are at least two mechanisms involved in LPS inhibition of the ovarian cycle: one 
involving disruption of GnRH/LH pulses and, therefore, reduced oestradiol secretion; and 
the other preventing the ability of the surge-generating mechanism to respond to the 
preovulatory increase in oestradiol (Battaglia et al., 1999, Karsch and Battaglia, 2002). 
Here, we extend these observations by showing that the latter mechanism involves 
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suppression of activated ERα-containing cells in the ARC and mPOA. Furthermore, our 
results show that there is a time difference between the two disruptive mechanisms, 
indicating that the regulating factors may be different. In support of this, Harris et al., 
(2000) report that prostaglandins secreted after LPS have the ability to attenuate GnRH 
pulses, but administration of the prostaglandin synthesis inhibitor flurbiprofen cannot 
reverse the LH surge delay observed after this stressor (Breen et al., 2004). Cortisol is 
known to suppress pulsatile LH secretion in a dose-dependent fashion (Debus et al., 
2002). However, in the present study, cortisol increased to maximum concentrations 
immediately after the administration of LPS (i.e., 2h after treatment) and is, therefore, a 
potential candidate for the immediate inhibition of ERα-containing neurones. In 
accordance, Pierce et al., (2009) and Wagenmaker et al., (2009a) report that cortisol 
disrupts the positive feedback effect of oestradiol to trigger an LH surge. In addition, ~ 
70% of ERα cells co-express glucocorticoid receptors type II (GRII; the mPOA and ARC 
(Dufourny and Skinner, 2002). We observed an increase in plasma progesterone 
concentrations after LPS, however, the timing of maximum values varied considerably 
between animals, from 2h to 10h after treatment and, therefore, we cannot determine 
which mechanism is affected by LPS-induced increases in progesterone. It is noteworthy 
that progesterone has been implicated in both inhibition of GnRH pulses (Karsch et al., 
1987) and blocking the surge mechanism (Kasa-Vubu et al., 1992, Skinner et al., 1998, 
Richter et al., 2002, Smith et al., 2003, Richter et al., 2005). The potential influence of 
pyrexia, remains to be determined, however, our previous studies showed that 
maximum body temperatures after the same dose of LPS occurred 4h after treatment 
(Fergani et al., 2011) indicating that pyrexia may contribute to the attenuation of GnRH 
pulses, presumably via prostaglandin. The effects of LPS were still evident 12h after 
treatment, when the percentage of activated ERα neurones remained at low levels. 
Taking in to consideration that these animals did not have an LH surge at the same time 
as controls, we can conclude that the inhibition of ERα neurone activation is a major 
contributing factor to the LH surge disruption in response to an immune/inflammatory 
challenge in the ewe. This compliments our recent results in which the absence of an LH 
surge was accompanied by a failure of highly oestradiol-receptive kisspeptin neurones to 
be activated (Chapter 3).  
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Intriguingly, the percentage of ERα neurones that were transcriptionally activated was 
not altered in the VMN by LPS, even though the total number of c-Fos positive cells in 
this area increased (Chapter 3). A possible explanation for this is that the VMN contains 
very few GRII (Dufourny and Skinner, 2002) and is not directly influenced by cortisol. 
Somatostatin cells in the VMN contain ERα (70% of the total ER immunoreactive cells in 
this area; Herbison, 1995), therefore, we speculate that at least some of the ERα 
neurones in the VMN activated after LPS are, indeed, somatostatin in phenotype. 
Another possible cell type could be ERα containing inhibitory GABA cells which are 
abundant in the rat VMN (Luine et al. 1997).  
Interestingly, there was a split response in the insulin-treated animals with two out of 
four having an intense increase in the VMN, and a concurrent decrease in the mPOA, of 
the percentage of activated ERα neurones 3h after treatment (insulin-responders), 
whereas the remaining two ewes were similar to controls (insulin-non-responders). An 
equivalent divergence was observed in our previous studies when 10 out of 20 animals 
treated with insulin did not have a delay in sexual behaviour or the LH surge (insulin-
non-delayed subgroup; Fergani et al., 2011) and did not display an intense 
transcriptional activation in the PVN and VMN (insulin-non-responders; Chapter 3). This 
discrepancy is often observed after insulin administration (Fergani et al., 2011, Chapter 
3). The reason for this is not known, however, the only observed hormonal difference 
between the two groups of animals was a subtle increase in plasma progesterone 
(Fergani et al., 2011). In contrast, the percentage of activated ERα neurones 3h after 
treatment in the ARC increased in both insulin subgroups. This concurs with our recent 
findings that acute insulin administration in the late follicular phase immediately 
increases the number of activated kisspeptin cells in the ARC (Chapter 3). Therefore, the 
increased percentage of activated ERα neurones observed in the present study may be, 
at least in part, kisspeptin cells.  
Plasma oestradiol concentrations began to decrease immediately after insulin treatment 
and this coincided with the increase in activated ERα cells in the ARC and VMN but a 
decrease in the mPOA. The reason for the time lag in oestradiol decrease between 
insulin and LPS groups is not known. However, hypoglycaemia is induced immediately 
after insulin administration and is considered to be the cause of GnRH/LH pulse and 
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surge inhibition leading to disruption of the surge mechanism (Dobson and Smith 2000, 
Smith et al., 2003). Indeed the GnRH pulse and surge generator is particularly sensitive 
to reduced glucose concentrations in rats (Kawaguchi et al., 1998).  However, the 
immediate decrease of plasma oestradiol concentrations may reflect a quicker inhibition 
of steroidogenesis in the ovary after insulin compared to LPS (Shakil et al., 1994, 
Downing et al., 1999, Battaglia et al., 2000).  
Plasma cortisol concentrations increased simultaneously in both insulin sub-groups as 
observed in our earlier study (Fergani et al., 2011), in which cortisol concentrations 
increased after insulin treatment in animals whether the LH surge was delayed or not, 
indicating that cortisol alone is not responsible for LH surge disruption after insulin. In 
support of this, the insulin-induced LH surge delay is not reversed by the 
progestin/glucorticoid receptor antagonist RU486 (Dobson and Smith 2000). 
Interestingly, Wagenmaker et al., (2009b) report similar findings after the application of 
a layered psychosocial stress paradigm, i.e., the stressor appears to have a central effect 
by attenuating GnRH pulses but this is not reversed by RU486, indicating that cortisol 
was not the mediator. It is possible that insulin-induced hypoglycaemia and psychosocial 
stress are less intense stressors than the dose of LPS used and, therefore, cortisol 
production is not sufficient enough to have a hypothalamic effect. Indeed in the present 
study after LPS or following infusion of cortisol to interfere with the LH surge 
(Wagenmaker et al., 2009b), plasma cortisol concentrations reached a mean maximum 
of 157 and 172ng/ml, respectively. In contrast, after insulin-induced hypoglycaemia and 
psychosocial stress, maximum cortisol concentrations were much lower, i.e., 70 and 57 
ng/ml, respectively.  
In conclusion, the present findings clearly show that the ERα activational pattern differs 
during the follicular phase of intact ewes, as well as between regions at specific time 
points. Based on our observations, we hypothesise that once circulating progesterone 
concentrations have decreased and oestradiol concentrations reach a specific ‘threshold’ 
(approximately 6-7h before the expected LH surge onset) ERα cells in the ARC become 
transcriptionally active. ERα cells in the VMN are activated later than the ARC, and this 
coincides with the exhibition of sexual behaviours supporting existing evidence that the 
VMN is involved in behavioural regulation. In the mPOA, ERα cells followed a different 
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temporal pattern and were activated gradually. Nonetheless, ERα cell activation was 
maximum during the LH surge in all these areas, indicating a role in oestradiol positive 
feedback and GnRH surge secretion. However, this activational pattern was disturbed by 
acute insulin or LPS administration in the late follicular phase. Interestingly, LPS inhibited 
the activation of ERα cells in the ARC and mPOA but not the VMN, whereas insulin 
stimulated activation in the ARC and the VMN and inhibited the mPOA (the latter two in 
half of the animals). Thus, disruption of the LH surge by acute stressors involves 
stimulation and/or inhibition of ERα neurone activation and this varies between stress 
type or intensity, but in both cases may lead to the disruption of the LH surge.  
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Fig 1. A,C,E: Mean % (±SEM) of ERα containing cells that co-expressed c-Fos in the ARC, mPOA and VMN at 
different stages during the follicular phase of control ewes. Animals are grouped according to time as well 
as hormonal and behavioural status; i.e., grouped into those killed at 0h and 16h after PW (n=4-5), those 
killed before the onset of sexual behaviour (Before behaviour, n=3), those killed after the onset of sexual 
behaviour but before exhibiting an LH surge (After behaviour, n=5) and those killed after the onset of both 
sexual behaviour and during the LH surge (Surge, n=3). Within each panel, differences between the 
percentages are indicated by different letters on top of each bar (P<0.05). B,D,F: Regression graphs 
showing the correlation between the % of ERα containing cells that co-express c-Fos (% ERα/c-Fos) in the 
ARC, mPOA and VMN against the % change from 0h to the mean two consecutive highest or lowest 
concentrations for oestradiol (o, E; dotted line) or progesterone (■, P; solid line), respectively. 
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Fig. 2 Sets of photomicrographs from the ARC nucleus that were dual-labelled for c-Fos containing cells ( 
A,D) and their co-expression with ERα (B,E) in control animals at 31 h after PW (A, B, C) as well as 3 h after 
LPS treatment in the late follicular phase (D, E, F). Panels on the bottom (C, F) are computer-generated 
merged images of the two top panels illustrating co-expression of c-Fos and ERα. Examples of single and 
double labelled cells are marked through the panels with arrowheads and arrows, respectively. Scale bars 
= 20 μm. 3V = third ventricle. 
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Fig. 3 Sets of photomicrographs from the mPOA that were dual-labelled for c-Fos 
containing cells (A,D) and their co-expression with ERα (B, E) in control animals at 40 h 
after PW (during the surge; A, B, C). Panels on the bottom (C, F) are computer-generated 
merged images of the two top panels illustrating co-expression of c-Fos and ERα. The right 
panels (D, E, F) are the higher magnifications (Scale bar: 50 μm) of the boxed areas shown 
in the left panels (A, B, C; scale bar: 20 μm). Examples of single- and double-labelled cells 
are marked through the panels with arrows and arrowheads, respectively.  
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Fig 4. Mean (±SEM) % of ERα containing cells that co-express c-Fos in the ARC, VMN and mPOA at 
different times during the follicular phase of control and treated ewes. Animals are grouped according to 
killing time after PW i.e. control ewes at 0h, 16h, 31h and 40h (n=4-5 per group; black bars) as well as after 
insulin at 31h (insulin-responders, n=2; white bars and insulin-non-responders, n=2; hatched bars) and LPS 
at 31h and 40h (n=4 for both times; grey bars). Due to the split response in the mPOA and VMN after 
insulin treatment, statistical analysis was not carried out and the data are presented for information. 
However, in the ARC, there were no split responses observed and, therefore, statistical analysis was 
carried out with both groups combined (n=4). Treatment with insulin or LPS was at 28h after PW. Within 
each panel, differences between percentages are indicated by different letters on top of each bar (P<0.05). 
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Table 1 Mean (± SEM) numbers of c-Fos and ERα containing cells in the ARC, mPOA, and VMN 
Group 
Region 
No of c-Fos positive cells No of ERα positive cells 
ARC mPOA VMN ARC mPOA VMN 
0 h 86,1 ± 19,4 45,8 ± 6,6 65,2 ± 4.0 52,3 ± 26,9 15,2 ± 4,1 38,0 ± 8,34 
 
16 h 
 
131,4 ± 22,9 
 
58,3 ± 17,9 
 
83,5 ± 24,3 
 
57,9 ± 19,5 
 
17,2 ± 3,4 
 
49,8 ± 16,4 
 
31 h control 
 
171,5 ± 26,5 
 
79,0 ± 18,1 
 
96,0 ± 28,2 
 
96,6 ± 21,1 
 
39,5 ± 13,0 
 
49,6 ± 14,4 
 
31h LPS 
 
185,8 ± 15,9 
 
161,4 ± 15,2* 
 
211,5 ± 34,6* 
 
41,3 ± 16,6 
 
37,1 ± 22,5 
 
78,0 ± 12,9 
 
31h insulin-responders 
 
226,5 ± 12,0 
 
90,0 ± 18,5 
 
199,0 ± 21,0 
 
79,2 ± 2,2 
 
32,5 ± 13,5 
 
139,0 ± 24,0 
 
31h insulin-non-responders 
 
259,3 ± 47,3 
 
143,8 ± 10,8 
 
75,5 ± 10,5 
 
156,8 ± 77,3 
 
81,5 ± 22,5 
 
72,0 ± 9,0 
40h control 156,5 ± 19,1 95,7 ± 23,4 179,4 ± 33,3* 89,7 ± 19,3 59,0 ± 26,2 100,4 ± 20,8* 
40 h LPS 147,9 ± 32,3 120,4 ± 28,5 203,3 ± 12,7* 59,9 ± 18,2 26,0 ± 6,6 75,3 ± 12,7 
ARC c-Fos:      * P<0.05 compared to 0h control groups 
mPOA c-Fos: * P<0.05 compared control groups. 
VMN c-Fos:   * P<0.05 compared to 0h, 16h and 31h control groups. 
VMN ERα:     * P<0.05 compared to 0h, 16h, 31h control groups.  
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Chapter 5 
Kisspeptin, dynorphin and neurokinin B co-expression with c-Fos in the middle and 
caudal ARC at different times during the follicular phase of intact ewes and alteration 
after insulin or endotoxin.  
 
 
Keywords: Kisspeptin, dynorphin, neurokinin B, c-Fos, ewe, insulin, LPS, stress, GnRH 
surge, LH surge. 
Abstract 
The aim of the present study was to determine the activation pattern of kisspeptin, 
neurokinin B and dynorphin (KNDy) cells in the middle and caudal ARC during the 
follicular phase of intact ewes, as well as investigating whether patterns are altered by 
stressors. Follicular phases of intact ewes were synchronised with progesterone vaginal 
pessaries. Control animals were killed at 0, 16, 31 and 40h (n=5-6 per group) after 
progesterone withdrawal (PW; time zero). At 28h, groups of animals received insulin (4 
iu/kg) or endotoxin (LPS; 100 ng/kg) and were subsequently killed at 31h (insulin; n=5 
and LPS; n=5) or 40h (LPS; n=5). LH surges occurred only in 40h control ewes. Activation 
patterns were established using c-Fos (a marker for neuronal activation) with dual- and 
triple-label immunohistochemistry. In control ewes, the maximum percentage of 
dynorphin cells co-expressing c-Fos was observed at 31h after PW and before the onset 
of sexual behaviour (52 and 56%, respectively; P<0.05, compared to 0h and 16h control 
groups), whereas the maximum kisspeptin and neurokinin B cells co-expressing c-Fos 
occurred at 40h after PW (49 and 42%, respectively; P<0.05 for both) specifically in 
animals exhibiting an LH surge (64 and 50%, respectively; P<0.05, compared to all other 
control groups). Furthermore, at 31h after PW, the number of cells containing dynorphin 
increased compared to kisspeptin cells (59.9 ± 6.2 versus 37.2 ± 3.0 total number of cells; 
P<0.05). However, LPS decreased the percentage of dynorphin cells co-expressing c-Fos 
(at 31h and 40h after PW; to 23% and 11%, respectively; P<0.05) and kisspeptin cells (at 
40h after PW; to 22%; P<0.05). In contrast, at 31h after PW (i.e., 3h after treatment), 
insulin decreased the percentage of dynorphin cells co-expressing c-Fos in two of the 
insulin-treated animals (to 21 and 33%; insulin-responders) but not in the other two; 
whereas the percentage of activated kisspeptin cells increased in all insulin-treated 
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animals (52%; P<0.05). Neurokinin B was not altered by either treatment. These results 
indicate that KNDy cells are involved in the GnRH/LH surge mechanism and its disruption 
after LPS or insulin involves alteration of kisspeptin and dynorphin (but not neurokinin B) 
cell activation.  
Introduction 
The ovarian steroid hormone milieu varies during the oestrous cycle and involves 
positive and negative feedback on gonadotrophin-releasing hormone (GnRH) neurones. 
The decrease in progesterone concentrations after luteolysis along with an increase of 
oestradiol is responsible for the sudden and massive release of GnRH that evokes the 
pituitary luteinizing hormone (LH) surge, responsible for ovulation in mammals. 
However, the majority of studies indicate that GnRH neurones have very few, if any, 
receptors for ovarian steroids (Herbison et al. 1993, Lehman and Karsch 1993, Sullivan et 
al. 1995, Scott et al. 2000, Skinner et al. 2001). Therefore, these hormones exert 
modulatory effects mainly through intermediate neurones containing steroid receptors 
(Herbison 1998, Herbison et al. 2001, Hrabovszky et al. 2001, Smith and Jennes 2001). 
Recent evidence has revealed that the hypothalamic neuropeptide kisspeptin mediates 
steroidal influence on GnRH neurones across a large number of species (Smith 2008, 
Roseweir and Millar 2009; Lehman et al. 2010; Chapter 3). Furthermore, nearly all 
kisspeptin cells in the arcuate nucleus (ARC; specifically the middle and caudal aspects), 
but not the preoptic area (POA), co-localise two other neuropeptides that are important 
in the control of GnRH secretion: neurokinin B and dynorphin (Foradori et al., 2006, 
Goodman et al., 2007, Topaloglu et al., 2009, Lehman et al., 2010a). Thus, this ARC cell 
group co-localises neuropeptides that are both stimulatory (kisspeptin) and inhibitory 
(dynorphin) to GnRH secretion (Pillon et al., 2003, Dungan et al., 2006; Kauffman et al., 
2007, Lehman et al., 2010b) and are thus called KNDy cells (co-localising kisspeptin, 
neurokinin B and dynorphin; Cheng et al., 2009, Lehman et al., 2010a). Furthermore, 
95% of KNDy cells possess oestradiol receptor α (ERα; Franceschini et al., 2006) and 
progesterone receptors (PR; Faradori et al., 2002) indicating that they may mediate both 
positive and negative feedback effects of ovarian steroids on GnRH secretion.  To date 
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KNDy cells have not been associated with the control of oestrous behaviour (Kauffman 
et al. 2007).  
We have recently shown that activation of kisspeptin immunoreactive cells (assessed by 
the co-expression with c-Fos) increases intensely in the rostral, middle and caudal ARC 
during the LH surge compared to other stages in the follicular phase (Chapter 3). As 94% 
kisspeptin cells co-localise dynorphin and 80% co-localise neurokinin B, with an equally 
high reciprocal co-localisation (Goodman et al., 2007), immunohistochemical detection 
of kisspeptin protein may reflect the presence of all three neuropeptides. Thus, 
immunohistochemical analysis of dynorphin or neurokinin B with c-Fos might produce 
an identical pattern to that observed in kisspeptin cells. However, in the ewe, kisspeptin 
and dynorphin immunoreactivity and/or gene expression fluctuates depending on 
hormonal and gonadal status (Faradori et al., 2005, Smith et al., 2007, Merkley et al., 
2009, Smith et al., 2009, Smith 2009). Therefore, we hypothesise that, in an intact ewe 
model, endogenous fluctuation of the ovarian steroid hormone milieu during the 
follicular phase is associated with variation in protein expression and, therefore, 
different activation patterns for each neuropeptide cell phenotype. 
There is evidence that KNDy neurones may mediate the effects of stressors on the 
reproductive neuroendocrine axis. Indeed, a few studies report down-regulation of the 
hypothalamic kisspeptin system in rats and male rhesus monkeys after metabolic or 
immune/inflammatory stressors, such as negative energy balance (Castellano et al. 
2010), short term fasting (Wahab et al. 2010) or administration of E. coli endotoxin (LPS; 
Iwasa et al. 2008, Kinsey-Jones et al. 2009). Furthermore, each of these stressors was 
accompanied by suppression of the hypothalamic-pituitary-gonad axis. We have recently 
shown that a sudden activation of the hypothalamus-pituitary-adrenal axis by LPS in the 
late follicular phase lowered plasma oestradiol concentrations and delayed onsets of 
pre-copulatory behaviours, oestrus and the LH surge of free-running intact ewes; 
whereas, insulin-induced hypoglycaemic stress had the same effect in only 50% of 
animals (Fergani et al., 2011). Furthermore, immunohistochemical analysis of kisspeptin 
or ERα combined with c-Fos revealed that this disruption after LPS or insulin is 
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respectively accompanied by inhibited or stimulated activation of ERα and kisspeptin 
cells in the ARC (Chapter 3, Chapter 4). However, the effects of stressors on dynorphin 
and neurokinin B immunoreactivity and activation in the ARC have not yet been 
investigated.  
In the present study, we examined brain tissue of intact ewes sacrificed at various times 
during the follicular phase with or without the administration of insulin or LPS. Our aims 
were to: 1) map the pattern of kisspeptin, dynorphin and neurokinin B transcriptional 
activation (by measuring co-expression with c-Fos; Hoffman et al., 1993) in the middle 
and caudal ARC, where most of these neurones are located; 2) correlate changes in 
these patterns with contemporaneous plasma progesterone and oestradiol 
concentrations, as well as signs of sexual behaviour and the LH surge; 3)  compare co-
expression between kisspeptin and dynorphin using triple label immunohistochemistry 
(kisspeptin/dynorphin/c-Fos); and 4) establish whether immunoreactivity and/or co-
expression vary during the follicular phase. Finally, we sought to determine whether the 
disruption of the surge mechanism after LPS or insulin involves inhibition of kisspeptin, 
dynorphin and/or neurokinin B  activation in the middle and caudal ARC, as well as 
describing the temporal relationships between these changes and alterations in plasma 
steroid concentrations. 
Materials and Methods 
Animals, study design and blood sampling procedure 
In this study, we used tissue collected during the breeding season; details are given in 
Chapter 3. 
Visual observation of oestrous behaviour 
Details are given in Chapter 3. 
Tissue collection 
Details are given in Chapter 3. 
 c-Fos and dynorphin or neurokinin B dual-label immunofluorescence 
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c-Fos/dynorphin or c-Fos/neurokinin B  dual-label immunofluorescence was carried out 
on 40μm sections containing middle and caudal levels of the ARC (three sections for 
each level and neuropeptide combination). All steps were performed at room 
temperature unless otherwise stated. Antibodies were diluted with 2.5% normal donkey 
serum (catalogue item S2170, Biosera, UK), 1% Triton X-100 (T9284, Sigma-Aldrich, UK) 
and 0.25% sodium azide (Sigma) in 0.1M phosphate buffer saline, pH 7.2 (PBS). Free-
floating sections were washed thoroughly in PBS for 2h to remove the cryoprotectant 
solution followed by 1h incubation in blocking solution (10% donkey serum in PBS). This 
was followed by 72h incubation at 40C with polyclonal rabbit anti-c-Fos antibody (AB-5, 
PC38, Calbiochem, Cambridge, MA, USA) at a dilution of 1:5,000. After incubation with 
the primary antiserum, sections were washed thoroughly and incubated with donkey 
anti-rabbit Cy3 (711-165-152, Jackson Immunoresearch, West Grove, PA) diluted 1:500 
for 2h. A second immunofluorescent procedure was then performed, as described 
above, to localise the second primary antibodies: rabbit anti-dynorphin A serum (T-4268, 
Peninsula Laboratories, LLC, San Carlos, CA), at a dilution of 1:10000 or rabbit-anti-
neurokinin B serum (T-4450, Peninsula Laboratories, LLC, San Carlos, CA), at a dilution of 
1:1,000, both incubated for 72h at 40C and then visualised using donkey-anti-rabbit 
Dylight 488 (715-485-151, Jackson Immunoresearch West Grove, PA) at a dilution of 
1:500. Thereafter, sections were washed with PBS followed by a final wash with double-
distilled water, mounted on chrome alum gelatine-coated slides and cover-slipped with 
Vectashield anti-fading mounting medium (H-1000, Vector Laboratories Ltd, UK). The c-
Fos (Ghuman et al. 2010), dynorphin A and neurokinin B (Faradori et al., 2006, Goodman 
et al., 2007) antibodies have been validated previously for use in ovine neural tissue. In 
addition, negative controls omitting one of the primary antibodies completely 
eliminated the appropriate fluorescence without obviously affecting the intensity of the 
other fluorescent probe.  
c-Fos, dynorphin and kisspeptin triple-label immunohistochemistry 
c-Fos/dynorphin/kisspeptin triple-label immunohistochemistry was carried out on 
sections containing middle and caudal levels of the ARC (three sections for each level). 
This consisted of an immunoperoxidase protocol in which nuclear c-Fos was detected 
first with diaminobenzidine as chromogen (DAB; brown reaction product) followed by 
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visualisation of dynorphin and kisspeptin with immunofluorescence. As dynorphin and 
kisspeptin antibodies were both derived in the rabbit, we used a previously described 
modified protocol (Hunyady et al., 1996, Goodman et al., 2007, Cheng et al., 2010). In 
brief, the first antigen was visualised using a very low concentration of primary antibody 
with tyramide amplification solution (TSA). Next, the second antigen was visualised 
using normal concentrations of primary antibody and detection with fluorophore-
conjugated secondary antibody. The immunohistochemical procedure was carried out at 
room temperature unless otherwise stated. Washes with PBS were performed after 
every step, except after blocking with donkey serum. Antibodies were diluted as 
described above. Free-floating sections were washed thoroughly in PBS for 2h to remove 
the cryoprotectant solution followed by a 15min incubation in 40% methanol and 1% 
hydrogen peroxide (H2O2; 316989, Sigma-Aldrich, UK) in PBS to inactivate endogenous 
peroxidases. Sections were then incubated for 1h in blocking solution (10% donkey 
serum in PBS), followed by a 72h incubation in rabbit anti-c-Fos antibody  at a dilution of 
1:5,000 at 40C. After incubation with primary antiserum, sections were labeled with 
biotinylated donkey anti-rabbit IgG (711-065-152, Jackson Immunoresearch West Grove, 
PA) at 1:500 for 2h, followed by 90 min in Vectastain Elite ABC kit (1:250 in PBS; PK6100, 
Vector Laboratories Ltd, UK). Nuclear c-Fos was visualised by 5 min incubation in DAB 
(SK-4100, Vector Laboratories, Ltd, UK). The second immunohistochemical procedure 
consisted of blocking with H2O2 and donkey serum (as described above) and incubation 
for 72h in rabbit anti-kisspeptin (lot 564; gift from Prof. Alain Caraty, INRA Nouzilly, 
France) at a dilution of 1:150,000 at 40C. Following incubation, sections were labeled 
with biotinylated donkey anti-rabbit IgG (1:500; for 2h) and then incubated in Vectastain 
Elite ABC kit (1:250; for 90 min). The signal was amplified in TSA for 10 min (1:200; New 
England Nuclear Life Science Products Life Sciences, Boston, MA) diluted in PBS with 
0.003% H2O2 as substrate (Cheng et al., 2010) and then labeled with streptavidin 
conjugated AlexaFluor 488 (S11223, Molecular Probes, Eugene, OR, USA) at a dilution of 
1:100 for 2h. A third immunohistochemical procedure was then performed and 
consisted of blocking (as described above) followed by a 72h incubation with rabbit anti-
dynorphin diluted 1:10,000 and subsequent labeling with donkey anti-rabbit Cy3 (711-
165-152, Jackson Immunoresearch West Grove, PA) at a dilution of 1:500 for 2h. Finally, 
sections were washed, mounted on chrome alum gelatine-coated slides, dried, and 
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cover-slipped with Vectashield anti-fading mounting medium (H-1000; Vector 
Laboratories Ltd, UK). Negative controls included omission of either primary antibody 
and resulted in a complete lack of staining for the corresponding peptide. Slides were 
stored covered at 40C until analysed. 
Data collection and analysis 
Dual-labeled sections were examined under an epi-fluorescent microscope (Zeiss Axio 
Imager. M1) and photographed by digital microphotography (Hamamatsu ORCA I-ER 
digital camera, Hamamatsu Photonics, Welwyn Garden City, Herts) using a 20× 
objective. Photographs (acquired with an image analysis program AxioVision; Zeiss 
Imaging Systems) consisted of single c-Fos staining, single dynorphin or neurokinin B 
staining as well as a merged image to produce a spectral combination of green 
(fluorescein) and red (rhodamine). Triple-labeled sections were similarly examined for 
single c-Fos staining, single dynorphin and single kisspeptin as well as a merged image of 
the two latter to produce a spectral combination of green (fluorescein) and red 
(rhodamine). Sections were evaluated unilaterally and each of three photographs per 
section was taken from a random field within each area/section. All photographs were 
imported into Image J version 1.42q, and counts performed using the cell count plug-in. 
The observer was unaware of the animal identity and group. The mean total number 
and percentage of single-, dual- or triple-labeled cells was summed from the 
photographs of each section and then averaged for each ewe and compared using GLM 
ANOVA, followed, when appropriate, by Tukey’s multiple comparisons post hoc test. 
Mean data (±SEM), as presented in figures and results, were calculated by averaging 
values for each group. 
The data were analysed in two ways: the first consisted of control ewe data grouped 
according to time as well as hormonal and sexual behavioural status; i.e., grouped into 
those killed at 0h and 16h after PW, those killed at 31h after PW but before the onset of 
sexual behaviour (Before behaviour, n=3), those killed at 31h or 40h after PW, after the 
onset of sexual behaviour but before exhibiting an LH surge (After behaviour, n=5) and 
those killed after the onset of both sexual behaviour and during the LH surge (Surge, 
n=3). This grouping allowed for a detailed comparison of neuropeptide profiles in 
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control animals at different stages of the follicular phase in our intact-ewe model. 
Secondly, control and treated animals data were grouped according to time of killing 
after PW, and this was used to compare treatment effects. 
During data analysis, it became clear that there was a split response in the insulin group 
regarding the percentage of dynorphin cells that co-expressed c-Fos in the ARC. 
Therefore, this group was separated into two subgroups referred to hereafter as insulin-
responders or insulin-non-responders (verified previously in Chapter 3 as with or 
without c-Fos activation in the paraventricular nucleus, respectively). As this division 
reduced the group size to n=2/group, statistical analysis was not undertaken, but the 
data are presented for information. When responses were not different between sub-
groups, data were combined and analysed with n=4.  
 
Peripheral plasma progesterone and oestradiol values fluctuated between animals, thus, 
regression analysis was used to examine the association between the percentage of 
change from 0h to the two mean consecutive lowest or highest progesterone or 
oestradiol values, respectively, and the percentage of kisspeptin, dynorphin and 
neurokinin B cells that co-expressed c-Fos (i.e., were activated) in the ARC of control 
animals. 
Results 
Luteinising hormone (LH) and behavioural profiles. 
Shown in chapter 3 
Control ewes: Dynorphin and c-Fos co-expression in the middle and caudal ARC at 
different stages during the follicular phase, in animals grouped by behaviour (dual 
immunohistochemical study). 
The percentage of dynorphin cells that co-expressed c-Fos was greatest in the ‘Before 
behaviour’ group compared to earlier stages in the follicular phase (P<0.05; Fig. 1A). 
Thereafter, there was a gradual decrease until the LH surge (Fig. 1A). 
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Control ewes: Kisspeptin, dynorphin and c-Fos co-expression in the middle and caudal 
ARC at different stages during the follicular phase in animals grouped by behaviour 
(triple immunohistochemical study). 
The percentage of kisspeptin cells that co-expressed c-Fos sequentially increased from 
0h to ‘Before behaviour’, and to ‘After behaviour’ (P<0.05 for all comparisons; Fig. 2A). 
Animals in the ‘Surge’ group displayed a two-fold increase in the percentage of 
kisspeptin cells that co-expressed c-Fos compared to the ‘After behaviour’ group 
(P<0.05; Fig. 2A). In contrast, there was a two-fold increase in the percentage of 
dynorphin cells that co-expressed c-Fos in the ‘Before behaviour’ group, compared to 0h 
and 16h (P<0.05 for both; Fig. 2C). This increase was maintained ‘After behaviour’ but 
not in the ‘Surge’ group (Fig. 2C). The pattern of changes in the proportion of cells co-
expressing dynorphin and c-Fos was similar visualised by dual- or triple-staining (Figs. 1A 
and 2C). 
The number of immunoreactive cells, as well as the percentage co-expression between 
kisspeptin and dynorphin cells, in the middle and caudal ARC, varied during the follicular 
phase (Fig. 3). In summary, the number of kisspeptin or dynorphin cells was greater 
‘After behaviour’ compared to 0h, or 0h and 16h, respectively but, there were more 
dynorphin cells compared to kisspeptin cells ‘Before behaviour’ (P<0.05 for all 
comparisons; Fig. 3A). The percentage of kisspeptin cells co-expressing dynorphin was 
lower in the ‘Surge’ group (i.e., when there were more single-labelled kisspeptin cells) 
compared to 16h, ‘Before behaviour’ and ‘After behaviour’ (P<0.05 for all comparisons; 
Fig. 3B), whereas there were fewer dynorphin cells co-expressing kisspeptin (i.e., there 
were more single labelled dynorphin cells) ‘Before behaviour’ and ‘After behaviour’ 
compared to 0h and 16h (P<0.05 for all comparisons; Fig. 3B).  
Control ewes: Neurokinin B and c-Fos co-expression in the middle and caudal ARC at 
different stages during the follicular phase in animals grouped by behaviour (dual 
immunohistochemical study). 
The percentage of neurokinin B cells that co-expressed c-Fos sequentially increased from 
0h to 16h and thereon to ‘Before behaviour’, ‘After behaviour’ as well as animals in the 
‘Surge’ group (P<0.05 for ‘Surge’ compared to other stages; Fig. 2E). The number of cells 
with neurokinin B immunoreactivity was greater in the ‘After behaviour’ and ‘Surge’ 
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groups compared to all other stages in the follicular phase (P<0.05 for all comparisons; 
Fig. 3C).  
Oestradiol 
Oestradiol data have been presented in Chapter 3. Using regression analysis, the 
percentages of kisspeptin or neurokinin B cells that co-expressed c-Fos were positively 
associated with the percentage change in concentration from 0h to the mean two 
consecutive highest plasma oestradiol values in the middle and caudal ARC (P=0.005, 
RSq=36% and P=0.002, RSq=41% for kisspeptin and neurokinin B, respectively). This was 
not the case for dynorphin cells (P=0.5; Fig. 2B, 2D, 2F).  
Progesterone 
Progesterone data have been presented in chapter 3. Again using regression analysis, 
the percentages of kisspeptin, dynorphin or neurokinin B cells that co-expressed c-Fos 
were positively associated with the percentage change in concentration from 0h to the 
mean two consecutive lowest plasma progesterone values in the middle and caudal ARC 
(P=0.002 RSq=41%, P=0.001 RSq=47% and P=0.001 RSq=50% for kisspeptin, dynorphin 
and neurokinin B, respectively; Fig. 2B, 2D, 2F).  
Cortisol 
Cortisol data have been presented in Chapter 3. 
Control, insulin or LPS: Dynorphin and c-Fos co-expression in the middle and caudal ARC 
at different times during the follicular phase, in animals grouped by hours after PW (dual 
immunohistochemical study).   
With respect to PW, the percentage of dynorphin cells that co-expressed c-Fos in 
controls was increased at 31h compared to all other times examined in the follicular 
phase (P<0.0001; Fig. 1B). However, 31h after PW (i.e., 3h after LPS or insulin 
administration), there was a marked decrease in the percentage of dynorphin cells that 
co-expressed c-Fos in the LPS groups (P<0.05, Fig. 1B) and the insulin-responders (Fig. 
1B), but not in the insulin-non-responders, compared to 31h controls (Fig. 1B).   
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Control, insulin or LPS: Kisspeptin, dynorphin and c-Fos co-expression in the middle and 
caudal ARC at different times during the follicular phase, in animals grouped by hours 
after PW (triple immunohistochemical study).  
With respect to PW, the percentage of kisspeptin cells that co-expressed c-Fos in 
controls was increased at 31h and 40h compared to all other times examined in the 
follicular phase (Fig. 4A).  However, 31h after PW (i.e., 3h after insulin or LPS 
administration), the percentage of kisspeptin cells that co-expressed c-Fos increased in 
both insulin sub-groups (from 32.8 ± 4.3 to 51.8 ± 4.8%; combined insulin-responders 
and insulin-non-responders; P<0.05; Fig. 4A), whereas the LPS group was not different to 
controls (Fig. 4A). At 40h after PW (i.e., 12h after LPS administration), the percentage of 
kisspeptin cells that co-expressed c-Fos was markedly lower in LPS treated animals 
compared to controls (P<0.05; Fig. 4A). 
The percentage of dynorphin cells that co-expressed c-Fos in controls was increased at 
31h and at 40h after PW compared to 0h and 16h control groups (P<0.05; Fig. 4B). 
However, at 31h i.e., 3h after insulin or LPS administration, the percentage of dynorphin 
cells that co-expressed c-Fos was lower in the LPS group (P<0.05) and in the insulin-
responders (Fig. 4B), but not the insulin-non-responders. At 40h this was still evident in 
the LPS group i.e., 12h after LPS administration (P<0.05; Fig. 4B). The patterns of 
changes in the proportion of cells co-expressing dynorphin and c-Fos were similar 
visualised by dual- or triple-staining (Figs. 1B and 4B). Photomicrographs from the ARC 
triple-labelled with kisspeptin, dynorphin and c-Fos are shown in Fig. 5. 
The number of immunoreactive cells is given in Tables 1 and 2, as well as the percentage 
co-expression between kisspeptin and dynorphin cells, in the middle and caudal ARC, 
during the follicular phase or after LPS or insulin treatment. In summary, the numbers of 
kisspeptin cells were greater in 31h and 40h control groups compared to 0h, whereas 
dynorphin cell number increased in the 31h compared to 0h and 16h control groups and 
at 40h compared to the 0h control group. In addition, there were more immunoreactive 
dynorphin cells than immunoreactive kisspeptin or neurokinin B cells in the 31h control 
groups (Table 1). Treatment with LPS decreased the number of cells with dynorphin 
immunoreactivity, whereas insulin decreased both kisspeptin and dynorphin 
immunoreactivity at 31h compared to the control group (Table 1).  
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Control, insulin or LPS: Neurokinin B and c-Fos co-expression in the middle and caudal 
ARC at different times during the follicular phase, in animals grouped by hours after PW 
(dual immunohistochemical study).   
The percentage of activated neurokinin B cells in controls was greatest at 40h compared 
to 0h and 16h control groups (P<0.05, Fig.4C). LPS or insulin administration had no effect 
on the percentage of activated neurokinin B cells at any time after treatment (Fig. 4C). 
The number of neurokinin B immunoreactive cells did not vary during the follicular 
phase, or after LPS or insulin treatment, with respect to PW (Table 1). Photomicrographs 
of sections from the ARC dual-labeled with neurokinin B and c-Fos are shown in Fig. 6.  
Discussion 
The results of the present study show that, in the middle and caudal ARC, maximum 
transcriptional activation of kisspeptin and neurokinin B cells occurs during the LH surge, 
whereas maximum activation of dynorphin cells is observed 1-2h before the expected 
onset of sexual behaviour and approximately 6-7 hours before the expected LH surge 
onset, at a time when plasma oestradiol concentrations are increasing. Furthermore, at 
this time only, the number of dynorphin cells increased compared to kisspeptin. 
However, LPS administration in the late follicular phase lowered plasma oestradiol 
concentrations and prevented dynorphin and kisspeptin cell activation in the middle and 
caudal ARC. In contrast, insulin prevented dynorphin activation in half the treated 
animals, whereas kisspeptin activation was stimulated in all insulin-treated animals. 
Neurokinin B activation was not altered by either treatment. These data implicate 
kisspeptin, neurokinin B and dynorphin (KNDy cells) as differential mediators of 
oestradiol feedback at different times within the follicular phase to elicit the GnRH/LH 
surge, and furthermore, alterations after LPS or insulin were associated with disruption 
of the LH surge. 
Kisspeptin is a potent stimulator of the GnRH neuroendocrine system in sheep (Smith et 
al., 2008, Lehman et al., 2010a). Cells containing kisspeptin are involved in the oestradiol 
positive feedback mechanism, which leads to the GnRH/LH surge and ovulation in a 
large number of species (Clarkson et al. 2008, Clarkson and Herbison 2009, Oakley et al. 
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2009, Smith et al. 2009, Lehman et al, 2010b). However, the time of kisspeptin cell 
activation relative to the stimulatory oestradiol signal, as well as the location of the 
kisspeptin cells that respond within the ovine ARC, varies between studies, gonadal state 
(i.e., OVX versus intact) and method of detection (i.e., immunohistochemistry versus in 
situ hybridization). For example, Estrada et al., (2006) report an increase in kisspeptin 
mRNA in the caudal ARC during the pre-ovulatory period, with further activation in the 
rostral ARC during oestrus in intact ewes, whereas, Smith et al., (2009) found activated 
kisspeptin cells in the middle and caudal ARC of OVX ewes 1h after an oestradiol 
treatment known to stimulate positive feedback. However, the same study (Smith et al., 
2009) reports an increase in kisspeptin mRNA, in the middle and caudal ARC, only during 
the late follicular phase. We have recently mapped kisspeptin cell activation at various 
times during the follicular phase of intact ewes and found that the percentage of 
activated kisspeptin cells increased in the rostral, middle and caudal ARC during the LH 
surge (Chapter 3). A similar finding has been reported by Merkley et al., (2009), with an 
increase in kisspeptin cell activation in all areas of the ARC in OVX animals undergoing an 
LH surge. The present study also concurs with our previous findings, as we observed a 
gradual increase in the percentage of activated kisspeptin cells in the middle and caudal 
ARC during the follicular phase with a further two-fold increase during an LH surge. 
Furthermore, during the surge, the percentage of kisspeptin cells that co-expressed 
dynorphin decreased (i.e., there were more single labelled kisspeptin cells) compared to 
other times in the follicular phase, suggesting an overall shift towards excitation. In 
addition, the percentage of activated kisspeptin cells increased as plasma oestradiol 
values increased, whereas there was an inverse association with decreasing 
progesterone concentrations.  
Neurokinin B is a member of the tachykinin neuropeptide family and is abundant in the 
ARC of many species (Abel et al., 1999, Goubillion et al., 2000, Latronico et al., 2009). 
Central administration of a neurokinin B receptor agonist stimulates LH secretion in 
sheep and monkeys (Billings et al., 2010; Ramaswamy et al., 2010), whereas in humans, 
mutations of either neurokinin B or its receptor (neurokinin 3 receptor; NK3R) are 
associated with gonadotrophin deficiency and pubertal failure (Topaloglu et al., 2009). In 
the present study, the percentage of activated neurokinin B cells gradually increased in 
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parallel with increasing plasma oestradiol concentrations during the follicular phase with 
maximum activation during the LH surge. A similar pattern was observed for kisspeptin 
activation; however, there was no abrupt increase in neurokinin B during the LH surge as 
observed with kisspeptin. Even though neurokinin B appears to be a stimulating factor of 
the GnRH/LH surge in the ewe, the mechanism by which this may be achieved is not yet 
clear as NK3R are not co-localised in GnRH neurones but on KNDy cells (Amstalden et al., 
2009). A proposed model for the actions of neurokinin B to control KNDy cell activity is 
outlined in Lehman et al., (2010b) and Maeda et al., (2010), suggesting that neurokinin 
B/NK3R signaling plays a role in facilitating and synchronizing activation of kisspeptin 
neurones. This mode of secretion is proposed for the control of GnRH pulses; however, a 
similar mode of action could also be employed for the control of the GnRH surge 
mechanism.  
Endogenous opioids peptides (EOPs) play an important role in the inhibition of GnRH 
secretion (Goodman et al., 1995). Recent evidence indicates that dynorphins located in 
the POA, anterior hypothalamus and ARC are the primary EOP mediating progesterone 
negative feedback during the luteal phase (Goodman et al., 2004, Faradori et al., 2005). 
In the present study during the follicular phase, maximum dynorphin cell activation in 
the middle and caudal ARC occurred when plasma oestradiol concentrations were 
increasing and plasma progesterone concentrations were already low, approximately 6-
7h before the expected LH surge and the concurrent maximum kisspeptin cell activation. 
Furthermore, at that specific point, and not at other examined times in the follicular 
phase, the number of dynorphin cells increased compared to kisspeptin-only cells, 
whereas the percentage of dynorphin cells that co-expressed kisspeptin was at its lowest 
(i.e., there were more single-labelled dynorphin cells), suggesting a overall shift towards 
inhibition. In the present study, the percentage of activated dynorphin cells was not 
associated with increasing plasma oestradiol concentrations, in contrast to a negative 
relationship with plasma progesterone values. It is possible that, once progesterone 
influence decreases below a threshold, there is an increase in the percentage of 
dynorphin cells that are activated, irrespective of oestradiol concentrations.  
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Our observations are consistent with a role of KNDy cells in the GnRH surge mechanism. 
KNDy cells become active in the middle and caudal ARC at a time when plasma 
oestradiol concentrations are increasing (approximately 6-7h before the expected LH 
surge onset), and remain activated during the late follicular phase and during the LH 
surge. However, the balance of neuropeptide expression within this cell population 
varies throughout the late follicular phase. Initially, there is a shift of the net balance 
towards inhibition by dynorphin, followed by a swing towards excitation by kisspeptin 
presumably facilitated by neurokinin B under the influence of increasing oestradiol 
concentrations. As KNDy cells send projections towards the mPOA (Lehman et al., 
2010b) and ME (Amstalden et al., 2005, Smith et al., 2011), these signals may be directly 
or indirectly transmitted to GnRH cell bodies and/or terminals. The physiological role of 
an increase in dynorphin cell activation prior to the LH surge is not known. However, 
these observations are consistent with the hypothesis that a reduction in inhibition 
(disinhibition) of GnRH secretion by endogenous opioid systems in the hypothalamus is 
permissive of the preovulatory GnRH/LH surge (Karla, 1993, Walsh and Clarke, 1996, 
Dobson et al., 2003) and may, therefore, be a part of oestradiol positive feedback 
mechanism. It appears that KNDy cells in the ARC may contribute to this role. 
Alternatively, in the OVX ewe, an injection of oestradiol known to elicit positive feedback 
induces an initial negative feedback effect (Clarke et al. 1988, Caraty et al., 1989), which 
may play a role in preventing premature activation of GnRH neurones, allowing an 
increase in the releasable pool of GnRH as well as increasing GnRH receptor number 
(Clarke et al. 1988, Walsh and Clarke, 1996, Dobson et al. 2003). It may be that 
increasing plasma oestradiol concentrations in the follicular phase of intact ewes 
produce a similar effect, reflected by an increase in dynorphin cell activation followed by 
preovulatory positive feedback (accompanied by kisspeptin and neurokinin B activation). 
However, as the percentage of activated dynorphin cells increases just before the 
initiation of sexual behaviour, we cannot rule out the possibility that this increase may 
be involved in the initiation of signs of sexual behaviour.   
In the present study, the number of immunoreactive kisspeptin, dynorphin and 
neurokinin B cells varied during the follicular phase with maximum cell numbers for all 
three neuropeptides observed in the late, rather than early, follicular phase. 
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Furthermore, there were more dynorphin immunoreactive cells compared to kisspeptin-
only cells in animals 1-2h before the expected onset of sexual behaviour and 
approximately 6-7h before the expected surge onset. This may be because each 
neuropeptide co-localised in KNDy cells is influenced by ovarian steroids in different 
ways. Indeed, OVX (i.e., the lack of steroid influence) increases neurokinin B and 
kisspeptin gene expression in the ovine ARC, while oestradiol replacement prevents this 
increase (Pillon et al., 2003, Smith et al., 2007, Smith et al., 2008). Similar results are also 
seen when kisspeptin protein is measured by immunohistochemistry (Pompolo et al., 
2006, Smith et al., 2007). However, OVX reflects a state where GnRH/LH secretion is 
elevated, indicating that the kisspeptin system mirrors GnRH secretion (Estrada et al., 
2006). In contrast, OVX decreases pre-prodynorphin mRNA in the ARC (Faradori et al., 
2004), whereas progesterone treatment did not prevent the effect, raising the possibility 
that oestradiol stimulates pre-prodynorphin expression in this area (Faradori et al., 
2005). Therefore, it is not surprising that endogenous fluctuating steroid concentrations 
in the present study resulted in different activation patterns in kisspeptin, neurokinin B 
and dynorphin, even though these neuropeptides are known to co-localise in ARC 
neurones (Goodman et al., 2007).  It would be of great interest to perform in situ 
hybridization for both kisspeptin and dynorphin mRNA to detect possible differences in 
the timing of maximum increase during the follicular phase of intact ewes to confirm the 
present findings.  
Dynorphin cells have been observed in the magnocellular neurones of the 
paraventricular nucleus (Goodman et al., 2007) and pre-prodynorphin mRNA in this area 
increases in response to psychological stress (i.e., isolation) or dehydration in ewes 
(Matthews et al., 1993), whereas, there is no change after long-term alterations in 
bodyweight (Iqbal et al., 2003). However, to the best of our knowledge, there are no 
equivalent data for the actions of stressors on dynorphin cells located in the ARC. In 
contrast, a few studies report down-regulation of the ARC kisspeptin system in rats and 
male rhesus monkeys after metabolic or immune/inflammatory stressors, such as 
negative energy balance (Castellano et al. 2010), short term fasting (Wahab et al. 2010) 
or administration of LPS (Iwasa et al. 2008, Kinsey-Jones et al. 2009). In the present 
study, LPS administration in the late follicular phase lowered plasma oestradiol 
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concentrations and prevented dynorphin and kisspeptin cell activation in the middle and 
caudal ARC. Interestingly, plasma oestradiol concentrations decreased 8h after the 
administration of LPS, whereas a decrease in the percentage of activated dynorphin 
neurones occurred much sooner (3h after treatment). In contrast, the decrease in 
percentage kisspeptin cell activation was evident later (12h after LPS treatment). It has 
been suggested that there are at least two mechanisms integrated during LPS disruption 
of the ovarian cycle; one involving disruption of GnRH/LH pulses thereby reducing 
oestradiol secretion, and the other preventing the ability of the surge-generating 
mechanism to respond to the preovulatory increase in oestradiol (Battaglia et al., 1999, 
Karsch and Battaglia, 2002). Our present data indicate that dynorphin inhibition is 
involved in the second rather than the first option, as it occurred before the suppression 
of oestradiol. In contrast, kisspeptin cell activation may have been inhibited either due 
to the prevention of dynorphin increase (thus, disrupting a necessary chain of events 
leading to the GnRH surge), or due to decreased GnRH/LH pulsatility and consequent 
decrease in oestradiol. In this aspect, there are various factors that may act as mediators 
of this disruption. Cortisol suppresses pulsatile LH secretion in a dose-dependent fashion 
(Debus et al., 2002). However, in the present study, cortisol increased to maximum 
concentrations 2h after LPS and is, thus, a potential candidate for the immediate 
inhibition of dynorphin neurones and, therefore, the surge mechanism. In accordance, 
Pierce et al., (2009) and Wagenmaker et al., (2009a) report that cortisol disrupts the 
positive feedback effect of oestradiol to trigger an LH surge. Indeed, ~ 70% of ERα 
containing cells co-localise glucocorticoid receptors type II (GRII) in the ARC (Dufourny 
and Skinner, 2002) and it is likely that at least some of these are in KNDy cells, although 
this remains to be investigated. We observed an increase in progesterone 
concentrations after LPS, however, the timing of increased values varied considerably 
between animals, from 2h to 10h after treatment and, therefore, we cannot hypothesise 
which mechanism might be affected by this increase. It is noteworthy that progesterone 
has been implicated in both inhibition of GnRH pulses (Karsch et al., 1987) and blocking 
the surge mechanism (Kasa-Vubu et al., 1992, Skinner et al., 1998, Richter et al., 2002, 
Smith et al., 2003, Richter et al., 2005). The potential influence of pyrexia remains to be 
determined; however, our previous studies showed that maximum body temperatures 
occurred 4h after treatment (Fergani et al., 2011) indicating that pyrexia, presumably via 
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prostaglandins, may contribute to the attenuation of GnRH pulses. Nonetheless, as 
these animals did not have an LH surge at the same time as controls, we conclude that 
the inhibition of dynorphin and kisspeptin cell activation in the middle and caudal ARC is 
a major contributing factor to LH surge disruption in response to an 
immune/inflammatory challenge in the ewe. This compliments our recent results in 
which the absence of an LH surge was accompanied by a failure of ERα-containing 
neurone activation (Chapter 4).  
Interestingly, there was a split response in the insulin-treated animals with two animals 
showing a decrease in the percentage of dynorphin cells that were activated (similar to 
LPS; insulin-responders), whereas the remaining two were similar to controls (insulin-
non-responders). A similar divergence was observed in a previous study (Fergani et al., 
2011) when 10 out of 20 animals treated with insulin did not have a delay in sexual 
behaviour or the LH surge (insulin-non-delayed subgroup). It is plausible that the animals 
with no dynorphin inhibition would have gone on to have an LH surge at a similar time 
as the controls, whereas the others would have had a delayed surge, similar to LPS 
treated animals. Interestingly, plasma cortisol concentrations increased equally in both 
insulin sub-groups. This was also observed in our earlier study indicating that cortisol is 
not solely responsible for the LH surge disruption after insulin (Fergani et al., 2011). 
From the present results, we can also conclude that cortisol is not the key disruptor of 
dynorphin activation. In contrast, the percentage of activated kisspeptin neurones 
increased 3h after treatment in the middle and caudal ARC in both insulin subgroups. 
This implicates KNDy cells as mediators of metabolic cues to influence reproduction, 
even though the reason for this differential effect on kisspeptin and dynorphin 
activation is not understood. Interestingly, neurokinin B activation was not altered by 
either stressor. The reason for this is not known, however, this finding provides evidence 
that neurokinin B is not a target for stressors and suggests that it may act as a facilitator 
in communicating signals between KNDy cells (Lehman et al., 2010b, Meada et al., 
2010), but is not sufficient to stimulate an LH surge.  
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In conclusion, follicular phase ewes, 1-2h before the expected onset of sexual behaviour 
and approximately 6-7h before the expected LH surge onset, have cells within the ARC 
that contain ERα and respond to increasing plasma oestradiol concentrations by 
becoming transcriptionally active (Chapter 4). Furthermore, activation of ERα cells is 
maintained throughout the late follicular phase and during the LH surge (Chapter 4). The 
results of the present study provide evidence that this activation pattern may reflect 
KNDy neurone activation in the middle and caudal ARC and suggests that these cells play 
a role in the GnRH surge mechanism. However, the balance of neuropeptide expression 
within this cell population appears to vary throughout the late follicular phase; initially, 
there is a shift of the net balance towards inhibitory dynorphin followed by a swing 
towards excitatory kisspeptin presumably facilitated by neurokinin B. By contrast, acute 
LPS treatment prevented the LH surge from occurring and this was accompanied by a 
failure of kisspeptin and dynorphin neurone activation. Interestingly, insulin prevented 
dynorphin activation in two of the treated animals, whereas kisspeptin cell activation 
was stimulated in all insulin-treated animals, implicating KNDy cells as mediators of 
metabolic cues to influence reproduction. This indicates that KNDy cell activation is part 
of a physiological chain of events leading up to the GnRH/LH surge and alteration after 
insulin or LPS is associated with stress-induced suppression of reproductive parameters. 
Further studies, using in situ hybridisation at various times in the follicular phase to 
detect potential differences in the activational patterns of dynorphin and kisspeptin, 
would be beneficial.  
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Fig. 1 Mean % (±SEM) dynorphin cells that co-express c-Fos in the middle and caudal ARC at various times 
during the follicular phase of intact ewes as determined by dual-label immunohistochemistry. Animals in 
Panel A are grouped according to time as well as hormonal and sexual behavioural status (see text); i.e., 
grouped into those killed at 0h and 16h after PW (n=5 for both), those killed before the onset of sexual 
behaviour (Before behaviour, n=3), those killed after the onset of sexual behaviour but before exhibiting 
an LH surge (After behaviour, n=5) and those killed after the onset of both sexual behaviour and during 
the LH surge (Surge, n=3). In Panel B, animals are grouped according to killing time after PW i.e., control 
ewes at 0h, 16h, 31h and 40h (n=4-5 per group; black bars) as well as after LPS at 31h and 40h (n=4 for 
both times; grey bars) and insulin at 31h (insulin-responders, n=2; white bars and insulin-non-responders, 
n=2; hatched bars). Due to a split response in dynorphin co-expression with c-Fos after insulin treatment, 
statistical analysis was not carried out but the data are presented for information. Treatment with insulin 
or LPS was at 28h after PW. Within each panel, differences between the percentages are indicated by 
different letters at the top of each bar.  
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Fig. 2 Mean % (±SEM) kisspeptin (A), dynorphin (C) and neurokinin B (E) containing cells that co-express c-
Fos in the middle and caudal ARC at various stages during the follicular phase of control ewes as 
determined by dual- and triple-label immunohistochemistry (neurokinin B/c-Fos and 
kisspeptin/dynorphin/c-Fos, respectively). Animals are grouped according to time as well as hormonal and 
behavioural status (for details, see Fig 1 legend).  Within each panel, differences between the percentages 
are indicated by different letters on top of each bar (P<0.05). Panels B,D,F: Regression graphs showing the 
association between the % kisspeptin (B), % dynorphin (D) and % neurokinin B (F) cells that co-express c-
Fos in the middle and caudal ARC against the % change in concentration from 0h to the mean two 
consecutive highest or lowest concentrations for oestradiol (o, E; dashed line) or progesterone (■, P; solid 
line), respectively. 
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Fig 3. A: Mean (±SEM) number of kisspeptin (black bars) and dynorphin (white bars) cells. B: Mean % 
(±SEM) kisspeptin cells co-expressing dynorphin (black bars) and dynorphin cells co-expressing kisspeptin 
(white bars). C: Mean (±SEM) number of neurokinin B cells (black bars). Mean (±SEM) numbers and 
percentages are per section from the middle and caudal ARC at various stages during the follicular phase 
of control ewes as determined by dual- and triple-label immunohistochemistry (neurokinin B/c-Fos and 
kisspeptin/dynorphin/c-Fos, respectively). Animals are grouped according to time as well as hormonal and 
behavioural status (for details, see Fig 1 legend). Within each panel and type of cell, differences between 
numbers and percentages are indicated by different letters on top of each bar (P<0.05). Differences 
between cell types are linked with a line (P<0.05).  
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Fig 4. Mean % (±SEM) kisspeptin (A), dynorphin (B) and neurokinin B (C) cells that co-express c-Fos in the 
middle and caudal ARC at various times during the follicular phase of control and treated ewes as 
determined by dual- and triple-label immunohistochemistry (neurokinin B/c-Fos and 
kisspeptin/dynorphin/c-Fos, respectively). Animals are grouped according to killing time after PW i.e., 
control ewes at 0h, 16h, 31h and 40h (n=4-6 per group; black bars) as well as after LPS at 31h and 40h 
(n=4 for both times; grey bars) and insulin at 31h (insulin-responders, n=2; white bars and insulin-non-
responders, n=2; hatched bars). Due to the split response in dynorphin co-expression with c-Fos after 
insulin treatment, statistical analysis was not carried out but the data are presented for information. 
However, there were no split responses observed in kisspeptin and neurokinin B co-expression with c-Fos 
and therefore statistical analysis was carried out in both groups combined (n=4). Treatment with insulin or 
LPS was at 28h after PW. Panel A: * P<0.05 compared to 0h and 16 h control groups. Panel B: * P<0.05 
compared to all other groups. Panel C: * P<0.05 compared to 0h and 16 h control groups. Differences 
between groups are also linked with a line (P<0.05).  
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Fig. 5 Sets of photomicrographs in the ARC nucleus that were triple-labelled for c-Fos containing cells 
(A,D,G) and co-expression with kisspeptin (B,E,H) and dynorphin A (C,F,I) in control animals at 31 h after 
PW (A,B,C), at 40h after PW (i.e., during the surge; D,E,F) as well as 3h after LPS treatment in the late 
follicular phase (G,H,I). Examples of dual- and triple-labelled cells are marked with arrowheads and 
arrows, respectively. Note the presence of dual-labelled cells (arrowheads) reflecting the imbalance in 
neuropeptide expression in intact ewes during the follicular phase. Original magnification: ×20 
(A,B,C,G,H,I), original magnification:×40 (D,E,F).  
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Fig. 6 Photomicrographs from the ARC nucleus that were dual-labelled for neurokinin B cells and their co-
expression with c-Fos in control animals at 31h after PW (A and B) as well as during the LH surge (C and D). 
The right panels in each section are the higher magnifications (original magnification: ×40) of the boxed 
areas shown in the left panels (original magnification: ×20). White arrows indicate examples of dual-
labelled cells. 3V = third ventricle.  
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Table 1. Mean (± SEM) number of cells expressing kisspeptin, dynorphin or neurokinin B immunoreactivity 
in the middle and caudal ARC as determined by dual- and triple-label immunohistochemistry (neurokinin 
B/c-Fos and kisspeptin/dynorphin/c-Fos, respectively) in ewes examined at various times after PW.  
 
 Kisspeptin Dynorphin Neurokinin B 
 
0 h 22.6 ± 6.8 28.9 ± 9.5 19.1 ± 4,0 
 
16 h 
 
29.8 ± 12.1 
 
35.1 ± 11.9 
 
23.3 ± 9.1 
 
31 h control 
 
37.2 ± 3.0* 
 
59.9 ± 6.2*# 
 
30.0 ± 7.5 
 
31h LPS 
 
29.0 ± 7.4 
 
28.9 ± 5.4 
 
28.8 ± 10.3 
 
31h insulin-responders 
 
25.2 ± 9.0 
 
15.0 ± 6.0 
 
17.7 ± 1.2 
 
31h insulin-non-responders 
 
26.0 ± 2.2 
 
30.7 ± 1.2 
 
34.5 ± 8.0 
40h control 42.1 ± 11.9* 53.5 ± 11.8**    39.2 ± 6.9 
40 h LPS 33.6 ± 9.5 35.6 ± 9.1    29.2 ± 2.3 
 
Kisspeptin: * P<0.05 within a column, greater than 0h control group. 
Dynorphin:  * P<0.05 within a column, greater than 0h, 16h and LPS groups. 
     ** P<0.05 within a column, greater than 0h. 
       # P<0.001 within a row, greater than kisspeptin and neurokinin B. 
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Table 2. Mean (± SEM) percentage of kisspeptin cells that co-express dynorphin and mean (± SEM) 
percentage of dynorphin cells that co-express kisspeptin in the middle and caudal ARC as determined by 
triple-label immunohistochemistry (kisspeptin/dynorphin/c-Fos) in ewes examined at various times after 
PW. 
  
         
 % kisspeptin cells that co-express dynorphin % dynorphin cells that co-express kisspeptin 
 
0h 81.9 ± 10.5# 64.7 ± 7.4 
 
16h 
 
93.4 ± 3.2*# 
 
73.1 ± 4.5* 
 
31h control 
 
90.1 ± 1.8*# 
 
56.8 ± 4.9 
 
31h LPS 
 
70.3 ± 9.6 
 
69.0 ± 9.8 
 
31h insulin-responders 
 
76.0 ± 7.3 
 
67.1 ± 9.8 
 
31h insulin-non-responders 
 
97.3 ± 2.7 
 
51.9 ± 11.5 
40h control 83.8 ± 5.8# 63.6 ± 5.8 
40h LPS 84.5 ± 4.5 75.6 ± 2.8* 
 
% kisspeptin cells that co-express dynorphin: 
*P<0.05 within a column, greater than 31h LPS.  
# P<0.05 within a line, greater than % dynorphin cells that co-express kisspeptin.  
% dynorphin cells that co-express kisspeptin:  
*P<0.05 greater than all other groups.  
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Chapter 6 
Dopamine, β-endorphin, neuropeptide Y and somatostatin co-expression with c-Fos in 
the mediobasal hypothalamus at different times during the follicular phase of intact 
ewes, and alteration after insulin or endotoxin.  
 
Keywords: Dopamine, β-endorphin, neuropeptide Y, somatostatin, c-Fos, ewe, insulin, 
LPS, stress, GnRH surge, LH surge. 
 
Abstract 
The aim of the present study was to determine the activation pattern of dopamine, β-
endorphin, neuropeptide Y and somatostatin cells in the mediobasal hypothalamus 
(MBH) during the follicular phase of intact ewes, as well as investigating whether these 
patterns are altered by stressors. Follicular phases of intact ewes were synchronised 
with progesterone vaginal pessaries. Control animals were killed at 0, 16, 31 and 40h 
(n=5-6 per group) after progesterone withdrawal (PW; time zero). At 28h, groups of 
animals received insulin (4 iu/kg) or endotoxin (LPS; 100 ng/kg) and were subsequently 
killed at 31h (insulin; n=5 and LPS; n=5) or 40h (LPS; n=5). LH surges occurred only in 40h 
control ewes. Activation patterns were established using c-Fos (a marker for neuronal 
activation) with dual-label immunofluorescence. In the ARC of control ewes, the 
percentage of dopamine cells co-expressing c-Fos (i.e., activated cells) were decreased 
before the onset of sexual behaviour and remained low until the LH surge (from 70 to 
26%; P<0.05) whereas β-endorphin activation was lower during the LH surge (from 41 to 
10%; P<0.05). By contrast, neuropeptide Y activation tended to be higher during the 
surge (from 21 to 36%; P<0.08) whereas somatostatin activation in the ARC and VMN 
was greater during the LH surge compared to other stages in the follicular phase (from 
14 and 9% to 47 and 73%, respectively; P<0.05). However, insulin increased the 
percentage of activated β-endorphin, neuropeptide Y and somatostatin cells in the ARC, 
at 31h after PW (i.e., 3h after treatment; to 71, 72 and 63%, respectively, P<0.05 for 
each comparison, compared to controls killed at the same time), but there was no effect 
on dopamine activation. Activation of the above neuro-phenotypes in the ARC was not 
affected by LPS treatment. In the VMN, at 31h after PW (i.e., 3h after insulin or LPS 
treatment) activation of somatostatin cells was greater in all LPS treated animals (from 8 
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to 27%; P<0.05) but only in two of the insulin-treated animals (to 55 and 76%; insulin-
responders) but not in the other two (to 5 and 6%; insulin-non-responders). These 
results indicate that there is a specific temporal pattern of dopamine, β-endorphin, 
neuropeptide Y and somatostatin activation in the ARC and VMN during the follicular 
phase of intact ewes. This is disturbed by acute LPS or insulin administration in the late 
follicular phase in a stress-specific manner.  
 
Introduction 
Gonadotrophin-releasing hormone (GnRH) neurones constitute the final common 
pathway of a complex neuronal network responding to the circulating steroid hormone 
milieu to control ovulation and sexual behaviour (Karsch et al., 1997, Caraty et al., 2002). 
However, the precise mechanisms that control each function are not yet fully 
understood. In the late follicular phase, increasing concentrations of oestradiol, secreted 
by the dominant follicle(s), trigger the onsets of the GnRH/LH (luteinising hormone) 
surges as well as sexual behaviour (de Greef et al., 1987, Moenter et al., 1990, Fabre-Nys 
and Martin 1991, Xia et al., 1992). However, steroid hormone signals do not impinge 
directly on GnRH cells as they do not possess progesterone receptors (PR) or oestradiol 
receptors subtype α (ERα; Shivers et al., 1983, Herbison and Theodosis 1992, Lehman 
and Karsch, 1993, Sullivan et al. 1995, Scott et al. 2000, Skinner et al., 2001). GnRH 
neurones have been reported to contain oestrogen receptor β (ERβ; Skynner et al., 
1999; Hrabovszky et al., 2001, Herbison et al. 2001, Jansen et al., 2001, Skinner and 
Dufourny 2005) but their role is not fully elucidated, although considered minor (Scott et 
al. 2000, Orikasa and Sakuma 2003, Maeda et al., 2010). Thus, it is generally accepted 
that cells in the brain that possess ERα are the main mediators of the feedback effects of 
steroid hormones and they in turn secrete neurotransmitters to influence the GnRH 
network (Caraty et al. 1998, Herbison 1998, Smith and Jennes 2001, Herbison 2008).  
Various types of stressors have the ability to block or delay the LH surge and sexual 
behaviour (Dobson et al., 1999, Dobson and Smith 2000, Fergani et al., 2011). We have 
recently shown that a sudden activation of the hypothalamo-pituitary-adrenal axis in the 
late follicular phase by the immunological stressor endotoxin (i.e., lipopolysaccharide; 
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LPS) lowered plasma oestradiol concentrations and delayed the onsets of pre-copulatory 
behaviours, oestrus and the LH surge of free-running intact ewes; whereas the 
metabolic stressor insulin-induced hypoglycaemia had the same effect in only 50% of 
animals (Fergani et al., 2011). Immunohistochemical analysis of c-Fos protein expression 
(a marker of neuronal transcription activation; Hoffman et al., 1993) revealed that this 
disruption is accompanied with the activation of unknown cell types located in the ARC 
and VMN (Chapter 3). 
In the ewe, the mediobasal hypothalamus (MBH; comprising ARC and VMN), contains a 
dense population of neurones expressing ERα (Blache et al., 1994), and constitutes the 
major site of action for oestradiol to regulate the induction of both the preovulatory 
GnRH surge and sexual behaviour (Blache et al., 1991, Caraty et al., 1998). These brain 
areas also contain several types of neurones, sub-populations of which co-express ERα, 
including those that contain tyrosine hydroxylase (TH; a biosynthetic enzyme marker for 
dopamine), β-endorphin and neuropeptide Y in the ARC, as well as somatostatin in the 
ARC and VMN (Antonopoulos et al., 1989, Lehman et al., 1988, Willoughby et al., 1995). 
These neuro-phenotypes are therefore, potential candidates to be involved in the 
generation of the GnRH surge or sexual behaviour. In contrast, stress-induced 
alterations may play a role in reproductive dysfunction. 
During the follicular phase, dopaminergic input to the MBH facilitates the expression of 
sexual behaviour. Extra-cellular dopamine concentrations are high when peripheral 
oestradiol values are low, but dopamine concentrations decrease after oestradiol 
reaches maximum values in the late follicular phase (Melis and Argiolas, 1995, Fabre Nys 
et al., 2003). It is possible that stress-induced disruption of sexual behaviour may involve 
extended dopamine accumulation in the MBH. A sub-population of DA neurones in the 
ARC contain ERα (3-15%; Lehman and Karsch, 1993, Skinner and Herbison, 1997), 
whereas 20% of dopamine cells provide input towards the VMN (Qi et al., 2008). 
Therefore, such cells are good candidates to facilitate stimulatory or inhibitory changes. 
Opioids are considered as a brake, which must be removed for the LH surge to occur 
(Kalra, 1993, Dobson et al., 2003). We have recently shown that changes in dynorphin 
expression are associated with GnRH inhibition during the late follicular phase (Chapter 
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5), whereas β-endorphin could be acting synergistically in this respect. This latter opioid 
has also been implicated in the stress-induced disruption of the LH surge after insulin 
(Dobson and Smith, 2000, Ghuman et al., 2011) but whether this is a stress-specific 
response remains to be investigated.  
In the rat, neuropeptide Y (NPY) is involved in the regulation of GnRH secretion (Kalra et 
al., 1995, Pelletier et al., 1990, Watanobe and Takebe, 1992, Sahu et al., 1995) but 
specific actions (inhibitory or stimulatory) depend on the underlying endocrine status 
(Kalra et al., 1991). However, in sheep, its role is less clear and results are conflicting. 
Studies using various metabolic stressors implicate NPY neurone activation under 
conditions of negative energy balance, leading to an increase in NPY mRNA expression 
(Adam et al. 1997, Henry et al. 2000). A similar response may be obtained after insulin or 
LPS administration in the late follicular phase of sheep.  
Short-term oestradiol treatment in ovariectomised (OVX) ewes increases somatostatin 
activation in the VMN in a sex-specific manner (Robinson et al., 2010). Interestingly, in 
rats, somatostatin is one of the most potent inhibitors of electrical excitability of GnRH 
neurones identified thus far (Bhattarai et al., 2010) and inhibits the LH surge when 
administered centrally (Van Vugt et al. 2003). It is, therefore, possible that somatostatin 
containing cells are activated via an unknown mechanism to mediate stress-induced 
disruption of the LH surge. 
In the present study, we examined brain tissue of intact ewes sacrificed at various times 
during the follicular phase with or without the administration of insulin or LPS. Our 
objective was to map the pattern of transcriptional activation of dopamine, β-
endorphin, NPY neurones in the ARC as well as somatostatin neurones in the ARC and 
the VMN (by measuring co-expression with c-Fos, a marker of neuronal activation; 
Hoffman et al., 1993). We also aimed to correlate these patterns with peripheral plasma 
progesterone and oestradiol concentrations, as well as the exhibition of sexual 
behaviour and the LH surge. Furthermore, we sought to determine whether the 
disruption of the surge mechanism after LPS or insulin administration in the late 
follicular phase involves alteration in the activation of these neuro-phenotypes. 
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Materials and Methods 
Animals, study design and blood sampling procedure 
In this investigation we used tissue collected during the breeding season for an earlier 
study, details of which are given in Chapter 3. 
Visual observation of oestrous behaviour 
Details are given in Chapter 3. 
Tissue collection 
Details are given in Chapter 3. 
 c-Fos and DA or β-endorphin or neuropeptide Y or somatostatin dual-label 
immunofluorescence 
Dual-label immunofluorescence was carried out on 40μm sections containing middle 
and caudal levels of the ARC (three sections for each level and each neuropeptide 
combination). All steps were performed at room temperature unless otherwise stated. 
Antibodies were diluted with 2.5% normal donkey serum (catalogue item S2170, 
Biosera, UK), 1% Triton X-100 (T9284, Sigma-Aldrich, UK) and 0.25% sodium azide 
(Sigma) in 0.1M phosphate buffer saline, pH 7.2 (PBS). Free-floating sections were 
washed thoroughly in PBS for 2h to remove the cryoprotectant solution followed by 1h 
incubation in blocking solution (10% donkey serum in PBS). This was followed by 72h 
incubation at 40C with polyclonal rabbit anti-c-Fos antibody (AB-5, PC38, Calbiochem, 
Cambridge, MA, USA) at a dilution of 1:5,000. After incubation with the primary 
antiserum, sections were washed thoroughly and incubated for 2h with donkey anti-
rabbit Cy3 (711-165-152, Jackson Immunoresearch, West Grove, PA) diluted 1:500. A 
second immunofluorescence procedure was then performed, as described above, to 
localise the second primary antibody: mouse anti-tyrosine hydroxylase serum (MAB318, 
Millipore, Billerica, MA), at a dilution of 1:20,000 or rabbit-anti-β-endorphin serum (T-
4041, Peninsula Laboratories, San Carlos, CA, at a dilution of 1:500), or rabbit-anti-
neuropeptide Y serum (N9528, Sigma-Aldrich, UK at a dilution of 1:5,000) or anti-rabbit 
somatostatin-14 serum (T-4103, Peninsula Laboratories, San Carlos, CA, at a dilution of 
1:500), each incubated for 72h at 40C and then visualised using donkey-anti-mouse 
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Dylight 488 (715-485-151, Jackson Immunoresearch West Grove, PA) or donkey-anti-
rabbit Dylight 488 (715-485-152, Jackson Immunoresearch West Grove, PA), accordingly, 
both at a dilution of 1:500. Thereafter, sections were washed with PBS followed by a 
final wash with double-distilled water, mounted on chrome alum gelatine-coated slides 
and cover-slipped with Vectashield anti-fading mounting medium (H-1000; Vector 
Laboratories Ltd, UK). The c-Fos (Ghuman et al. 2010), tyrosine hydroxylase (Robinson et 
al., 2010), β-endorphin (Ghuman et al., 2010), neuropeptide Y (Skinner and Herbison, 
1997) and somatostatin-14 (Robinson et al., 2010) antibodies have been validated 
previously for use in ovine neural tissue. In addition, negative controls omitting one of 
the primary antibodies completely eliminated the appropriate fluorescence without 
obviously affecting the intensity of the other fluorescent probe.  
Data analysis 
Dual-labeled sections were examined under an epi-fluorescent microscope (Zeiss Axio 
Imager. M1) and photographed by digital microphotography (Hamamatsu ORCA I-ER 
digital camera, Hamamatsu Photonics, Welwyn Garden City, Herts) using a 20× 
objective. Photographs acquired with an image analysis program AxioVision (Zeiss 
Imaging Systems) and consisted of single c-Fos staining, single dopamine or β-endorphin 
or neuropeptide Y or somatostatin staining as well as a merged image to produce a 
spectral combination of green (fluorescein) and red (rhodamine). The areas examined 
were (as defined by Welento et al., 1969): the VMN (4 photographs per section) and the 
ARC (3 photographs per section; middle and caudal levels). Sections were evaluated 
unilaterally and each photograph was taken from a random field within each 
area/section. All photographs were imported into Image J version 1.42q, counts 
performed using the cell count plug-in. The observer was unaware of the animal identity 
and group. The mean total number and percentage of single- or dual-labelled cells was 
summed from the photographs of each section and then averaged for each ewe and 
compared between groups with GLM ANOVA, followed, when appropriate, by Tukey’s 
multiple comparisons post hoc test. Mean (±SEM), as presented in figures and results, 
was calculated by averaging values for each group. For all analyses, statistical 
significance was considered when P<0.05 and tendencies for significance when 
0.05>P<0.09. 
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The data were analysed in two ways: the first consisted of control ewe data grouped 
according to time as well as hormonal and sexual behavioural status; i.e., grouped into 
those killed at 0h and 16h after PW, those killed at 31h after PW but before the onset of 
sexual behaviour (Before behaviour, n=3), those killed at 31h or 40h after PW, after the 
onset of sexual behaviour but before exhibiting an LH surge (After behaviour, n=5) and 
those killed after the onset of both sexual behaviour and during the LH surge (Surge, 
n=3). This grouping allowed for a detailed comparison of neuropeptide profiles in 
control animals at different stages of the follicular phase in our intact-ewe model. 
Secondly, control and treated animals data were grouped according to time of killing 
after PW, and this was used to compare treatment effects. 
During data analysis, it became clear that there was a split response in the insulin group 
regarding the percentage somatostatin cells that co-expressed c-Fos in the VMN. 
Therefore this group was separated into two subgroups referred to hereafter as insulin-
responders or insulin-non-responders (verified previously in Chapter 3 as with or 
without c-Fos activation in the paraventricular nucleus, respectively). As this division 
reduced the group size to n=2/group, statistical analysis was not undertaken, but the 
data are presented for information. When responses were not different between sub-
groups, data were combined and analysed with n=4. 
Peripheral plasma progesterone and oestradiol values fluctuated between animals, thus, 
regression analysis was used to examine the association between the percentage of 
change from 0h to the two mean consecutive lowest or highest progesterone or 
oestradiol values, respectively, and the percentage of dopamine, β-endorphin, NPY or 
somatostatin cells that co-expressed c-Fos (i.e., were activated) in the ARC and VMN of 
control animals. 
 
Results 
Luteinising hormone (LH) and behavioural profiles. 
As shown in chapter 3 
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Control ewes: Dopamine and c-Fos co-expression in the middle and caudal ARC at 
different stages during the follicular phase, in animals grouped by behaviour. 
The percentage of dopamine cells that co-expressed c-Fos decreased in the ‘Before 
behaviour’, ‘After behaviour’ and ‘Surge’ stages, compared to 0h and 16h (P<0.05 for 
each comparison; Fig. 1A).  
Control ewes: β-endorphin and c-Fos co-expression in the middle and caudal ARC at 
different stages during the follicular phase, in animals grouped by behaviour. 
The percentage of β-endorphin cells that co-expressed c-Fos was greater in the 16h and 
‘After behaviour’ groups compared to 0h and ‘Surge’ stages (P<0.05 for both 
comparisons; Fig. 1B).  
Control ewes: NPY and c-Fos co-expression in the middle and caudal ARC at different 
stages during the follicular phase in animals grouped by behaviour. 
The percentage of NPY cells that co-expressed c-Fos did not vary during the follicular 
phase, although, percentages tended to be higher in the ‘Surge’ group (P<0.08; Fig. 1C).  
Control ewes: Somatostatin and c-Fos co-expression in the middle and caudal ARC and 
VMN at different stages during the follicular phase in animals grouped by behaviour. 
The percentage of somatostatin cells that co-expressed c-Fos in the middle and caudal 
ARC and the VMN was greatest in the ‘Surge’ group compared to other stages in the 
follicular phase (P<0.05 for both; Fig. 1D and Fig. 4A). Photomicrographs from the ARC 
dual-labelled with dopamine or β-endorphin or neuropeptide Y or somatostatin and c-
Fos are shown in Fig. 2. 
Oestradiol 
Oestradiol data have been presented in Chapter 3. Using regression analysis, the 
percentages of NPY cells that co-expressed c-Fos in the ARC and somatostatin cells that 
co-expressed c-Fos in the ARC and VMN were positively associated with the percentage 
change in concentration from 0h to the mean two consecutive highest plasma oestradiol 
values (P=0.008, RSq=29%, P=0.000, RSq=69% and P=0.000, RSq=78%, respectively; Fig. 
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3C, 3D and Fig. 4C, respectively) but not for dopamine or β-endorphin cells (P=0.4 and 
P=0.09; Fig. 3A, 3B).  
Progesterone 
Progesterone data have been presented in Chapter 3. Using regression analysis, the 
percentage of dopamine cells that co-expressed c-Fos is positively associated with the 
percentage change in concentration from 0h to the mean two consecutive lowest 
plasma progesterone values in the ARC (P=0.000 RSq=73%; Fig. 3A) but not for β-
endorphin, NPY in the ARC and somatostatin in the ARC and VMN (P=0.6, P=0.2, P=0.1 
and P=0.1, respectively; Fig. 3B, 3C, 3D and Fig. 4C).  
Cortisol 
Cortisol data have been presented in Chapter 3. 
 
Control, insulin or LPS: Dopamine and c-Fos co-expression in the middle and caudal ARC 
at different times during the follicular phase, in animals grouped by hours after PW. 
The percentage of dopamine cells that co-expressed c-Fos n controls was greatest at 0h 
and 16h control groups compared to other times examined in the follicular phase 
(P<0.05 for both; Fig. 5A). LPS or insulin had no effect on the percentage of dopamine 
cells that co-expressed c-Fos at any time examined after treatment (Fig. 5A). The 
number of dopamine immunoreactive cells was increased in the 40h control compared 
to 0h controls (P<0.05; Table 1).  
Control, insulin or LPS: β-endorphin and c-Fos co-expression in the middle and caudal 
ARC at different times during the follicular phase, in animals grouped by hours after PW.  
The percentage of β-endorphin cells that co-expressed c-Fos in controls was greater in 
the 16h and 31h control groups than the 0h and 40h control groups (P<0.05 for both; 
Fig. 5B). However, at 31h after PW (i.e., 3h after insulin administration), the percentage 
of β-endorphin cells that co-expressed c-Fos increased in both insulin sub-groups 
compared to other groups (from 38.3 ± 4.8 to 70.9 ± 1.7%; combined insulin-responders 
and insulin-non-responders; P<0.05; Fig. 5B). LPS did not have the same effect (Fig. 5B). 
The number of β-endorphin immunoreactive cells was greater in the 31h and 40h 
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control groups and 31h and 40h LPS groups (compared to 0h controls P<0.05 for all; 
Table 1). 
Control, insulin or LPS: NPY and c-Fos co-expression in the middle and caudal ARC at 
different times during the follicular phase, in animals grouped by hours after PW.  
The percentage of NPY cells that co-expressed c-Fos in controls did not vary during the 
follicular phase of control ewes (Fig. 5C). However, at 31h after PW (i.e., 3h after insulin 
administration) the percentage of NPY cells that co-expressed c-Fos increased in both 
insulin sub-groups (from 18.9 ± 2.0 to 72.2 ± 5.5%; combined insulin-responders and 
insulin-non-responders; P<0.05; Fig. 5C). LPS did not have an effect (Fig. 5C); 
furthermore, the number of NPY immunoreactive cells did not vary across the follicular 
phase of controls and was not affected by treatment (Table 1).  
Control, insulin or LPS: Somatostatin and c-Fos co-expression in the middle and caudal 
ARC and VMN at different times in the follicular phase, in animals grouped by hours after 
PW. 
The percentages of somatostatin cells that co-express c-Fos in the middle and caudal 
ARC and in the VMN were increased at 40h compared to other times examined in the 
follicular phase (P<0.05; Fig. 5D and Fig. 4B, respectively). However, at 31h after PW (i.e., 
3h after insulin administration) the percentage of somatostatin cells that co-expressed c-
Fos in the middle and caudal ARC increased in both insulin sub-groups (from 14.3 ± 3.3% 
to 63.0 ± 9.4%; combined insulin-responders and insulin-non-responders; P<0.05; Fig. 
5D). LPS did not have an effect and results were not different to controls at any time 
(Fig. 5D). By contrast, at 31h after PW (i.e., 3h after LPS or insulin administration), the 
percentage of somatostatin cells that co-expressed c-Fos in the VMN increased in the 
LPS group (P<0.05) and the insulin-responders sub-group; Fig. 4B). At 40h after PW (i.e., 
12h after LPS administration), when the majority of animals were having an LH surge, 
LPS and control groups were not different (Fig. 4B). The number of somatostatin 
immunoreactive cells in the middle and caudal ARC, as well as in the VMN, did not vary 
during the follicular phase of control and was not affected by treatment (Table 1). 
Photomicrographs from the VMN dual-labelled with somatostatin and c-Fos are shown 
in Fig. 6. 
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Discussion 
The aim of the present study was to map the activation pattern of various 
neuropeptides implicated in the sequence of events leading up to the GnRH/LH surge 
and sexual behaviour in intact ewes and determine how these altered after the 
application of two stressors; insulin or LPS.  We focused on two brain areas that are 
important for the steroid feedback control of GnRH release in the sheep: the middle and 
caudal ARC and the VMN (Blache et al., 1991, Caraty et al., 1998). Within these regions, 
we investigated neurones that contain dopamine, β-endorphin, NPY and somatostatin.  
Pattern of dopamine activation in the middle and caudal ARC during the follicular phase 
of control ewes. 
There are several populations of dopaminergic cell groups within the hypothalamus 
(Tillet and Thibault, 1989) and some of these have been implicated in the control of 
reproduction. For example, DA neurones located in the A15 retrochiasmatic area are 
indirectly stimulated by oestradiol (as they do not contain ERα) to inhibit GnRH secretion 
during anoestrus but not the breeding season (Bertrand et al., 1998, Anderson et al., 
2001, Adams et al., 2006, Goodman et al., 2010). During an induced follicular phase in 
OVX ewes, dopamine was implicated in the control of sexual behaviour (Fabre-Nys and 
Gelez, 2007). In the present study, the percentage of activated dopamine neurones in 
the middle and caudal ARC was greater in the early follicular phase (0h and 16h after 
PW, i.e., 12-28h before the expected onset of sexual behaviour). Thereafter, there was a 
decrease and dopamine neurone activation was low in animals before and during sexual 
behaviour and the LH surge. These results are consistent with a biphasic role of 
dopamine as described by Fabre-Nys et al., (1994, 2003). Using microdialysis, Fabre-Nys 
et al., (1994) showed that in progesterone-primed OVX ewes, extra-cellular 
concentrations of dopamine in the MBH are high at the end of the luteal phase. This is 
followed by a sharp decrease after oestradiol administration and preceding the onset of 
sexual behaviour (Fabre-Nys et al., 1994). Our own data indicate that the activational 
patterns of dopamine cells are highly co-related with plasma progesterone 
concentrations. It is, therefore, probable that progesterone, via dopamine, acts as a 
brake on the neuronal circuits mediating the expression of sexual behaviour. Thereafter, 
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increasing oestradiol concentrations remove dopamine inhibition and sexual behaviour 
is initiated 12h later. The present findings suggest that the source of dopaminergic input 
to the MBH is derived, at least in part, from cells located in the middle and caudal ARC. 
We have recently shown that ERα-containing cells in the VMN are activated concurrently 
with the exhibition of sexual behaviours providing evidence that the VMN may be 
involved in this function (Chapter 4). Indeed, 20% of dopamine neurones provide input 
towards the VMN (Qi et al., 2008) providing a possible pathway for the control of female 
sexual behaviour. However, the cells that receive dopaminergic input within the VMN 
remain to be elucidated. 
Pattern of dopamine activation in the middle and caudal ARC during the follicular phase 
of LPS or insulin treated ewes. 
In the present study, sexual behaviour did not occur within the study time-frame in the 
majority of treated ewes, whereas in a few ewes, oestrous signs commenced but were 
disturbed by the stressors. Progesterone and dopamine administration facilitate the 
expression of sexual behaviour while oestradiol concentrations are low but are 
inhibitory once oestradiol values increase above a threshold (Fabre-Nys et al., 2003). 
This may constitute a potential pathway for the stress-induced suppression of oestrous 
behaviour observed in the present study. However, LPS or insulin did not alter dopamine 
activation in the ARC and, therefore, it remains to be established whether other 
dopamine populations, such as those in the PVN, may account for the disruption.  
 
In the present study, cortisol increased to maximum concentrations immediately after 
the administration of LPS or insulin (i.e., 2h after treatment) and this steroid is, 
therefore, a potential candidate for the inhibition of sexual behaviours (Pierce et al., 
2008). However, cortisol is able to inhibit oestradiol-induced sexual receptivity (i.e., 
oestrus) but not other components of sexual behaviour which were also disturbed in our 
study (Pierce et al., 2008, Papargiris et al., 2011). Therefore, cortisol may contribute, but 
cannot be the sole mediator of stress-induced disruption of sexual behaviour. We also 
observed a very small increase in plasma progesterone concentrations after LPS. This 
subtle change may be one of the mechanisms by which all sexual behaviours were 
blocked (Scaramuzzi et al., 1971, Fabre-Nys 1998, Fabre-Nys and Gelez 2007).  
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Pattern of β-endorphin activation in the middle and caudal ARC during the follicular 
phase of control ewes. 
β-endorphin cells represent another potential relay point for conveying the influence of 
oestradiol onto GnRH neurones. In the middle and caudal ARC, 15-20% of β-endorphin 
cells contain ERα (Lehman and Karsch, 1993) whereas, β-endorphin or pro-
opiomelanocortin (POMC) fibres directly innervate GnRH cells in the rat (Leranth et al., 
1988) and monkey (Thind and Goldsmith, 1988). In the ewe, β-endorphin neurones 
project from the ARC directly to the POA (Whisnant et al., 1992, Jansen et al., 2003, 
Dufourny et al. 2005) where the majority of GnRH cells are located (Lehman et al. 1986), 
although direct contact has not been confirmed. In the present study, activation of β-
endorphin cells increased 16h after PW, remained in this state throughout the late 
follicular phase but decreased in animals exhibiting an LH surge. These results are 
consistent with those of Domanski et al. (1991), who demonstrated a decrease in β-
endorphin concentrations in the ARC/ME (median eminence) of intact ewes 10–12 h 
before the onset of the preovulatory GnRH and LH surges. Similar results have been 
obtained in rats (Wise et al., 1990, Bohler et al., 1991, Rosie et al., 1992, Petersen et al., 
1993). We have recently shown that dynorphin cell activation in the middle and caudal 
ARC also increases prior to, but not during, the LH surge (Chapter 5). These observations 
are consistent with the hypothesis that a reduction in inhibition (disinhibition) of GnRH 
secretion by endogenous opioid systems in the hypothalamus is permissive of the 
preovulatory GnRH/LH surge (Kalra, 1993, Walsh and Clarke, 1996, Dobson et al., 2003). 
Increased opioid influence during the follicular phase may play a role in preventing 
premature activation of GnRH neurones, allowing an increase in the releasable pool of 
GnRH, as well as increasing GnRH receptor number (Clarke et al. 1988, Walsh and Clarke, 
1996, Dobson et al. 2003).  
Our results conflict with those of Walsh et al. (1998), who did not observe any difference 
in POMC mRNA levels in the ARC of ewes between the luteal phase of the cycle 
compared to the follicular phase (24h after cloprostenol) and the period of the 
preovulatory LH surge. Taylor et al., (2007) observed an increase in POMC mRNA at the 
time of the peak of the GnRH surge in OVX ewes. The reason for this divergence 
between studies is not known, although it may reflect differences in methods of 
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detection (i.e., immunohistochemistry of c-Fos induction in β-endorphin cells versus 
POMC gene transcription). Indeed, various POMC gene products other than β-
endorphin, such as α-melanocyte stimulating hormone may have differential effects on 
the reproductive axis compared to β-endorphin (Gonzalez et al. 1997, Scimonelli et al., 
2000). 
Pattern of β-endorphin activation in the middle and caudal ARC during the follicular 
phase of LPS or insulin treated ewes. 
Insulin treatment increased the percentage of activated β-endorphin neurones 3h after 
treatment in the middle and caudal ARC in both insulin subgroups. Indeed, opioids have 
been implicated in LH suppression after insulin treatment in the ewe (Clarke et al., 1990, 
Smith et al., 2003). Furthermore, infusion of the non-specific opioid antagonist, 
naloxone just before insulin administration prevented the delay in the onset of the LH 
surge observed after insulin alone (Dobson and Smith, 2000). Our results conflict with 
those of Ghuman et al. (2011), who observed a decrease in β-endorphin activation in the 
ARC after insulin treatment. However, the dose used in that study was larger than the 
one used here (5 iu/kg versus 4 iu/kg) and was administered later in the follicular phase 
(34h after PW versus 28h after PW); this could account for the divergent results. Indeed, 
this leads us to believe that the dose of insulin and the level of hypoglycaemia, as well as 
the time of administration may be of importance in disruptive mechanisms. LPS did not 
have the same effect, and β-endorphin activation was not altered. Therefore, it appears 
that β-endorphin is a mediator of insulin-induced disruption of the LH surge, but this 
effect is stressor specific.  
Pattern of NPY activation in the middle and caudal ARC during the follicular phase of 
control ewes. 
NPY is widely distributed in the central nervous system but its role in reproductive 
functions is attributed to the population of neurones located in the ARC (Kalra and 
Crowley, 1992). In the rat, NPY is involved in the regulation of GnRH secretion (Kalra et 
al., 1991, Pelletier et al., 1992, Watanobe and Takebe, 1992, Sahu et al., 1995) but 
specific actions depend on the endocrine status. For example, in rats, NPY stimulates 
GnRH release in the presence of oestradiol, but inhibits GnRH release during oestradiol 
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absence (Kalra et al., 1992). In the sheep, the role of NPY in the regulation of GnRH is 
less clear. NPY administered intracerebroventricularly (icv) suppressed release of LH in 
OVX and OVX oestradiol-treated sheep, whereas NPY mRNA was more abundant during 
the luteal phase than prior to the surge (Malven et al., 1992, McShane et al., 1992, 
Estrada et al., 2003). However, in follicular phase ewes, icv administration of anti-NPY 
serum delayed the onset of the preovulatory LH surge, implying a stimulatory role in this 
process (Porter et al., 1993). Furthermore, icv NPY infusion stimulated the synthesis and 
storage of LH but not its release in prepubertal lambs (Wankowska et al., 2002, Wójcik-
Gładysz et al., 2003). In addition, a stimulatory effect on GnRH release by NPY infusion 
into the ME was observed in intact sexually active ewes, but only in the follicular, and 
not in the luteal, phase of the oestrous cycle (Advis et al., 2003). In the present study, 
NPY activation did not vary across the follicular phase, however, it tended to be higher in 
animals that were exhibiting an LH surge. Furthermore, this pattern of activation was 
positively correlated to plasma oestradiol concentrations. The reason for this divergence 
between results in not known, however, studies in rats (Crowley and Kalra, 1987), 
rabbits (Khorram et al., 1987), and monkeys (Woller and Terasawa, 1992) provide 
evidence for the existence of two mechanisms, one inhibitory and one stimulatory, 
through which endogenous NPY regulates GnRH. About one third of NPY neurones co-
localise γ-aminobutyric acid (GABA; Horvath et al., 1997). Furthermore, all GnRH 
neurons express GABA receptors in rats (Clarkson and Herbison, 2006) and GABA 
terminals are in close contact with GnRH neurones in the mPOA of sheep (Jansen et al., 
2003, Sliwowska et al., 2006,). Interestingly, GABA release can hyperpolarise or 
depolarise GnRH neurones depending on the presence of oestradiol (DeFazio et al., 
2002, Moenter and DeFazio, 2005, Ghuman et al., 2008) in agreement with opposing 
NPY effects on LH secretion. However, the origin of the GABAergic inputs to GnRH 
neurones is not fully elucidated, and therefore further studies are necessary to explore 
NPY/GABA interaction modulating GnRH secretion.  
Pattern of NPY activation in the middle and caudal ARC during the follicular phase of LPS 
or insulin treated ewes. 
NPY neurones have been considered good candidates to operate as neuroendocrine 
mediators, linking alterations in energy balance signals to the reproductive axis (Hill et 
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al., 2008). According to this paradigm, NPY neurones are activated under conditions of 
negative energy balance, leading to an increase in NPY mRNA expression (Adam et al. 
1997, Henry et al. 2000).  In accordance, our data show that insulin treatment in the late 
follicular phase, increased NPY neurone activation 3h after treatment in the middle and 
caudal ARC in both insulin subgroups. Indeed, repeated administration of insulin up-
regulates NPY mRNA in the hypothalamus of rats (Briski et al., 2010), whereas, secretory 
activity of NPY cells is enhanced by starvation (Chailou et al., 2002) or long-term under-
nutrition (Polkowska and Gładysz, 2001) in sheep. Furthermore, we report that LPS does 
not have the same effect and NPY neurone activation is not altered after the application 
of this stressor in the late follicular phase.  
Pattern of somatostatin activation in the middle and caudal ARC and VMN during the 
follicular phase of control ewes. 
Within the MBH of the ewe, numerous somatostatin neurones are present in the ARC 
and the ventrolateral division of the VMN (Willoughby et al., 1995, Bruneau and Tillet, 
1998).  However, the physiological role of these cells is not fully understood. In the 
present study, there was an increase in the percentage of activated somatostatin 
neurones in the ARC and the VMN during the LH surge compared to other stages in the 
follicular phase. Furthermore, this activational pattern was positively correlated to 
plasma oestradiol concentrations. In the ovine VMN, 30% somatostatin neurones 
express ERα (Herbison, 1995, Scanlan et al., 2003), and this accounts for 70% of the total 
number of ERα-containing cells in the VMN (Herbison, 1995). Projections from the VMN 
terminate in close opposition to about half of the GnRH cells bodies in the ovine mPOA 
(Goubillon et al., 2002) and somatostatin receptor 2 (SSTR2) is co-expressed within ovine 
GnRH neurones (Robinson et al., 2010). Our results indicate that somatostatin neurones 
in the VMN are directly regulated by oestradiol to transmit positive feedback to GnRH 
neurones during the surge. We also provide evidence for a similar effect of oestradiol in 
somatostatinergic neurones of the ARC. However, as relatively fewer cells in this 
population co-express ERα (13%; Scanlan et al., 2003), the variation in ARC somatostatin 
activation observed in the present study could also result from an indirect action of 
oestradiol via inter-neurones. Indeed, oestradiol treatment influences somatostatin 
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neurones in the VMN and ARC of guinea pigs and rats (Baldino et al., 1988, Werner et 
al., 1988, Zorrilla et al., 1990, Dufourny and Warembourg, 1999).  
In accordance with the present data, in OVX ewes injected intramuscularly with 
oestradiol to induce preovulatory GnRH and LH surges, the percentage of activated 
somatostatin neurones in the VMN and ARC was higher during the surge compared to 
non-oestradiol treated ewes (Scanlan et al., 2003). However, Robinson et al., (2010) 
demonstrated that a short (6h) treatment with oestradiol increased activation in 
somatostatin containing neurones in the VMN, and this was sex-specific. Pillon et al., 
(2004) reported a similar finding, with increased preprosomatostatin (PPS) mRNA 
expression in the VMN and the ARC after 4h of oestradiol administration. The latter two 
studies, in similar ewe models, suggest that somatostatin is activated in the early stages 
of the surge induction process. The reason for this time difference in somatostatin 
activation between the latter two studies and the present one is not known. It is 
possible that somatostatin neurones activated in the early stages of surge generation 
are the 30% of somatostatin neurones that contain ERα, while those activated at the 
time of the GnRH surge belong to the 70% of non-ERα somatostatin cells. Interestingly, 
icv administration of somatostatin abolished LH pulsatility and dramatically decreased 
the mean basal level of LH secretion (Pillon et al., 2004). This is most likely achieved via 
GnRH neurone inhibition, as somatostatin inhibits in vitro release of GnRH from rat 
mediobasal hypothalamic slices (Rotsztejn et al. 2002). Together, all these observations 
lead to a hypothesis that the majority of somatostatin neurones are activated during the 
surge and this may be important for termination of GnRH/LH secretion.    
We cannot rule out that the alterations in somatostatin activation that we observed 
could be related to the regulation of growth hormone (GH) secretion. Oestradiol 
modulates GH release particularly at the time of the preovulatory LH surge, when a 
coincident surge of GH has been observed in sheep (Landefeld and Suttie, 1989, Malven 
et al., 1995, Dutour et al., 1997, Scanlan and Skinner, 2002).  
Pattern of somatostatin activation in the middle and caudal ARC and VMN during the 
follicular phase of LPS or insulin treated ewes. 
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Our data support a role for somatostatin in stress-induced disruption of the LH surge. 
We observed an increase in somatostatin activation in the VMN, 3h after LPS treatment 
in all the animals and two insulin-treated animals (insulin-responders), but not the other 
two. By contrast, ARC somatostatin neurones were activated in both insulin sub-groups. 
There are several hypotheses for the role of somatostatin during stress. First, as 
mentioned above,  somatostatin is one of the most potent inhibitors of electrical 
excitability of GnRH neurones identified thus far in rats (Rotsztejn et al. 2002, Bhattarai 
et al., 2010) and inhibits the LH surge when administered centrally (Van Vugt et al. 
2003). It is, therefore, possible that somatostatin cells are activated via an unknown 
mechanism to mediate stress-induced disruption of the LH surge via direct action on 
GnRH cells (Robinson et al., 2010). Second, in the rat, either acute or chronic stressful 
stimuli suppress pulsatile secretion of GH from the pituitary gland (Lenox et al. 1979) 
and this suppression is mediated by hypothalamic somatostatin (Terry et al. 1976). 
Specifically, it has been postulated that nutrient deficiency (such as fasting) as well as 
central administration of interleukin-1 (a cytokine product of LPS administration) inhibits 
GH secretion in the sheep by a mechanism dependent on the stimulation of 
hypothalamic somatostatin (Rettori et al., 1994, Polkowska, 1996, Henry et al., 2001, 
Córdoba-Chacón et al., 2011). In the rat, at least 70% of somatostatin neurones from the 
periventricular region, but not those in MBH, project to the ME and form a final 
common pathway for the regulation of GH secretion from the anterior pituitary (Kawano 
and Daikoku 1988, Merchenthaler et al. 1989). Somatostatin neurones in the MBH could 
be involved in this mechanism indirectly, via the activation of periventricular 
somatostatin neurones. However, the mechanism by which these cells are activated 
remains unknown. It is unlikely that cortisol mediates this effect as the VMN contains 
very few glucocorticoid receptor type 2 (Dufourny and Skinner, 2002). 
Interestingly, we observed a split response in the insulin-treated animals with two 
showing an intense activation of somatostatin cells in the VMN (similar to LPS), whereas, 
the other two were similar to controls. An equivalent divergence was observed in our 
previous studies when 10 out of 20 animals treated with insulin had a delay in sexual 
behaviour and the LH surge, whereas the other half did not (Fergani et al., 2011). 
Furthermore, the same two animals used in the present study had no activation in 
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somatostatin cells and did not display an intense transcriptional activation in the 
paraventricular nucleus (PVN) or VMN (insulin-non-responders; Chapter 3). Taken 
together, these observations indicate that somatostatin activation in the VMN may be 
an important factor in the stress-induced disruption of the LH surge. Further studies with 
a larger number of animals should confirm this finding.  
In conclusion, our results indicate that the activational patterns of dopamine, β-
endorphin, NPY and somatostatin in the middle and caudal ARC and in the VMN differ 
during the follicular phase of intact ewes. Specifically, events leading up to the GnRH/LH 
surge include: activation of dopamine cells decreasing 12h before the expected onset of 
sexual behaviour as well as an activational decrease in β-endorphin and increase in NPY 
and somatostatin cells during the GnRH/LH surge. However, this activational pattern was 
disturbed by acute stressors in the late follicular phase. Interestingly, insulin-treatment 
increased β-endorphin, NPY and somatostatin cell activation in the ARC, which was 
evident 3h after treatment, whereas LPS had no effect, indicating that these changes are 
stressor-specific. By contrast, somatostatin activation increased in the VMN 3h after LPS 
treatment in all animals and two insulin-treated animals (insulin-responders), but not 
the other two, indicating that this neuropeptide may be important in the stress-induced 
disruption of the LH surge. 
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Fig. 1 Mean % (±SEM) dopamine (A), β-endorphin (B), neuropeptide Y (C) and somatostatin (D) cells that 
co-express c-Fos in the middle and caudal ARC at different stages during the follicular phase of control 
ewes as determined by dual-immunofluorescence. Animals are grouped according to time as well as 
hormonal and behavioural status; i.e., grouped into those killed at 0h and 16h after PW (n=4-5), those 
killed before the onset of sexual behaviour (before behaviour, n=3), those killed after the onset of sexual 
behaviour but before exhibiting an LH surge (after behaviour, n=5) and those killed after the onset of both 
sexual behaviour and during the LH surge (Surge, n=3). Within each panel, differences between the 
percentages are indicated by different letters on top of each bar (P<0.05). * P<0.08.  
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Fig. 2 Photomicrographs from the ARC nucleus that were dual-labelled with c-Fos and tyrosine hydroxylase (a marker 
for dopamine; A,B) or β-endorphin (C,D), or neuropeptide Y (E,F) or somatostatin (G,H) in 0h control (A), 31h control 
(E,G), 40h control (during the LH surge; B,C,H) or 31h insulin-responders (D,F). White arrows indicate examples of 
dual-labelled cells. 3V = third ventricle. (Scale bar: 50 µm). 
3V 
3V 3V 
A B 
C D 
E F 
G H 
Dopamine/c-Fos 
β-endorphin/c-Fos 
Neuropeptide Y/c-Fos 
Somatostatin/c-Fos 
184 
 
 
 
1251007550250
100
80
60
40
20
0
% change from 0h values
%
 d
o
p
a
m
in
e
/c
-F
o
s
1251007550250
100
80
60
40
20
0
% change from 0h values
%
 β
-e
n
d
o
rp
h
in
/c
-F
o
s
 
1251007550250
100
80
60
40
20
0
% change from 0h values
%
 n
e
u
ro
p
e
p
ti
d
e
 Y
/c
-F
o
s
1251007550250
100
80
60
40
20
0
% change from 0h values
%
 s
o
m
at
o
st
at
in
/c
-F
o
s
 
  
Fig. 3. Regression graphs showing the association between the % dopamine (A; % dopamine/c-Fos), % β-
endorphin (B; % β-endorphin/c-Fos), % neuropeptide Y (C; % neuropeptide Y/c-Fos) and % somatostatin 
(D; % somatostatin/c-Fos) cells that co-express c-Fos in the middle and caudal ARC of control ewes against 
the % change in concentration from 0h to the mean two consecutive highest or lowest concentrations for 
oestradiol (o, E; dashed line) or progesterone (■, P; solid line), respectively. 
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 Fig 4. Mean % (±SEM) somatostatin cells that co-express c-Fos in the VMN during the follicular phase of 
control and treated ewes as determined by dual-immunofluorescence. Animals in Panel A are grouped 
according to time as well as hormonal and behavioural status; i.e., grouped into those killed at 0h and 16h 
after PW (n=4-5), those killed before the onset of sexual behaviour (before behaviour, n=3), those killed 
after the onset of sexual behaviour but before exhibiting an LH surge (after behaviour, n=5) and those 
killed after the onset of both sexual behaviour and during the LH surge (Surge, n=3). In Panel B animals are 
grouped according to killing time after PW i.e., control ewes at 0h, 16h, 31h and 40h (n=4-6 per group; 
black bars) as well as after LPS at 31h and 40h (n=4 for both times; grey bars) and insulin at 31h (insulin-
responders, n=2; white bars and insulin-non-responders, n=2; hatched bars). Due to the split response in 
insulin-treated animals, statistical analysis was not carried out and the data are presented for information. 
Treatment with insulin or LPS was at 28h after PW. Within each panel, differences between the 
percentages are indicated by different letters on top of each bar (P<0.05). Panel C: Regression graph 
showing the association between the % somatostatin cells that co-express c-Fos in the VMN (% 
somatostatin/c-Fos) of control ewes against the % change in concentration from 0h to the mean two 
consecutive highest or lowest concentrations for oestradiol (o, E; dashed line) or progesterone (■, P; solid 
line), respectively. 
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Fig 5. Mean % (±SEM) dopamine (A), β-endorphin (B), neuropeptide Y (C) and somatostatin (D) cells that 
co-express c-Fos in the middle and caudal ARC across the follicular phase of control ewes as determined 
by dual-immunofluorescence. Animals are grouped according to killing time after PW i.e., control ewes at 
0h, 16h, 31h and 40h (n=4-6 per group; black bars) as well as after LPS at 31h and 40h (n=4 for both times; 
grey bars). There were no split responses observed in the 31h insulin-treated animals i.e., insulin-
responders (n=2; white bars) and insulin-non-responders (n=2; hatched bars) and therefore statistical 
analysis was carried out in both groups combined (n=4). Treatment with insulin or LPS was at 28h after 
PW. Within each panel, differences between the percentages are indicated by different letters on top of 
each bar (P<0.05). 
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Fig. 6 Photomicrographs from the VMN that were dual-labelled for somatostatin cells and their co-
expression with c-Fos. In 31h control (A) and LPS treated (B) ewes. White arrows indicate examples of 
dual-labelled cells. 3V = third ventricle. (Scale bar: 50 µm). 
 
 
 
 
 
 
 
 
 
 
 
Somatostatin/c-Fos A B 
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Table 1. Mean (±SEM) number of cells expressing dopamine, β-endorphin, neuropeptide Y or somatostatin 
immunoreactivity in the middle and caudal ARC and VMN as determined by dual-immunofluorescence in 
ewes examined at various times after PW.  
 
 
Dopamine 
(ARC) 
β-endorphin 
(ARC) 
Neuropeptide Y 
(ARC) 
Somatostatin 
(ARC) 
Somatostatin 
(VMN) 
 
0 h   28.0 ± 6.2 47.5 ± 11.3 22.6 ± 9.1 48.9 ± 15.1 29.8 ± 9.9 
 
16 h 
 
42.3 ± 10.5 
 
56.5 ± 15.4 
 
38.2 ± 9.5 
 
55.6 ± 16.9 
 
25.9 ± 15.9 
 
31 h control 
 
40.3 ± 15.5 
 
83.3 ± 13.0* 
 
22.6 ± 3.6 
 
36.5 ± 10.3 
 
22.3 ± 6.0 
 
31h LPS 
 
39.5 ± 14.8 
 
109.8 ± 19.5* 
 
26.4 ± 7.6 
 
32.1 ± 5.6 
 
28.0 ± 5.7 
 
31h insulin-
responders 
 
75.5 ± 9.5 
 
71.8 ± 6.2 
 
 21.3 ± 12.8 
 
36.0 ± 4.8 
 
54.8 ± 14.8 
 
31h insulin-non-
responders 
 
70.0 ± 5.2 
 
 81.8 ± 20.7 
 
 32.3 ± 13.8 
 
 29.2 ± 9.8 
 
 44.5 ± 19.5 
40h control  60.5 ± 4.5* 92.0 ± 9.4*      33.8 ± 6.1    58.1 ± 16.0    36.5 ± 17.2 
40 h LPS  53.1 ± 10.8 93.9 ± 6.6*      41.4 ± 17.6     52.0 ± 21.1     58.8 ± 18.0 
 
Dopamine: * P<0.05 within a column, greater than 0h control group. 
β-endorphin:  * P<0.05 within a column, greater than 0h control group.  
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Conclusions and Further work 
The studies contained in this thesis have contributed significantly to answering the 
following questions: 
How does the application of acute stressors in the late follicular phase affect the timing 
of sexual behaviour and the LH surge? 
One of the aims in the present thesis was to compare the effects of two different 
stressors insulin or LPS, administered during the late follicular phase (i.e., 28h after PW 
and ~ 8-9h before the expected LH surge onset), on sexual behaviour and LH profiles. 
Control animals in both of the studies began exhibiting sexual behaviour approximately 
28-30h after PW and had an LH surge ~ 36-38h after PW, but these were delayed by the 
application of stressors. In the first study (Chapter 2), LPS delayed both the onsets of 
behaviour and the LH surge by ~22 h. By contrast, responses to the administration of 
insulin resulted in two sub-groups: the timing of pre-ovulatory behaviour and the LH 
surge was not affected in half the ewes (10 out of 20; insulin-non-delayed) but, in the 
other half (10 out of 20; insulin-delayed), the onset of behaviour was delayed by ~7 h 
and the LH surge by ~17 h, resulting in a separation of the two events by 10h. Similarly, 
in our second study (Chapter 3, 4, 5, 6), LPS treated animals did not have an LH surge at 
the same time as controls, and sexual behaviour did not occur within the study time-
frame for the majority of treated ewes, whereas in a few ewes, oestrous signs 
commenced but were disturbed by the stressor.  
The fact that insulin-treated animals were able to overcome the inhibition of the 
behaviour generating mechanism quicker than the inhibition of the GnRH surge 
generating mechanism by 10 h, suggests that these two events are regulated 
independently and provides a model that can be used to identify the specific neuronal 
systems that control behaviour distinct from those initiating the GnRH surge. In the 
present thesis, it was not possible to make this comparison, as brain tissue was retrieved 
from insulin-treated animals at a time when the distinction between delayed and non-
delayed animals could not be made. The separate mechanisms might be elucidated by 
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repeating the study with a larger number of animals and more time points for brain 
sampling. 
As successful reproduction requires follicular maturation and oestradiol biosynthesis, 
induction of the LH surge, ovulation, and expression of sexual behaviour to be co-
ordinated within a tight time-frame, the separation observed after a ‘weaker’ stressor 
such as insulin may have detrimental effects on fertility via mechanisms impacting on 
oocyte quality and embryo viability. The effects of insulin on these parameters remain to 
be investigated.  
The reason for the 10h disparity between sexual behaviour and LH surge onsets 
observed after insulin-treatment is not known, however, it is possible that GnRH pulses 
were restored before the pituitary regained sensitivity to GnRH and, therefore, 
behaviour was driven centrally by the GnRH pulses (Caraty et al., 1998, Caraty et al., 
2002). Simultaneous GnRH/LH pulse and oestrus monitoring, although practically 
challenging, could help to elucidate this point.  
How does the application of acute stressors in the late follicular phase effect peripheral 
hormone concentrations?  
Oestradiol 
In both studies, plasma oestradiol concentrations in control animals were elevated by 
~28h, reached a maximum at ~32h-36h after PW and then began to decrease just as the 
LH surge occurred. In study 1, oestradiol concentrations decreased after either stressor, 
and remained low for a period equivalent to the LH surge delay. It is, therefore, 
hypothesised that when a stressor is applied during the late follicular phase, the 
duration of the LH surge delay is related to the duration of oestradiol signal disruption. 
Interestingly, Insulin-non-delayed ewes had two types of oestradiol profiles, with some 
ewes appearing to be unaffected by treatment, whilst others had a sudden decrease in 
concentrations followed by a quick recovery. In study 2, oestradiol concentrations 
decreased within 2h after insulin treatment, but only after 8h following LPS 
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administration. The reason for this time lag in oestradiol decrease between the two 
stressors is not known, however, this finding suggests that the mechanisms of GnRH/LH 
pulse inhibition after the two stressors may be different.  
Progesterone 
In control animals, progesterone concentrations were decreased by 16h after PW and 
remained low during the follicular phase. In study 1, insulin-delayed and LPS groups had 
an increase in progesterone concentrations and this subtle change may have been one 
of the mechanisms by which all sexual behaviours and the LH surge were blocked in 
these groups. In addition, an increase in progesterone (probably of adrenal gland origin) 
was the only stress-hormone difference between insulin-delayed and insulin-non-
delayed sub-groups, indicating that this steroid may play an important role in stress-
induced disruption of reproductive parameters. 
Cortisol 
Cortisol increased to maximum concentrations 2h after administration of insulin or LPS 
in both studies. This increase was greater after LPS treatment indicating that this may be 
a ‘stronger’ stressor than insulin. Interestingly, cortisol increased in an identical fashion 
between insulin-delayed and insulin-non-delayed animals in study 1. This unexpected 
finding provides direct evidence that cortisol is not a key disruptor of either the LH surge 
or sexual behaviour after insulin administration in intact ewes.   
What neuronal pathways control sexual behaviour in the ewe? 
ERα-cell activation in the VMN coincides with the exhibition of sexual behaviours 
supporting existing evidence that the VMN is involved in behavioural regulation (Chapter 
4; Blache et al., 1991). As 70% of ERα-containing cells in the VMN synthesise 
somatostatin (Herbison, 1995), it is plausible to speculate that this neuro-phenotype 
may be involved, but this requires further investigation. In Chapter 6, the percentage of 
activated dopamine neurones in the middle and caudal ARC was greater in the early 
follicular phase but decreased before and during sexual behaviour and the LH surge. It is, 
therefore, probable that progesterone, via dopamine, acts as a brake on the neuronal 
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circuits mediating the expression of sexual behaviour. Thereafter, increasing oestradiol 
concentrations overcome dopamine inhibition and sexual behaviour is initiated 12h 
later. Indeed, 20% of dopamine neurones provide input towards the VMN (Qi et al., 
2008) and could be a possible pathway for the control of female sexual behaviour. 
However, the cells that receive dopaminergic input within the VMN remain to be 
elucidated. It would be of great interest to determine whether somatostatin cells 
contain dopamine receptors and/or receive contact from dopaminergic fibres. 
Alternatively, as ERα-cells in the ARC become transcriptionally active before the 
activation of ERα-cells in the VMN and the concurrent exhibition of sexual behaviours, 
dopamine may act locally and transmit the disinhibiting signal to the VMN via unknown 
ARC inter-neurones.  
What neuronal pathways control the GnRH surge in the ewe?  
Activational patterns of neuro-phenotypes in the ARC at various stages during the 
follicular phase leading up to the GnRH/LH surge in intact ewes are shown in Fig. 1. In 
follicular phase ewes, ERα-cell activation was maximum during the LH surge in the ARC, 
VMN and mPOA indicating a role for these areas in oestradiol positive feedback and 
GnRH surge secretion. However, ERα-cells in the ARC are the first to become 
transcriptionally active (~6-7h before the expected surge onset), indicating that the 
surge induction process begins in this area, possibly when increasing oestradiol 
concentrations reach a specific ‘threshold’. Signals may then be transmitted to the VMN 
and mPOA (Chapter 4). Chapter 5 provides evidence that this activation pattern in the 
ARC may reflect KNDy neurone activation and confirms that these cells play an 
important role in the generation of the GnRH surge mechanism. However, the balance 
of neuropeptide expression within this cell population appears to vary throughout the 
late follicular phase; initially (~6-7h before the expected surge onset), there is a shift of 
the net balance towards inhibitory dynorphin followed by a swing towards excitatory 
kisspeptin presumably facilitated by neurokinin B (during the surge).  As KNDy cells send 
projections towards the mPOA (Lehman et al., 2010) and ME (Amstalden et al., 2005, 
Smith et al., 2011), these signals may be directly or indirectly transmitted to GnRH cell 
bodies and/or terminals. Further studies, using in situ hybridisation at various times in 
the follicular phase to detect potential differences in the expression patterns of 
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dynorphin and kisspeptin, would be beneficial in furthering these findings. Other 
neuronal changes during the GnRH surge include a decrease in β-endorphin and an 
increase in NPY and somatostatin activation in the ARC as well as an increase in 
somatostatin in the VMN and kisspeptin in the mPOA. These results are, therefore, 
consistent with a role for kisspeptin during the surge but do not implicate this cell type 
in the early stages of surge activation. In contrast, dynorphin appears to have this role, 
as dynorphin containing cells are activated prior to the surge (but not during), and 
possibly constitutes a very early step in a chain of events leading to the GnRH surge in 
the ewe.  
What neuronal pathways are activated for the disruption of sexual behaviour after the 
application of acute stressors in the late follicular phase? 
Dopamine facilitates the expression of sexual behaviour while oestradiol concentrations 
are low but is inhibitory once oestradiol values increase above a threshold (Fabre-Nys et 
al., 2004). This may constitute a potential pathway for the stress-induced suppression of 
sexual behaviour. However, LPS or insulin did not alter dopamine activation in the ARC 
and, therefore, it remains to be established whether other dopamine populations, such 
as those in the PVN, may account for the disruption. Cortisol increased to maximum 
concentrations immediately after the administration of LPS or insulin (i.e., 2h after 
treatment) and this steroid is, therefore, a potential candidate for the inhibition of 
sexual behaviours. However, cortisol is able to inhibit oestradiol-induced sexual 
receptivity (i.e., oestrus) but not other components of sexual behaviour that were also 
disturbed in the present studies (Pierce et al., 2008, Papargiris et al., 2011). Therefore, 
cortisol may contribute, but cannot be the sole mediator of stress-induced disruption of 
sexual behaviour. A small increase was observed in plasma progesterone concentrations 
after LPS (study 1 and 2) and insulin-delayed (study 1) animals. This subtle change may 
be the main mechanism by which all sexual behaviours were blocked (Scaramuzzi et al., 
1971, Fabre-Nys 1998, Fabre-Nys and Gelez 2007). However, the neuroendocrine 
centres which are targets for progesterone, and are activated to inhibit sexual 
behaviour, remain to be elucidated.  A potential role for dopamine is proposed. 
Performing microdialysis in the MBH during stress-induced disruption of sexual 
behaviour could shed some light on this aspect. 
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What neuronal pathways are activated for the disruption of the GnRH surge after the 
application of acute stressors in the late follicular phase? 
The neuroendocrine alterations observed in the present studies after insulin or LPS are 
shown in Table 1. Insulin or LPS administration in the late follicular phase disturbed the 
majority of the neuronal activation patterns investigated. Our results suggest that these 
two stressors activate common as well as stress-specific inhibitory pathways. 
Interestingly, in study 2, some split responses were observed in certain parameters after 
insulin-treatment. As this division reduced the group size to n=2/group, statistical 
analysis was not undertaken, but the data are presented for information. Further studies 
with a larger number of animals should confirm these findings. The main split response 
observed involved two insulin-treated animals showing an intense c-Fos activation in the 
PVN (insulin-responders) whereas the other two were not different to controls (insulin-
non-responders). A similar divergence was observed in study 1. Taking into account the 
fundamental importance of the PVN in response to stress (Antoni, 1986), it is speculated 
that the animals with no activation in the PVN would have gone on to have an LH surge 
at a similar time as the controls, whereas the others would have had a delayed surge. 
Even though the reasons for these split responses are not yet clear, this unexpected 
finding provides information about which alterations are involved in the stress-induced 
disruption of the LH surge. Interestingly, cortisol concentrations increased equally in 
both insulin sub-groups. The reason for this divergence is not known, and it is 
particularly interesting that even though PVN activation did not occur, plasma cortisol 
concentrations were elevated. In this aspect, Tilbrook and Clarke (2006) discuss the 
existence of individuals that are more sensitive to the negative feedback of 
glucocorticoids, resulting in stress hypo-responsiveness. Thus, insulin may be a less 
severe stressor than LPS, and certain individuals being more stress-resilient, are able to 
recover from the stress axis activation very quickly.  
 
Our results indicate that KNDy cells are targets of immune/inflammatory and metabolic 
stressors. LPS treatment was accompanied by a failure of dynorphin neurone activation 
whereas, insulin prevented dynorphin activation in insulin-responders only. Dynorphin 
inhibition in the ARC is, therefore, a common parameter between LPS and insulin-
responders and may be important in disrupting a necessary chain of events leading to 
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the GnRH surge. A split response was also observed in somatostatin activation in the 
VMN: these cells were activated in LPS and insulin-responders but not insulin-non-
responders. In rats, somatostatin is one of the most potent inhibitors of electrical 
excitability of GnRH neurones identified thus far (Rotsztejn et al. 2002, Bhattarai et al., 
2010) and inhibits the LH surge when administered centrally (Van Vugt et al. 2003). It is, 
therefore, possible that somatostatin cells are activated via an unknown mechanism to 
mediate stress-induced disruption of the LH surge. 
In the present study, we have shown, for the first time in the ewe, that there is an 
abundance of CRFR type 2 in the lower part of the ARC and the ME. In addition, 21% 
kisspeptin cells express this type of receptor and that doubled after LPS treatment. This 
indicates that CRFR type 2 may be involved in down-regulation of kisspeptin 
transcriptional activation. However, there was a large number of CRFR type 2 that co-
localised with cells of unknown phenotype. There are, therefore, two possible pathways 
for CRF suppression of GnRH, one being the direct association of CRF and GnRH cell 
terminals in the external zone of the ME (Ghuman et al., 2010) and the other being the 
regulation of kisspeptin and other cell types in the ARC and ME via CRFR type 2.  
Interestingly, insulin increased kisspeptin, NPY, β-endorphin and somatostatin activation 
as well as overall c-Fos activation in the ARC in both sub-groups. This appears to be an 
insulin-specific response as the ARC plays a pivotal role in glucose-sensing and energy 
balance (Cone et al., 2001; Routh, 2003). Reciprocal connections have been identified 
between kisspeptin-NPY-POMC cells (Backholer et al., 2010). This network between the 
three cell types could co-ordinate reproduction and metabolic homeostatic systems. The 
present data suggest that somatostatin may also participate in this network. However, 
as these changes were observed in insulin-non-responders, they may not be disruptive 
to the LH surge. 
Cortisol and progesterone suppress pulsatile GnRH/LH secretion (Karsch et al., 1987, 
Debus et al., 2002, Oakley et al., 2009) and disrupt the positive feedback effect of 
oestradiol to trigger an LH surge (Kasa-Vubu et al., 1992, Skinner et al., 1998, Richter et 
198 
 
al., 2002, Smith et al., 2003, Richter et al., 2005, Pierce et al., 2009, Wagenmaker et al., 
2009a). However, as mentioned above, cortisol responses were similar between insulin 
sub-groups in both studies, indicating that this steroid is not the key disruptor of the LH 
surge, at least after insulin treatment. The only observed hormonal difference between 
delayed and non-delayed groups was a subtle increase in plasma progesterone (Chapter 
2), indicating that this may be an important inhibitory mechanism leading to the 
disruption of the LH surge.  
Finally, it is clear that the approaches taken in this thesis have expanded understanding 
of events in both control and stressed ewes. Studying activation of several neuro-
phenotypes at various times in the follicular phase with or without exposure to different 
stressors has made it possible to identify key steps in the control of stress-induced 
disruption of sexual behaviour and the GnRH/LH surge. 
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Fig. 1 Activational patterns of neuro-phenotypes in the ARC at various stages during the 
follicular phase relative to sexual behaviour and the GnRH/LH surge in intact ewes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kisspeptin/Neurokinin B 
Dynorphin 
Dopamine 
β-Endorphin 
Neuropeptide Y 
Somatostatin 
  0h                               16h                              29h                      37h              40h  (h after PW) 
Before 
behaviour 
After 
behaviour  Surge 
  0h                               16h                              29h                       37h              40h  (h after PW) 
Before 
behaviour 
After 
behaviour  Surge 
  0h                               16h                              29h                       37h              40h  (h after PW) 
Before 
behaviour 
After 
behaviour  Surge 
  0h                               16h                              29h                      37h              40h  (h after PW) 
Before 
behaviour 
After 
behaviour  Surge 
  0h                               16h                              29h                      37h              40h  (h after PW) 
Before 
behaviour 
After 
behaviour  Surge 
200 
 
Table 1. Effect of insulin or LPS administration during the late follicular phase of intact 
ewes on various hormonal, behavioural and neuropeptide parameters. 
Parameters 
Insulin-non-
responders 
Insulin-responders LPS 
Sexual behaviour = delayed delayed 
LH surge = delayed delayed 
Oestradiol 
↓ followed by a quick 
↑ 
↓ ↓ 
Progesterone = ↑ ↑↑ 
Cortisol ↑ ↑ ↑↑ 
Glucose ↓↓ ↓↓ ↓ 
c-Fos activation of the PVN = ↑ ↑↑ 
c-Fos activation of the ARC ↑ ↑ ↑ 
c-Fos activation of the VMN = ↑ ↑ 
c-Fos activation of the mPOA = = ↑ 
c-Fos activation of the ME = = = 
c-Fos activation of the BNST = = = 
c-Fos activation of the dBb = = ↑ 
% ERα-cell activation (ARC) = = ↓ 
% ERα-cell activation (VMN) = ↑ = 
% ERα-cell activation (mPOA) = ↓ ↓ 
% kisspeptin activation (ARC)* ↑ ↑ ↓ 
% kisspeptin activation (mPOA)* =  =  ↓ 
% dynorphin activation (ARC) = ↓ ↓ 
% neurokinin B activation (ARC) = = = 
% dopamine activation (ARC) = = = 
% β-endorphin activation (ARC) ↑ ↑ = 
% NPY activation (ARC) ↑ ↑ = 
% somatostatin activation (ARC) ↑ ↑ = 
% somatostatin activation (VMN) = ↑↑ ↑ 
Key: =no change compared to controls, ↓decrease compared to controls, ↑increase compared to  
            controls. Two arrows indicate a greater response in the particular parameter compared to the other  
            stressor. ** Decrease in the % kisspeptin activation was observed only 12h after LPS treatment,  
            whereas there was no equivalent measurement for insulin-treated animals. Differences between    
            insulin-responders or insulin-delayed and insulin-non-responders or insulin-non-delayed are  
            highlighted for emphasis.   
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Appendix 
 
Α) TISSUE PREPARATION-PERFUSION FIXATION 
Perfusion-fixation allows tissue to be fixed via the vascular system. Tissue should be 
fixed within several minutes of anoxia to prevent antigen degradation and to provide 
optimal staining. The procedure commonly washes blood from the vasculature before 
introducing the fixative.  
Method of perfusion fixation. 
1. Euthanasia: 20ml pentobarbital plus 25,000iu heparin (1 vial). 
2. Head retrieval: Each head was retrieved immediately, jugular veins occluded and 
perfused bilaterally via the carotid arteries using a peristaltic pump. 
3. Flush/blood vessel dilation: A total of 2 litres comprising: 
 2 litres phosphate buffer (pH 7.4; see later)  
 + 25,000iu heparin/ml (2 vials) 
 + 1% sodium nitrite. 
4. Zamboni’s fixative: Total 2 litres comprising: 
 200ml paraformaldehyde (4%; powder 
form) 
 + 150 ml picric acid (7.5%) 
 + 1650 phosphate buffer  
5. Zamboni’s + sucrose flush: Total 0.5 litres comprising: 
 0.5 litres Zamboni’s fixative 
 + 150 g sucrose (30%) 
6. The brain was left within the skull for a further 4 h  
7. PB sucrose wash-out:  Total 0.5 litres comprising: 
 0.5 litres phosphate buffer 
 + 200g sucrose (40%) 
 + 0.5g sodium azide (0.1 %)  
8. Dissect out the brain, cutting the cranial nerves 
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9. Retrieve a 17mm hypothalamic block (extending from the optic chiasma to the 
mammilary bodies).  
10. Immerse tissue in wash-out solution: at 40C for a week.  
11.  Freeze hypothalamic blocks  using isopentane and liquid nitrogen as described 
by Rosene et al. (1986)  
12. Store at -800C. 
Method of tissue sectioning 
 Thaw hypothalamic blocks in wash-out solution. 
 Place the tissue on the stage of the microtome and freeze with dry ice. Section at 
a thickness of 40μm and collect the sections from the knife blade with a buffer-
moistened brush. 
 Store sections in 96-well microtest plates with each section placed in an 
individual well filled with cryoprotectant solution (see later for recipe). 
 Store at -800C until processed for immunohistochemistry.  
 
B) IMMUNOSTAINING TECHNIQUES 
Immunohistochemistry, enzyme method for free-floating sections. 
1. Wash in PBS: for 2h and 4 changes. This wash is important because it removes 
cryoprotectant solution. 
2. Peroxidase Blocking: 1% H2O2, 40% methanol, in PBS. 
 For 15 min, in room temperature.  
For example: to make up 250 ml 
100 ml methanol 
8.35ml of H2O2 30% solution 
141.65 ml of PBS.  
3. Wash in PBS: 3 changes 5 minutes each 
4. Block with donkey serum: 10% in PBS.  
For 1h at room temperature. During this step primary antibody dilution can be 
done, ready to apply when this incubation is finished. 
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For example: to make up 50 ml 
5ml donkey serum 
in 45 ml PBS. 
5. Incubation in primary.   
A list of primary antibodies and dilutions are shown in Table 1. 
For 3 days in 40C.  
Dilute in antibody diluting solution (recipe below). If double-staining then always 
apply the nuclear stain first (i.e. c-Fos or ERα). 
6. Wash in PBS: for 2h and 4 changes. This wash is important because it removes 
unbound antibody. 
7. Incubate in biotinylated donkey anti-rabbit IgG:  
(Anti-Rb) if primary is raised in rabbit or (Anti-Mo) if primary is raised in mouse.  
Dilution 1:500. Adjust accordingly if background is too high or immunostaining 
too weak. Dilute in antibody dilution solution (recipe below).  
For 2h at room temperature.  
Make up your ABC solution for next step. 
8. Wash in PBS: 3 changes 5 minutes each 
9. Incubate in Vectastain Elite ABC kit. 
Needs to be made up at least half an hour before applied. 
Usual dilution 1:250. Adjust accordingly if background is too high or 
immunostaining too weak. Dilute in PBS. 
 For 1.5h in room temperature. There are 2 solutions A and B put in equal 
amounts and dilute in PBS. 
10. Wash in PBS: 3 changes 5 minutes each.  
11. Apply ni-DAB (black reaction product) or DAB alone (brown reaction product).  
Make up according to instructions. 
Incubate for 5min at room temperature. 
12. Wash in PBS: 3 changes 5 minutes each.  
Last wash in distilled water. 
13. Repeat from peroxidase blocking step, to stain for the second antibody or 
continue to next step if staining is completed. 
14. Mount sections: on chrome alum gelatine coated slides (recipe below). 
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15. Dry sections: for 3 days, covered to avoid dusting. 
16. Dehydrate in a series of solutions. Ethanol diluted in distilled water: 70%, 85%, 
96%, 100%, 100%, 100%, then Xylene.   
For 5 min in each solution. Carried out under a fume cupboard.  
17. Cover slip in DPX and store in room temperature.  
 
Immunofluorescence for free-floating sections. 
1. Wash in PBS: for 2h and 4 changes. This wash is important because it removes 
cryoprotectant solution. 
2. Block with donkey serum: 10% in PBS.  
For 1h at room temperature. During this step primary antibody dilution can be 
done, ready to apply when this incubation is finished. 
For example: to make up 50 ml 
5ml donkey serum 
in 45 ml PBS. 
3. Incubation in primary.   
A list of primary antibodies and dilutions are shown in Table 1. 
For 3 days in 40C.  
Dilute in antibody diluting solution (recipe below). If double-staining then always 
apply the nuclear stain first (i.e. c-Fos or ERα). 
4. Wash in PBS: for 2h and 4 changes. This wash is important because it removes 
unbound antibody. 
5. Incubate in secondary antibody: From here onwards cover to protect from 
light. 
(Anti-Rb) if primary is raised in rabbit or (Anti-Mo) if primary is raised in mouse.  
Dilution 1:500. Adjust accordingly if background is too high or immunostaining 
too weak. Dilute in antibody dilution solution (recipe above).  
For 2h at room temperature.  
6. Repeat from first washing step, to stain for the second antibody or continue to 
next step if staining is completed. 
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7. Wash in PBS: 3 changes 5 minutes each.  
Last wash in distilled water. 
8. Mount sections: on chrome alum gelatine coated slides (recipe below). 
9. Dry sections: for 10-20 min 
10. Cover slip with Anti-fade mounting medium and store in 40C.  
 
Triple Staining Method; combination of DAB and fluorescence staining for free-floating 
sections.  
This method consisted of an immunoperoxidase protocol in which nuclear c-Fos was 
detected first with diaminobenzidine as chromogen (DAB; brown reaction product) 
followed by visualisation of dynorphin and kisspeptin with immunofluorescence. As 
dynorphin and kisspeptin antibodies were of rabbit origin, we used a previously 
described modified protocol (Hunyady et al., 1996, Goodman et al., 2007, Cheng et al., 
2010). In brief, the first antigen was visualised using a very low concentration of primary 
antibody with tyramide amplification solution (TSA). Next, the second antigen was 
visualised using normal concentrations of primary antibody and detection with 
fluorophore-conjugated secondary antibody.  
 
1. Wash in PBS: for 2h and 4 changes. This wash is important because it removes 
cryoprotectant solution. 
2. Peroxidase Blocking: 1% H2O2, 40% methanol, in PBS. 
 For 15 min, in room temperature.  
For example: to make up 250 ml 
100 ml methanol 
8.35ml of H2O2 30% solution 
141.65 ml of PBS.  
3. Wash in PBS: 3 changes 5 minutes each 
4. Block with donkey serum: 10% in PBS.  
For 1h at room temperature. During this step primary antibody dilution can be 
done, ready to apply when this incubation is finished. 
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For example: to make up 50 ml 
5ml donkey serum 
in 45 ml PBS. 
5. Incubation in Anti-c-Fos.   
Recommended dilution is 1:5000. For 3 days in 40C.  
Dilute in antibody diluting solution (recipe below).  
6. Wash in PBS: for 2h and 4 changes. This wash is important because it removes 
unbound antibody. 
7. Incubate in biotinylated donkey anti-rabbit IgG:  
Dilution 1:500. Adjust accordingly if background is too high or immunostaining 
too weak. Dilute in antibody dilution solution (recipe below).  
For 2h at room temperature.  
Make up your ABC solution for next step. 
8. Wash in PBS: 3 changes 5 minutes each 
9. Incubate in Vectastain Elite ABC kit. 
Needs to be made up at least half an hour before applied. 
Usual dilution 1:250. Adjust accordingly if background is too high or 
immunostaining too weak. Dilute in PBS. 
 For 1.5h in room temperature. There are 2 solutions A and B put in equal 
amounts and dilute in PBS. 
10. Wash in PBS: 3 changes 5 minutes each.  
11. Apply ni-DAB.  
Make up according to instructions. 
Incubate for 5min in room temperature. 
12. Wash in PBS: 3 changes 5 minutes each.  
13. Repeat steps 2-4. 
14. Incubate in Anti-kisspeptin. 
Recommended dilution is 1:150000. For 3 days in 40C.  
Dilute in antibody diluting solution (recipe below). 
15. Repeat steps 7-10.  
16. Incubate in TSA. 
This step amplifies the kisspeptin protein signal. 
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Recommended dilution 1:200. For 10min in room temperature. 
Dilute in PBS with 0.003% H2O2 as substrate. 
17. Incubate in Streptavidin conjugated fluorophore. From here onwards cover to 
protect from light.  
Recommended: Streptavidin Conjugated AlexaFluor 488 at a dilution of 1:100 for 
2h. 
18. Repeat steps 3-4. 
19. Incubate in Anti-dynorphin. 
Recommended dilution is 1:10000. For 3 days in 40C.  
Dilute in antibody diluting solution (recipe below). 
20. Wash in PBS: 3 changes 20 minutes each.  
21. Incubate in secondary fluorophore. 
Recommended: Cy3 at a dilution of 1:500 for 2h. 
22. Wash in PBS: 3 changes 5 minutes each.  
Last wash in distilled water. 
23. Mount sections: on chrome alum gelatine coated slides (recipe below). 
24. Dry sections: for 10-20 min 
25. Cover slip with Anti-fade mounting medium and store in 40C.  
 
 
 
 
 
 
 
 
 
210 
 
 
 
Table 1. Dilution, source of purchase and references, that verify use in ovine neuronal 
tissue, of primary antibodies used in the present thesis.  
 
 
 
 
 
 
 
 
 
Antibody Host Dilution Source Reference 
Anti-c-Fos Rabbit 1:5000 Calbiochem Ghuman et al., 2011 
Anti-ERα Mouse 1:50 DAKO Franceschini et al., 2006 
Anti-TH Mouse 1:20000 Millipore Robinson et al., 2010 
Anti-NPY Rabbit 1:5000 Sigma 
Skinner and Herbison, 
1997 
Anti-Kisspeptin Rabbit 1:25000 Prof. Alain Caraty Franceschini et al., 2006 
Anti-Dynorphin A Rabbit 1:10000 
Peninsula 
Laboratories 
Goodman et al., 2007 
Anti-Neurokinin B Rabbit 1:1000 
Peninsula 
Laboratories 
Goodman et al., 2007 
Anti-Somatostatin Rabbit 1:500 
Peninsula 
Laboratories 
Robinson et al., 2010 
Anti-β-Endorphin Rabbit 1:500 
Peninsula 
Laboratories 
Ghuman et al., 2011 
Anti-CRFR type 2 Rabbit 1:4000 Abcam Lakshmanan et al. 2007 
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C) BUFFERS AND SOLUTIONS 
Sodium Phosphate Buffer (PB 0.1M) 
This buffer was made by mixing the two following stock solutions: 
Stock A 
0.2M Sodium di-hydrogen orthophosphate 1-hydrate  
 [Dissolve 27.6 gr NaH2PO4 1H2O (Mol. Wt. = 137.99)/litre of distilled water] 
Stock B 
0.2M Di-sodium hydrogen phosphate (anhydrous) 
[Dissolve 28.4 gr Na2HPO4 (Mol. Wt. = 142)/litre of distilled water] 
Mixing System 
For pH 7.2 sodium phosphate buffer, mix: 
Volume required 
(ml) 
Stock A (ml) Stock B (ml) Distilled water (ml) 
100 14 36 50 
1000 140 360 500 
3000 420 1080 1500 
5000 700 1800 2500 
 
Phosphate Buffered Saline (PBS 0.1M) 
This buffer solution was made up by adding 0.9% Sodium Chloride (NaCl) to the PB 
solution as prepared above.  
Cryoprotectant solution 
To make 1l stir and dissolve the following: 
 500 ml PB (0.1M) 
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 300gr Sucrose. Stir to dissolve. 
 10gr Polyvinylpyrrolidone (PVP-40). Stir to dissolve. 
 300ml ethylene glycol. Stir to dissolve. 
Adjust final volume to 1000ml with distilled water.  
Antibody Diluting Solution 
All antibodies were diluted with the following solution: 
 2.5% Normal Donkey Serum 
 1% Triton 
 0.25% Sodium Azide 
A large volume of this solution can be made and stored at 4oC. 
Chrome Alum Gelatine Coating for slides 
 Add 1gr Gelatine in 200 ml distilled water. Warm and stir to dissolve 
 Add 0.19gr Chrome Alum. Stir to dissolve. 
 Add 0.5gr Sodium Azide. Stir to dissolve. 
 Filter and store at room temperature.  
Dip clean (grease free) slides in the solution and leave to dry at room temperature for 
about 6 h, covering to keep dust-free. Once dried, slides can be packed together and this 
will not damage the coating.  
D) SHEEP BRAIN ATLAS 
Cressyl Fast Violet  
Preparation of stain 
Add 0.25gr of Cressyl fast violet in 100 ml of distilled water. The solution was dissolved 
by stirring and heating and then filtered. 5 drops of acetic acid was added to 100 ml of 
solution.  
 
Diluted in PBS (0.1M) 
213 
 
Method 
Slides were left in the above solution for 10 minutes in an oven at 600C. They were then 
rinsed in distilled water, differentiated in 96%, 100% alcohol and cleared in xylene. 
Finally slides were cover slipped with DPX.  
Sample sections from the sheep brain atlas are shown in Fig. 1. For the whole atlas 
please refer to the C.D. accompanied with the thesis. 
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Fig. 1 Sections 05 (a) and 28 (b) of the sheep brain atlas. The atlas consists of 34 consecutive sections, 
50 μm thick and 0.5 mm apart, extending from the optic chiasma to the mammilary bodies. 
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